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The interaction between molecules is the principle of life. The impressive 
network of cellular functions is regulated by a fine and complex interplay of 
several molecules, each of them playing a role at more than one node in the 
network. Such interactions are possible thanks to the structural plasticity of 
proteins, nucleic acids and small organic molecules, which can assume a large 
variety of three dimensional shapes and can present to the external world pockets 
and surfaces with different electrostatic and hydrophobic properties. Structural 
biology has been flourishing for the past two decades as the technique of choice to 
understand the mechanism of molecular recognition. The goal of the massive 
effort made in the past years in the structural characterization of molecules and 
complexes is to collect the necessary knowledge to unravel the secrets of 
molecular recognition. This effort has led to extraordinary successes, as the 
determination of the ribosome structure (Ramakrishnan, & Moore, 2001). 
Structural knowledge can be applied to design strategies for interfering with the 
molecular interaction at the cellular level, thereby influencing the cell life cycle. 
Besides the early established X-ray crystallography, other techniques are 
employed in structural biology. Among these, Nuclear Magnetic Resonance 
(NMR) can deliver structural information at atomic level, while Fluorescence 
Resonance Energy Transfer (FRET) or the recently blooming Electron 
Microscopy (EM) are used to obtain structural constraints on large systems at 
lower resolution.  
Solution NMR has experienced great progresses in the past two decades. While 
the upper limit in the size of the complexes that can be studied by NMR is limited 
with respect to X-ray crystallography, NMR offers the advantage to study the 
system in aqueous solution, where the conformational dynamics of the interacting 
molecules is conserved. Next to solution NMR, solid-state NMR, in the past 
almost exclusively used in material science, is gaining way in the study of 
biological systems, especially membrane proteins, thanks to recent 
methodological developments (Luca et al., 2003).  
In this work we study the molecular recognition mechanism in three biological 
systems via solution NMR: a) the protein tubulin in complex with the 
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microtubules stabilizing agent epothilone; b) the small peptidic toxin κM-
conotoxin RIIIK, derived from the sea snail Conus radiatus, in complex with K+ 
channels; c) the 30mer HIV TAR-RNA in complex with an aminoglycoside 
derivative.  
A large part of this work is dedicated to understand the mechanism of the 
conformational control exerted by small organic molecules on the protein tubulin. 
Several cellular processes, such as cell division, cell motility, cell transport and 
cell shape see tubulin as a major player (Nogales, 2001). The protein exists in a 
dynamic equilibrium between a hetero-dimeric form, constituted by α− and 
β−tubulin subunits, and a polymeric form, termed “microtubules”. Microtubules 
exert their cellular functions by interacting with other proteins, which affects their 
regulation and distribution within the cell. Any perturbation of the delicate 
equilibrium between the polymeric and dimeric forms of tubulin results in a 
strong perturbation of cellular function.  
Tubulin is an important target in cancer therapy. Tubulin-binding drugs can 
dramatically interfere with the tubulin polymerization equilibrium and therefore 
exhibit profound cytotoxic activity. One of the most important clinical anticancer 
drugs is the natural product paclitaxel (Taxol®), which inhibits human cancer cell 
growth through the stabilization of cellular microtubules. Over the last few years a 
diverse set of other (non-taxane) natural products from a variety of sources have 
been established to share the taxanes ability to stabilize microtubules (Altmann, 
2001), including epothilones A and B, discodermolide, eleutherobin, sarcodictyins 
A and B, laulimalide, peloruside A (Hood et al., 2002), and taccanololides E and 
A (Tinley et al., 2003). Other natural products, as dolastatin (Beckwith et al., 
1990), colchicine (Downing & Nogales, 1998), vinblastine (Wilson et al., 1982) 
and tubulysin (Sasse et al., 2000), have been found to destabilize microtubules, 
thereby exhibiting cytotoxic activity.  
Here, we have studied the basis of the interplay between tubulin and the potent 
microtubule stabilizing agent epothilone (Höfle et al., 1993). The scope of this 
work is to provide a framework to understand the mechanism of the 
conformational control exerted by epothilones on the tubulin polymerization 
equilibrium. NMR is particularly suited for this purpose, as tubulin is a highly 
dynamic molecule, which so far escaped crystallization in a physiologically 
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relevant form. The results presented here point to a complex network of binding 
events and conformational changes, which regulates the tubulin polymerization 
equilibrium. In contrast to the biological data, which fail to detect the binding of 
the microtubules stabilizing agents (MSAs) to non-polymerized protein, our data 
show that the binding of the MSAs, like epothilone and discodermolide, to soluble 
tubulin is the first event in the process of microtubules stabilization. In this work 
we have determined the conformation of epothilone bound to non-polymerized 
tubulin and the binding mode of the drug to the protein. The structural information 
obtained for the tubulin/epothilone complex allows us to propose a functional 
mechanism to explain the cytotoxic activity of epothilones. When compared to the 
electron crystallography (EC) data, obtained on tubulin artificially polymerized on 
Zn-stabilized sheets, the NMR results indicate that the binding mode of epothilone 
to tubulin depends on the polymerization state of the protein. This underlines the 
necessity of studying macromolecular complexes in solution, namely in an 
environment as close as possible to the physiological one. In order to gain the 
structural information necessary to define the structure of the epothilone/tubulin 
complex, we developed new NMR methodologies, which are broadly applicable 
to other ligand/receptor complexes in the process of structure-based drug design.  
The second part of this work focuses on the interaction between the small peptidic 
toxin κM-conotoxin RIIIK, derived by the sea snail Conus radiatus, and K+ 
channels. Because of their diverse physiological functions in excitable and 
nonexcitable cells, ion channels are targets of toxins from venomous organisms, 
including snakes, scorpions, sea anemones, and spiders. Despite the structural 
divergence of unrelated K+ channel targeted toxins, a convergent functional 
feature has been identified for a variety of toxins, including charybdotoxin from a 
scorpion, BgK from a sea anemone, and dendrotoxin from snakes. Although for 
the different toxins more than one site has been identified as being important for 
binding (Miller, 1995; Eriksson & Roux, 2002; Gao & Garcia, 2003), all these 
peptides share a dyad motif of a lysine and a hydrophobic, usually aromatic, 
residue, which plays a key role in the interaction with the target K+ channel 
(Stampe et al., 1994; Dauplais et al., 1997; Savarin et al., 1998; Gilquin et al., 
2002; Srinivasan et al., 2002). In particular, there is evidence that the lysine 
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residue of this functional dyad occludes the K+ channel pore (Miller, 1995; 
Eriksson & Roux, 2002; Gao & Garcia, 2003).  
Peptidic neurotoxins from the venomous cone snails (“conotoxins”) are well-
known, highly subtype-selective ligands that interact with a variety of different 
voltage-gated and ligand-gated ion channel targets. Here, we have conducted an 
extensive interdisciplinary study to characterize the interaction of a novel Conus 
peptide ligand, κM-conotoxin RIIIK (κM-RIIIK), with K+ channels. By means of 
a combined approach, including functional studies of the point mutated peptide, 
the solution structure of κM-RIIIK determined by NMR, mutant cycle analysis 
and docking calculations, we identified a novel pharmacophore for the blockade 
of voltage-dependent K+ channels by κM-RIIIK, which does not include a 
functional dyad. The binding mode of κM-RIIIK to K+ channels underlines the 
importance of basic residues in peptide toxins and suggests a new role for the 
hydroxyprolin residues present in conotoxins. This work provides a framework 
for a broader understanding of the pharmacological profiles of peptide toxins 
interacting with voltage- and ligand-gated ion channels. 
The third part of this work is dedicated to the trans activation responsive element 
(TAR) of the HIV viral RNA (Frankel, 1992; Jones & Peterlin, 1994). The 
discovery that RNA can exert several functions in the cell life cycle, as for 
example transcriptional control and catalysis, has triggered a wealth of 
biochemical and structural research around RNAs, including the targeting of RNA 
in the drug discovery process. In the human immunodeficiency virus (HIV), the 
interaction of the transcriptional activator protein, Tat, with TAR (Dingwall et al., 
1989; Churcher et al., 1993; Weeks et al., 1990; Weeks et al., 1991) together with 
associated cellular factors (Karn, 1999) is essential for the production of full-
length viral transcripts and, therefore the proliferation of the virus (Frankel, 1992). 
This fact suggests that a compound that binds to TAR-RNA, and prevents binding 
by Tat, could disrupt processive transcription and thereby inhibit viral growth. 
Moreover, a number of recent studies using peptidic and/or antisense agents have 
proved that TAR-binding compounds can show anti-viral activity in HeLa cells, 
apparently via inhibition of transcription (Arzumanov et al., 2001; Mischiati et 
al., 2001; Kaushik et al., 2002). The increasing success of protein structure-based 
drug design, together with recent progress in RNA structure determination, 
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reinforces the imperative to utilize high-resolution structure determination as a 
tool facilitating the process of RNA-targeted drug development. In this work, we 
study the interaction of the HIV-2 TAR-RNA with a cyclic neo aminoglycoside 
obtained via a “total synthesis“ approach. It is well established that small 
positively charged molecules, like aminoglycosides, interact with various RNA 
targets, including the TAR-RNA (Mei et al., 1995 and 1998, Wang et al., 1998; Hamy 
et al., 1998). The toxicity of natural aminoglycosides and the increasing 
development of antibiotic resistance underline the continuous need for new 
compounds that share an aminoglycosidic scaffold but can be easily derivatized to 
obtain drug leads with higher target specificity, less toxicity and activity on 
resistant viral or bacterial strains. The neo aminoglycoside used in this study can 
be obtained via a flexible and efficient total synthesis approach, which allows 
introducing different functional groups on the sugar moieties and 15N or 13C 
labeling for NMR studies. The structural studies on the complex of the HIV-2 
TAR-RNA with this neo aminoglycoside reveal a novel binding mode of the 
aminoglycosidic scaffold to the TAR-RNA, which includes both bulge and loop 
nucleotides of the RNA. The binding of a positively charged ligand to the loop of 
the TAR-RNA had not been observed before and is particularly significant. In fact 
both the bulge and the loop nucleotides of the TAR-RNA are involved in contacts 
with the protein Tat and other associated cellular factors, such as the transcription 
elongation factor P-TEFb, which are essential for viral replication (Dingwall et 
al., 1990; Richter et al., 2002). The P-TEFb complex binds to the loop of the 
TAR-RNA in a Tat dependent manner. However, the mechanism by which the Tat 
protein induces the binding of the P-TEFb complex to the TAR loop is not known. 
In our structural study we observe conspicuous structural rearrangements induced 
in the RNA hexanucleotide loop by the binding of the neo aminoglycoside. Such 
structuring of the TAR-RNA loop, following the binding of a positively charged 
ligand, allows us to propose a mechanism, by which the positively charged, 
arginine rich region of Tat protein structurally prepares the RNA loop for the 
binding of the P-TEFb complex. The structural information obtained in this study 
is leading the design of higher affinity binders, based on a similar 
aminoglycosidic scaffold and containing functional groups that are optimized for 
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TAR binding, which are expected to inhibit the binding of TAR to both the Tat 
protein and the P-TEFb complex.  
This work is organized in three sections, each dedicated to one of the three 
biological systems. All sections contain an introduction to the biological system, 
high-lightening the significance of the structural work, followed by a brief outline 
of the questions we wish to answer. The second chapter describes the employed 
methodology. The results of the structural/functional studies and a critical 
discussion of the outcome is presented in the following two chapters.  In two of 
the three projects, new NMR methodology was developed to answer unsolved 
structural questions. Here a special chapter (Chapter 3 of Part 1 and Chapter 5 of 
Part 3) is dedicated to the development of the novel NMR techniques.  
The first project, dealing with the conformation control exerted by epothilones on 
tubulin, is fruit of a collaboration with the Novartis Institutes for BioMedical 
Research and Prof. Altmann at the ETH, Zürich, who provided the epothilone 
samples and a wealth of expertise on epothilone structure-activity relationship 
data. The interaction of the peptidic toxin κM-RIIIK with the K+ channel was 
studied in collaboration with Dr. Terlau at the University of Lübeck, who 
conducted the functional studies and provided a rich expertise in the ion-channel 
field. The project on the TAR-RNA – aminoglycoside complex is the result of a 
productive collaboration with Prof. Kirschning at the University of Hanover, who 
provided the aminoglycoside analogue sample and continuously supported me in 
the course of my habilitation. All three projects greatly benefited from the 
interaction of my structural biology group with organic chemistry and functional 
biology groups, in a synergic effort aimed to use structural information as a tool to 





Conformational control of tubulin by microtubules 







1.1 The biological system. 
 
The tubulin. Tubulin exerts a fundamental role in several cellular 
processes, such as cell division, cell motility, cell transport and cell shape 
(Nogales, 2001). The protein undergoes a dynamic equilibrium between a hetero-
dimeric form, constituted by α− and β−tubulin subunits, and a polymeric form, 
called “microtubules”. Any perturbation of the delicate equilibrium between the 
polymeric and dimeric forms of tubulin results in a strong perturbation of cellular 
function. Tubulin can only polymerize when GTP is bound to the E site of the β 
subunit, and the nucleotide state of tubulin self-regulates polymerization in cells. 
Further regulation is provided in vivo by several stabilizing and destabilizing 
protein binding partners, such as stathmin, katanin or kin I kinesins.  
Tubulin is an important target in cancer therapy. Tubulin-binding drugs can 
dramatically interfere with the tubulin polymerization equilibrium and therefore 
exhibit profound cytotoxic activity. Paclitaxel (Taxol®), which inhibits cancer 
cell growth through the stabilization of cellular microtubules and interference with 
microtubule dynamics (Jordan, 2002), has become one of the most important 
clinical anti-cancer drugs for the treatment of metastatic breast and ovarian 
cancer, Kaposi’s sarcoma and non-small-cell lung cancer. However, in spite of 
their clinical importance, taxanes are associated with severe side effects 
(Rowinsky, 1997), induce multidrug resistance (MDR), and are ineffective in 
colon and prostate cancer. The overall profile of the taxanes highlights the 
tremendous potential that microtubule-stabilizing agents offer, as well as the need 
to discover agents with fewer side effects and an alternative activity spectrum. 
Over the last few years several other (non-taxane) natural products from a variety 
of sources have been proven to share the taxanes ability to stabilize microtubules 
(Altmann, 2001). Examples of such products are epothilones A and B (EpoA and 
EpoB), discodermolide, eleutherobin, sarcodictyins A and B, laulimalide, 
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peloruside A (Hood et al., 2002), and taccanololides E and A (Tinley et al., 2003). 
In spite of the structural diversity observed within this group of agents, several of 
the compounds have been reported to bind to the same binding site on 
microtubules as paclitaxel (PTX).  
In order to learn about the conformational changes that regulate tubulin 
polymerization, high resolution structural information is of crucial importance. In 
1998 the first three-dimensional structure of tubulin, assembled into two-
dimensional sheets in the presence of Zn ions and including the bound taxane 
docetaxel (Taxotere®), was solved by electron crystallography (Nogales et al., 
1998). In these sheets, protofilaments appear to be similar to those that form 
microtubules (Nogales et al., 1999), but they are associated in an antiparallel 
fashion. This structure has provided a wealth of information on tubulin folding 
and it has revealed a broad and flexible taxane binding pocket, where numerous 
ligands with different shapes could be easily accommodated.  
The paclitaxel binding site is on the inside surface of the microtubule and close to 
areas involved in lateral interactions. The lateral contact between protofilaments is 
characterized by the interaction of loop H1-S2 and helix H3 with the M loop (Fig. 
1.1). It has been proposed that the tubulin polymerization equilibrium is 
controlled by two conformational changes, involving helix H3 and the M loop, 
respectively. First, helix H3 in the primary sequence is preceded by loop T3, 
which binds the γ-phosphate of the E-site GTP. The destabilizing effect that GTP 
hydrolysis has on lateral contacts could be caused by a conformational change in 
the T3 loop, which is successively transmitted to helix H3. Second, the 
microtubule stabilizing effect of paclitaxel may be linked to the drug-mediated 
stabilization of a specific conformation of the M loop, similarly to the stabilizing 
effect exerted on the M loop by the long S9-S10 loop present in the α subunit. 
However, recent work of the Knossow and Nogales laboratories (Ravelli et al., 
2004; Gigant et al., 2005; Wang & Nogales, 2005) suggests that microtubules 
stabilization occurs via straightening of the curvature at the α and β units interface 
in protofilaments. Curved protofilaments cannot form appropriate lateral contacts 
and therefore do not assemble in microtubules; on the other hand straigtht 
protofilaments can associate laterally and assemble in microtubules. The curvature 
of the protofilaments is brought about by small rearrangements in the relative 
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orientation of the three subunits domains (the N-terminal domain nucleotide-
binding domain, the intermediate domain and the C-terminal domain) and by local 
structural differences. In particular a 2.5 Å translation of the helix H7 in the β 
subunit, which drags along the H6-H7 loop and the helix H6, is the major player 
in determining the curvature at the interface between heterodimers (Fig. 1.2). The 
binding of GTP has been proposed to regulate the equilibrium between the 
straight and bent tubulin conformations by blocking the H7 lever helix in its 
straight conformation through interaction with the N-terminal end of this helix. 
Thus, the regulation of the polymerization equilibrium of tubulin by GTP and 
tubulin-binding drugs is likely to be based on subtle conformational transitions 
brought about by intermolecular interactions. 
Understanding the mechanism of the conformational changes that regulate tubulin 
polymerization and how this mechanism is influenced by tubulin binding drugs is 
a challenging, attractive goal, which would open the doors to the design of new 
potent anti-cancer drugs and therefore to a planned control of cell division. 
              
   A                                                        B 
        
 
 Fig. 1.1 Secondary structure of the protein tubulin as derived by EC study on Zn-stabilized 
tubulin sheets (Nogales et al., 1998). B) Lateral contacts in the microtubules, as derived from the 8 






Fig. 1.2 Schematic representation of the straight and curved tubulin heterodimer showing the 
different position of the H6,H7 helices in the two conformations (reproduced from Ravelli et al., 
2004) 
 
Epothilones. In the search for tubulin-binding drugs with an improved 
pharmacological profile with respect to taxol, the epothilones, which compete 
with taxanes for the same tubulin binding pocket (Kowalski et al., 1997), appear 
to be extraordinarily promising. Isolated by Höfle and coworkers from the 
myxobacterium Sorangium cellulosum (Höfle et al., 1993), epothilones (Fig. 1.3) 
show a very low propensity to induce multidrug resistance (Bollag et al., 1995), 
are better deliverable to cells due to their higher solubility and possess cytotoxic 























R = H: Epothilone A  
R = CH3: Epothilone B 
R = H: Epothilone C (Deoxyepothilone A)  
R = CH3: Epothilone D (Deoxyepothilone B) 
Fig. 1.3 Chemical structures of epothilones 
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At present, five members of the epothilone family of structures are undergoing 
clinical trials, including epothilone B (EPO906), BMS-247550 (the lactam analog 
of epothilone B), KOS-862 (deoxyepothilone B, epothilone D), BMS-310705 (C-
21-amino epothilone B) (reviewed in Borzilleri & Vite, 2002; Altmann, 2003), 
and most recently, an analog of epothilone B of undisclosed structure, which is 
developed by Schering AG, Berlin. Since the discovery of the cytotoxic activity of 
epothilones, strong efforts have been made to derive a common pharmacophore 
model that could predict the binding mode of epothilones based on the binding 
mode of paclitaxel (Ojima et al., 1999; Wang et al., 1999; Giannakakou et al., 
2000). Despite the availability of biological data for more than 500 chemically 
modified epothilones, however, the structure-activity relationship (SAR) data 
were unable to provide a universal model of the ligand-protein complex. 
 
1.2 The question we ask. 
 
In this work we wish to answer the following questions: 
1. Which is the active conformation of epothilones? 
2. How do epothilones bind to tubulin and do they share a common 
pharmacophore with the taxanes? 
3. Do epothilones bind to unpolymerized tubulin and induce tubulin 
polymerization or do they bind exclusively to pre-formed microtubules? 
4. Which is the mechanisms by which epothilones control tubulin 
polymerization?  
The bioactive conformation of the epothilones is studied by NMR in solution. Our 
studies are conducted in D2O solution in the absence of GTP and Mg2+, which 
promote tubulin polymerization. Our goal is to prevent tubulin from forming 
microubules even in the presence of an excess of microtubules stabilizing agents, 
such as epothilone. The rationale behind it is the wish of decoupling the ability of 
the natural product to bind tubulin from that of promoting or inhibiting tubulin 
polymerization, as these two biological activities must not necessarily be linked. 
By doing so, we wish to study the initial binding of the drug to tubulin, an event 
which we think (and will prove) is required to induce the protein conformational 
change responsible for the promotion of microtubules formation. The 
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polymerization state of tubulin in the solution used for the NMR studies is 
verified by electron microscopy (EM).  
 
1.3 Significance of the work. 
 
While the last decade has witnessed significant progress in the 
understanding of the molecular mechanisms underlying the diverse group of 
diseases subsumed under the general term “cancer” (there are in fact more than 
150 different types of cancer), the successful treatment of these diseases is still far 
from routine and the development of improved drugs is of critical importance. In 
parallel with advances in cancer biology and apart from continued efforts in the 
area of classic cytotoxic agents, anticancer drug discovery in the more recent past 
has focused on targets related to e. g. cell cycle progression and signal 
transduction. However, the major types of solid human tumors (breast, lung, 
prostate, and colon), which constitute the vast majority of cancer cases today, are 
multi-causal in nature and there is a growing recognition that the treatment of 
solid tumors with “mechanism-based” agents is unlikely to be successful as 
monotherapy. Instead, improved treatment strategies are likely to involve 
combinations of e. g. signal transduction inhibitors with new and better cytotoxic 
agents. Thus the search for improved cytotoxics represents an important aspect of 
modern anticancer drug discovery and the identification of such agents will be 
critical for future advances in cancer therapy. 
We intend to unravel both the active conformation and the binding mode of 
epothilones to tubulin with the goal of defining the minimum requisites for 
biological activity. With the help of the three-dimensional model of the ligand 
/tubulin complex, we will propose a possible functional mechanisms that provides 
a rationale for the conformational control exerted on tubulin by epothilones. These 
data will improve our general understanding of the interaction of tubulin with 
small organic molecules and will assist the de novo design of structurally 
simplified tubulin binders with certain built in properties (e. g. with regard to 










The conformation of the ligand in complex with a macromolecular target 
can be studied NMR in solution for both tightly and weakly forming complexes. 
In the weak binding regime (koff > 104 Hz), the structure of the bound ligand is 
accessible also for very large complexes (>100 kDa), which are not amenable to 
NMR studies in the tight binding regime. When a small molecule binds to a 
macromolecular target with low affinity (kD > 10−6 M) (Fig. 2.1), its NMR 
observable A equals the population-weighted average of Abound and Afree. 
 
bound bound free freeA p A p A= +                            (Eq. 2.1) 
        
Equation 2.1 is applicable if the exchange is fast on the relaxation and chemical 
shift (CS) timescales of the system, namely koff is larger than the CS difference 
between the free and the bound forms of the ligand (only one NMR line is 
observed) and larger than the relevant relaxation constants (T1
−1or T2
−1) of the 
ligand-target complex. Under these conditions, the NMR observable Abound, 
developed during the state Lbound by a ligand molecule, will be transferred to the 
state Lfree and vice versa; this transfer process is mediated by the rapid exchange 
between Lbound and Lfree during the time t necessary to measure A. Thus, if the koff 
is larger than the transverse relaxation rate T2
−1 of the complex, the transverse 
relaxation rate T2
−1 of a ligand L in a mixture of ligand L and target T is given by: 
 
T2L
−1 = pL ,boundT2L ,bound−1 + pL, freeT2L, free−1                                 (Eq. 2.2) 
 
The individual populations pL,bound and pL,free depend on the kD and on the 
concentrations of L and T. From Eq. 2.2 it is evident that the resonances of the 
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ligand in a ligand-target mixture for which the T2 of the target is short can only be 
observed if pfree << pbound, namely if the ligand is in excess with respect to the 
target ([L] >> [T]). Under these conditions, even if T2L,bound is too short to allow 
for the observation of the resonances of the complex, the NMR signals of the 
observed free ligand carry valuable information on the NMR properties of ligand 
in the complex. 
In the weakly binding regime and when the complex size too large to observe the 
NMR lines of the receptor, the structure of the ligand in the bound form can be 
obtained via transferred-NOEs measurements. Similarly to Eq. 2.2, the averaged 
NOE observed between two protons HA and HB of a ligand in the presence of its 
weakly binding receptor can be described as: 
 
NOEAB = pL, freeNOEAB, free + pL,boundNOEAB,bound.                   (Eq. 2.3) 
 
If the correlation time of the complex is several orders of magnitudes larger than 
the correlation time of the free ligand, the NOEAB,bound will be much larger than 
the NOEAB,free, thus dominating the NOEAB even in the presence of an excess of 
free ligand (pL free > pL,bound). In particular, if the NOE of the free ligand in 
solution is positive, a sign change of the NOE is observed upon addition of target. 





Fig. 2.1. Cartoon showing the reversible binding of the Ligand L to the target T to form the 
complex LT. The conformation of the ligand can change upon binding. The NMR properties of the 
ligand are averaged according to Eq. 2.1. The ligand is in excess with respect to the target (pfree > 
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pbound). The average of Eq. 2.1 for the NMR properties that depend on the τc of the molecule (NOE, 
CCRR) is dominated by the bound term (second term), due to the fact that τc,bound >> τc,free. 
 
Epothilones bind to the soluble, non-microtubular form of tubulin in the fast 
exchange regime (koff > 10000 Hz). The tubulin-bound conformation of these 
compounds can be studied by tr-NOEs measurement at various mixing times 
conducted for a mixture of ligand and protein in 50:1 concentration ratio.  
However, for small non peptidic, flexible ligands like epothilone, the 
determination of the ligand structure from this kind of analysis is not accurate. 
Owing to the large conformational space available for the small ligand and to the 
absence of long-range distance restraints, multiple conformations can sometimes 
satisfy the same distance restraints set, derived from transferred-NOE 
measurements, and the unique biologically active structure cannot be determined 
unambiguously. Ambiguities among different conformations that satisfy a 
common NOE-derived distance set for a small molecule free in solution can 
commonly be lifted by the determination of dihedral angles through scalar 3J-
couplings. However, scalar couplings do not provide any angular structural 
information on the bound conformation of a ligand in fast exchange with its 
receptor. In the presence of an excess of ligand, the averaged scalar coupling JAB = 
pL, free JAB, free+ pL,bound JAB,bound is dominated by the contribution of the free form, as 
J couplings do not scale as a function of the correlation time of the complex. Reif 
et al. (Reif et al., 1997) demonstrated that Cross Correlated Relaxation (CCR) 
rates constitute a viable alternative to coupling constants for the determination of 
dihedral angles in large systems. Analogous to NOEs, CCR rates depend on the 
correlation time of the molecule and can therefore be used in a transferred fashion 
to derive angular structural information for a small ligand weakly bound to a 
macromolecule. This tool is unique, as it exclusively allows the measurement of 
ligand dihedral angles in a weakly bound complex. The use of CCR rates to derive 
angular information for a ligand weakly bound to a receptor was proposed for the 
first time in our laboratory (Carlomagno et al., 1999).  
The tubulin bound conformation of epothilone was poorly determined by tr-NOEs 
alone, as the conformation of the highly flexible 16-membered macrocycle could 
not be unambiguously defined. Therefore we developed a series of novel 
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experiments for the measurement of specific angles in the macrocycle via cross-
correlated relaxation rates. The general theory of CCR rates in a mixture of a 
ligand and its weakly binding receptor, together with some of the newly 
developed experiments, are described in Chapter 3. Briefly, CH–CH cross-
correlated relaxation rates (tr-CCR rates) for the determination of the C1-C2-C3-
C4, C5-C6-C7-C8, C12-C13-C14-C15, and C13-C14-C15-C16 torsion angles 
were measured in HCCH correlation experiments, which were adapted from the 
original pulse program (Felli et al., 1999) to achieve the desired selectivity on the 
various epothilone moieties. The O-C1-C2-C3 torsion angle was measured in a 
dipole-CSA (CSA = chemical-shift anisotropy) tr-CCR experiment that was 
adapted from the experiment used to measure CCR rates in the protein backbone 
(Yang et al., 1997). The C2-C3-C4-C5 and C14-C15-C16-C17 torsion angles 
were measured with the help of a newly developed tr-CCR experiment (see 
Chapter 3). The measurement of CCR rates requires the use of 13C labeled 
epothilone, which was obtained by shake flask fermentation of the 
myxobacterium Sorangium cellulosum, as described in the material section.  
Epothilone NMR experiments. The tubulin-bound conformation of epothilone A 
was calculated from 46 interproton-distance restraints and seven torsion-angle 
restraints measured for a 0.5 mM solution of epothilone A in water in the presence 
of 5 μM tubulin. The distance restraints were derived from transferred NOE 
experiments. To filter out spin-diffusion-mediated peaks, only those signals with 
opposite sign to the diagonal peaks in a transferred ROESYexperiment were taken 
into account. The NOE constraints used to calculate the structure of the tubulin-
bound conformation of epothilone were obtained from “transferred-NOE” 
experiments at mixing times of 100, 200, and 300 ms. The tr-ROESYexperiment 
had a mixing time of 60 ms with CW irradiation at a field strength of 3500 Hz. 
The dihedral-angle restraints were obtained by measuring CH–CH dipolar–dipolar 
and CH–CO dipolar–CSA transferred CCR rates for 60–70% 13C-labeled 
epothilone A. The transferred cross-correlated relaxation (tr-CCR) experiments 
were indispensable to obtain a unique description of the bound conformation, as 
more than one structure of the macrolide ring is compatible with the same H-H 
distance set (NOE intensities). The seven tr-CCR rates defined the torsion angles 
O1-C1-C2-C3, C1-C2-C3-C4, C2-C3-C4-C5, C5-C6-C7-C8, C12-C13-C14-C15, 
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C13-C14-C15-O1 and C14-C15-C16-C17. One particular problem in the 
determination of the bound conformation of epothilone was the stereospecific 
assignment of the two methyl groups at C4, which turned out to be opposite to the 
published assignment. The assignment of the two diastereotopic methyl groups 
had to be established as it was essential to determine the dihedral angle around the 
C3-C4 bond by cross-correlated relaxation and consequently detect the large 
conformational change that takes place in this region upon binding to tubulin. 
Owing to the paucity of protons around the C3-C4 bond and to the conformational 
averaging present in this region for epothilone in solution in the absence of 
tubulin, the stereospecific assignment of the methyl groups could not be carried 
out by a combination of NOE interactions and 3JCH coupling constants. Therefore, 
we relied on the combination of NOE experiments, 3JC,H and 3JC,C couplings 
constants (3JC2,C5, 3JC2,C22, and 3JC2,C23) measured for epothilone B in the absence 
of tubulin at −20ºC in dimethylformamide. Under these conditions, the 
macrocycle is in exchange between two conformations around the C3-C4 bond. 
Two pictures are compatible with the measured set of 3JC,H (3JC22,H3 ≈ 3JC5,H3 > 
3JC23,H3): 1) C22 = pro-R, C23 = pro-S, and a mixture of gauche+ and trans 
conformations around the C3-C4 bond; 2) pro S-C22, proR-C23, and a mixture of 
gauche+ and gauche−  conformations around the C3-C4 bond. The measured set 
of 3JC,C couplings (3JC2,C5 < 3JC2,C23 < 3JC2,C22) unequivocally confirms alternative 
2. The resulting stereospecific assignment is opposite to that previously published 
(Höfle et al., 1996). 
Structure calculations of the active conformation of epothilone. The structure 
of the tubulin-bound conformation of epothilone was determined by using the 
simulated annealing protocol, including NMR restraints, of the X-PLOR program 
(Brünger, 1992). The force field was adapted to include atom types occurring in 
epothilone A. Bond lengths and angles were taken from the X-ray structure of the 
free conformation. In addition, the force field included 46 NOE restraints and 
seven dihedral angles derived from tr-CCR rates. From a random starting point, an 
initial energy minimization of 50 steps, a high-temperature phase (32.5 ps, 6500 
steps, 2000 K) and two cooling phases (25.0 ps, 5000 steps, 2000 K?1000 
K/10.0 ps, 2000 steps, 1000 K?100 K) were performed. The closest local 
minimum was reached by applying a final energy minimization of 200 steps. This 
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protocol was repeated 100 times. Within the ten lowest energy structures, all 
dihedral angles have a standard deviation of less than 28º and the RMSD of the 
positions of the heavy atoms is 0.044 Å. 
Determination of the binding mode of epothilone to tubulin. While the 
bioactive conformation of a ligand weakly bound to a macromolecular receptor 
can be obtained by tr-NOE and tr-CCR experiments, the orientation of the ligand 
in the receptor binding pocket cannot be assessed by the available NMR 
techniques if the resonances of the receptor are broad beyond detection or, as in 
this case, the receptor cannot be obtained by recombinant techniques with the 
13C,15N and 2D labeling scheme necessary for NMR studies of large proteins. In 
this work, we developed a completely new NMR approach, which allows the 
determination of the relative orientation of two ligands in the receptor binding 
pocket in an “indirect” way, namely without observing the resonances of the 
protein. The method is based on the observation of protein-mediated 
intermolecular NOEs between two ligands binding weakly and competitive to a 
common receptor. If the orientation of one of the two ligands in the receptor 
binding pocket is known, either by crystallographic or FRET data, the orientation 
of the second ligand can be derived on the basis of the observed interligand 
NOEs. This methodology, that we called INPHARMA (Interligand NOE for 
PHARmacophore Mapping) is described in detail in the next chapter. Our idea is 
to derive the binding mode of epothilone to tubulin on the basis of the binding 
mode of paclitaxel to tubulin, which has been revealed by electron crystallography 
(Nogales et al., 1998). However, instead of paclitaxel, we use baccatin III (BacIII) 
(Fig. 3.5, Chapter 3), which shares a large portion of the chemical structure of 
paclitaxel, but lacks the side chain on the C13, which is responsible for the very 
poor solubility of paclitaxel. Our assumption is that the binding mode of BacIII to 
unpolymerized tubulin is analogous to that of paclitaxel to tubulin polymerized on 
Zn sheets. Although not effective in promoting tubulin polymerization (He et al., 
2000), BacIII binds to tubulin in the taxane binding pocket with a kD in the micro-
molar range, as demonstrated by NMR competition experiments between 
epothilone and baccatin in the presence of tubulin (see Chapter 3). The 
INPHARMA method was then applied to a mixture of the protein tubulin and the 
two ligands epothilone and baccatin III, in a concentration ratio of 1:50:50. Such 
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concentration ratios are typical for the observation of tr-NOEs of ligands binding 
to a target protein with a kD in the micro-molar range and allowed us to observe 
protein-mediated intermolecular NOEs between EpoA and BacIII by the 
INPHARMA method (Sanchez-Pedregal et al., 2005).  
This new methodology is of great significance for research in the pharmaceutical 
industry, as it provides an easy and quick method to derive a common 




Tubulin preparation and polymerization state. Tubulin was obtained 
from cytoskeleton (bovine brain, T238). The protein was dialyzed against a D2O 
solution containing 3 mM phosphate, 3 mM calcium and ca. 0.7 mM sodium at 
pH 7.0. For the determination of the tubulin bound conformation of EpoA, tubulin 
was dialyzed against a H2O solution containing 3 mM phosphate, 3 mM calcium 
and ca. 0.7 mM sodium at pH 7.0 lyophilized and dissolved in D2O prior to usage. 
In this buffer and in the absence of any ligand tubulin exists in the form of high 
molecular weight, inhomogeneous “aggregates” of α,β − dimers, as observed by 
electron microscopy (EM) and size-exclusion chromatography. The tubulin 
“aggregates” are disordered polymers (Fig. 2.2), and no microtubules or ordered 
polymers are formed under these conditions. We will refer to the “aggregates” as 
to the unpolymerized form of tubulin, where the term “unpolymerized” refers to 
the absence of ordered, microtubule-like polymers. Upon addition of EpoA, the 
size of the “aggregates” increases. Moreover, the addition of EpoA promotes 
polymerization of tubulin in the form of “tubules sheets” or “open microtubules” 
(Fig. 2.2). These ordered polymers are similar to microtubules, which are not 
correctly closed into the typical cylindric form. Similar polymers have also been 
observed in microtubules preparations stabilized by epothilone, as reported by 
Höfle and coworkers (GBF Scientific Reports, 2005), stabilized by paclitaxel, as 
reported by Diaz and Andreu (Diaz & Andreu, 1993) and in GMCPP 
microtubules formed at low temperature (Wang & Nogales, 2005). The sheets are 
often seen in fast grow conditions, where the microtubules do not have enough 
time to close while growing. The observation that epothilone induces the 
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reorganization of the tubulin “aggregates” into more ordered polymers indicates 
that the drug binds to the tubulin “aggregates” and induces a conformational 
change in the protein, which is necessary for the formation of the elongated 
polymers. While it is known that epothilones bind much tighter to microtubules 
than to soluble tubulin (Buey et al., 2004), our data demonstrate that epothilone 
functionally binds to unpolymerized soluble tubulin, inducing formation of 
ordered tubulin polymers, even in absence of Mg2+ and GTP. Baccatin does not 
promote formation of tubules sheets, in agreement with the lack of MT-stabilizing 
activity (Fig. 2.2). 
 
 A                                                              B        
       
C                                                         
              
 
Fig. 2.2 Electron microscopy (EM) images of tubulin (12μM) dissolved in a D2O solution 
containing 3 mM phosphate, 3 mM calcium and ca. 0.7 mM sodium at pH 7.0 (panel A). In panel 
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B the same tubulin sample was incubated for 1 hour with 0.6 mM epothilone A, leading to the 
formation of ordered polymers (microtubules sheets). In panel C the same tubulin sample was 
incubated for 1 hour with 0.6 mM baccatin In panel C no ordered polymers could be observed, in 
agreement with the lack of MT-stabilizing activity in baccatin.  
 
The structural data discussed in this work refer to the ligand bound to tubulin in 
the unpolymerized form. Tubulin “aggregates” are always seen in EM images of 
microtubules (Diaz & Andreu, 1993), underlying the biological importance of 
such disordered polymers in the conformational equilibrium of tubulin. The 
amount of epothilone bound to the microtubules sheets (Fig. 2.2) does not 
contribute to the NMR signal. This is due to the fact that only signals from fast 
exchanging ligands can be observed in the NMR experiments, while epothilones 
are known to bind tightly to microtubules (Buey et al., 2004). In agreement with 
this consideration we do not observe any change in the EpoA NOE signals with 
time, while the microtubules sheets precipitate out of solution in a few days. 
Moreover, the average correlation time τc of the tubulin-bound epothilone 
observed in the NMR spectra is approximately 1.3 μs, which roughly corresponds 
to 15 protein dimers, while the microtubules sheets observed in the EM images 
contain several hundreds of dimers. The average correlation time of 1.3 μs is thus 
incompatible with the hypothesis that the microtubules sheets measurably 
contribute to the observed NMR signal. 
Sample used for the determination of the epothilone active conformation. All 
the tr-CCR experiments were acquired for a solution of 13C-labeled epothilone A 
(0.5 mM)and tubulin (5 μM)in D2O. 13C-labeled epothilone was obtained by 
shake flask fermentation of the myxobacterium Sorangium cellulosum So ce90 by 
using a high epothilone-producing mutant, BCE99/41 (Novartis strain collection). 
The fermentation was performed by growing the strain in medium (1000 mL) 
containing 13C-labeled starch (13C6, 98%; 20 g) as carbohydrate source. Yields: 
epothilone A (20 mg) and epothilone B (15 mg), incorporation rate: 60–70% 13C. 
Sample used for the determination of the binding mode of epothilone tubulin. 
Interligand NOEs were measured between EpoA and BacIII for a mixture of 
EpoA (0.6 mM), BacIII (0.6 mM) and tubulin (12μM) in D2O containing 3 mM 
phosphate, 3 mM calcium and ca. 0.7 mM sodium at pH 7.0. In this preparation 
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tubulin was not lyophilized, as in the preparation used to determine the bioactive 
conformation of epothilone. Instead, the commercially available tubulin was 
dialysed against the desired buffer twice for 10 hours. We chose not to lyophilize 
tubulin, as we observed that lyophylization denatures a considerable amount of 
the protein, which is then unable to bind epothilone. Baccatin III was purchased 





New Methodology Development  
 
3.1 Cross-Correlated relaxation rates. 
 
Cross-correlated relaxation (CCR) rates constitute a valid alternative to 
coupling constants for the determination of dihedral angles (Reif et al., 1997). 
For high molecular weight systems the measurement of scalar coupling constants 
poses serious problems caused by large line-widths and by differential relaxation 
effects (Harbison, 1993; Norwood, 1993). Conversely, CCR measurements are 
feasible also for molecules of large size and have been successfully employed in 
the past years to determine dihedral angles in biomolecules. Additionally, we 
have reported on the usage of cross-correlated relaxation rates to derive angular 
structural information for a small ligand weakly bound to a macromolecule 
(Carlomagno et al., 1999; Blommers et al., 1999). Similarly to “transferred-
NOEs” (Ni, 1994; Clore & Gronenborn, 1982), “transferred-CCR rates” are 
informative of the bound conformation of the ligand, when the complex is in the 
fast exchange regime on the NMR time-scale. It is noted that coupling constants 
are unable to provide information on the bound conformation of the ligand, 
because their value is independent of the molecular correlation time.  
CCR rates measurements have been extensively employed for the determination 
of the tubulin-bound conformation of the microtubules-stabilizing agent 
epothilone A (EpoA) (see chapter 4 for results). The conformation of the 
intervening torsion angles between atoms O1 and C6 (Fig. 1.3) was poorly defined 
by transferred-NOE data and more than one structure of the macrolide ring was 
compatible with the NOE derived H-H distance set. However, chemical 
modifications data indicated this region as particularly important for the biological 
activity of epothilone, underlining the necessity of obtaining reliable structural 
data for this part of the macrolide ring. This was possible thanks to the 
measurement of four CCR rates that defined the torsion angles O1-C1-C2-C3, C1-
C2-C3-C4, C2-C3-C4-C5 and C5-C6-C7-C8 (Fig. 1.3). Additional CCR rates 
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measurements restricted the torsion angles C12-C13-C14-C15, C13-C14-C15-O1 and 
C14-C15-C16-C17. Three kinds of CCR rates were measured using the Γ-
quantitative approach: CH-CH dipolar-dipolar CCR (Felli et al., 1999), CO-CH 
CSA (Chemical Shift Anisotropy)-dipolar CCR (Yang et al., 1997) and CH-CH3 




Fig. 3.1 Cross and reference experiments for the measurement of the ΓC2H2’C3H3 and the ΓC2H2’’C3H3 
of epothilone in a Γ-quantitative HCCH correlation. The CCR rates are obtained by the ratio of the 
peak intensities in the cross and reference experiments: the ΓC2H2’C3H3 is obtained from the C3-H2’ 
peak and the ΓC2H2’’C3H3 from the C3-H2’’ peak. 
 
The example of epothilone A is representative of many other cases where angular 
structural information is required for the determination of the bio-active 
conformation of a ligand in a weakly formed complex; CCR rates are the only 
NMR parameters to carry such information. Unfortunately, CCR rates 
measurements require 13C labelled ligands. Some attempts have been made to 
develop new experiments to obtain CCR rates at natural abundance (Ilin et al., 
2003). The development of such methods is of great relevance, given the elevated 
costs associated with the chemical synthesis of 13C labelled ligands. 
A variety of pulse sequences to obtain dipolar-dipolar and CSA-dipolar CCR rates 
are available in the literature for proteins and nucleic acids. In principle similar 
sequences can be used to measure the same CCR rates in a “transferred” fashion 
for ligand-receptor complexes. It is advisable to adjust the pulse sequence for 
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every ligand, especially by introducing selective pulses, in order to optimize 
magnetization transfer efficiencies for the individual combinations of spins to be 
correlated. By adapting pulse sequences available in the literature we measured 
the O1-C1-C2-C3, C1-C2-C3-C4, C5-C6-C7-C8, C12-C13-C14-C15 and C13-C14-C15-O1 




Figure 3.2 Pulse sequence for the measurement of dipolar-dipolar cross-correlated relaxation 
between the (CH)22/23ave. vector and the (CH)3 vector in epothilone. Δ = 1/(21JCH); T = 1/(41JCC) = 7 
ms; Tc = 1/ (41JCC) = 7 ms; T1 = 1/(81JCC) = 3.5 ms; T1c = Tc. Delays 1-4 are equal to Trel/4 (Trel 
= 1/1JCC = 28 ms) in the cross experiment; in the reference experiment delay 1 = Trel/4 + Δ/8 = 
delay 3 and delay 2 = Trel/4 – Δ/8 = delay 4. φ1 = y; φ2 = x, -x; φ3 = 2(y), 2(-y); φ5 = 4(x), 4(-x); 
φ6 = 8(y), 8(-y); φ8 = x; φ10 = y;φ11 = 2(x,-x), 4(-x,x), 2(x,-x); φ4 = φ7 = φ9 = x. The pulses with 
phase φ4 and φ9 are Q3 pulses of 768 ms duration, centered at 63 ppm, to selectively invert the C3 
and C4 (C3 resonates at 70.9 ppm and C4 at 53.0 ppm); the pulse with phase φ7 is a Q3 pulse of 
512 ms duration centered at 37 ppm, to selectively invert the C22/23 and C4 (C22 resonates at 19.1 
ppm and C23 at 21.7 ppm). The proton carrier was at 4.78 ppm and the carbon carrier at 37 ppm; 
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spectral widths were 4807.69 Hz for proton and 8333.33 Hz for carbon. Carbon decoupling in 
acquisition consisted of a GARP modulated pulse train at 2.38 kHz field strength. 
 
The determination of the torsions around a C-C bond involving a quaternary 
carbon, as for the C2-C3-C4-C5 and C14-C15-C16-C17 torsion angles in EpoA, 
represents a challenging problem. In this case no CH-CH dipolar-dipolar CCR 
rate can be measured and no large CSA tensor is available for the measurement of 
a CSA-dipolar CCR rate. During this work, we developed a new experiment to 
access the C2-C3-C4-C5 and C14-C15-C16-C17 torsion angles. In the new approach 
we measure CH-CH cross correlated relaxation in a HaCa-Cb(CH3)c moiety, where 
the second C is a quaternary carbon. This rate allows to define the dihedral angle 
about the CaCb bond. We have applied the pulse sequence to a 100:1 mixture of 
13C-labeled epothilone A (Fig. 1.3) and tubulin to determine the dihedral angle 
about the C3-C4 and C15-C16 bond of epothilone in its bound conformation. In the 
following we will decribe in detail the measurement of the C2-C3-C4-C5 torsion 
angle. 
The dihedral angle about the C3-C4 bond of epothilone is accessible by measuring 
the dipolar-dipolar CCR rates between the (CH)3 vector and the (CH)22 or (CH)23 
vectors. The direction of the three CH bonds in each methyl group is averaged as 
a consequence of the fast rotation around the C4-C22 and C4-C23 bonds. Therefore, 
the (CH)22 and (CH)23 vectors assume an average orientation that is collinear with 
the C4-C22 and C4-C23 bonds, respectively.  
The pulse sequence used for the measurement of the ΓCH,CH rate between the 
(CH)3 vector and the (CH)22/23ave. vectors is shown in Fig. 3.2.  
Two experiments are recorded, yielding a cross and a reference spectrum 
(quantitative Γ approach) (Felli et al., 1999). The CCR rate is extracted from the 
ratio of peak intensities in the cross and reference experiment. The pulse sequence 
is optimized for maximum sensitivity of the cross experiment: the 
8Hz22/23Cy22/23Cz4Cy3 coherence present at point c is transformed by Γ 
(CH)22/23,(CH)3 into 8Cx22/23Cz4Cx3Hz3 with efficiency equal to 
3sinh(Γ(CH)22/23,(CH)3Trel)cosh2(Γ(CH)22/23,(CH)3Trel). The 
8Cx22/23Cz4Cx3Hz3 term is then transformed into Hx3 for detection. The delays 
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are optimized for optimal refocusing and defocusing of the couplings. Selective π 
pulses on the carbons prevent loss of magnetization to other passively coupled 
carbons. The details of the coherence transfers are provided in Fig. 3.1 and its 
legend. 
The cross and reference spectra are shown in Fig. 3.3. Two peaks are observed in 
the reference spectrum at the chemical shifts of C22 and C23 in ω1 and the 
chemical shift of H3 in ω2. In the cross spectrum the C23(ω1)-H3(ω2) peak is 
missing, indicating that the dipolar-dipolar CCR between the (CH)23ave. vector and 











Figure 3.3. Reference (left) and cross (right) spectra acquired with the sequence of Fig. 3.1. The 
peaks visible in the reference specrtum are at the chemical shift of C22 (19.1 ppm) and C23 (21.7 
ppm) in the carbon dimension and at the chemical shift of H3 (4.27 ppm) in the proton dimension. 
The cross experiment was four times longer than the reference experiment. 1024 and 64 complex 
points were acquired in t2 and t1, respectively. The final matrices were 2048 × 128 points. The gray 
lines represent negative contours. The sample contained 0.5 mM epothilone A and 5 μM tubulin 
dissolved in D2O. 
 
The quantitative value for the two CCR rates can be extracted according to the 
equation: 
 
Icross/Iref = tanh(Γ Trel)/sin2(πJCHΔ/2)cos2(πJCHΔ/2)            (Eq. 3.1) 
 
where Icross and Iref are the intensities of the peaks in the cross and reference 
experiment, respectively and Γ indicates the cross-correlated relaxation rate. The 
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measured CCR rates between the (CH)3 vector and the (CH)23ave. and (CH)22ave. 
vectors are 0.1 ± 0.1 and –1.4 ± 0.4, respectively. The error was calculated 
applying classical error propagation theory, assuming that the noise represents the 
experimental uncertainty of the peak intensities. 
The dependence of the two CCR rates on the C2-C3-C4-C5 dihedral angle θ is 
given in Eq. (3.2) and (3.3). The (CH)22ave. and (CH)23ave. vectors lie along the 
direction defined by the C4-C22 and C4-C23 bonds, respectively. The CCR rates 
Γ(CH)22,(CH)3 and Γ(CH)23,(CH)3 are scaled by P2[109.7°] = ½[3cos2(109.7°) – 
1] = –0.3296, due to the averaging of the C-H directions in each methyl group. 
 
Γ(CH)22,(CH)3 = –0.3296kτcP2[cos2109.7° sin2109.7°cos(θ)]                 (Eq. 3.2) 
Γ(CH)23,(CH)3 = –0.3296kτcP2[cos2109.7° sin2109.7°cos(θ − 120°)]      (Eq. 3.3) 
 
where k = (γCγHhμ0/8π2)2, τc is the effective correlation time of the molecule and θ 
is the torsion angle C2-C3-C4-C5.  A graphic representation of the dependence of 
the two CCR rates on the torsion angle θ is shown in Fig. 3.4 for a τc of 0.74 ns, 
which is the effective τc of epothilone in the presence of 5 μM tubulin, as 
estimated from other CCR measurements, and an order parameter S2 = 0.8 to 
account for internal motions. The stereospecific assignment of the methyl groups 
(C22 in pro-S and C23 in pro-R) was obtained by the combination of NOEs and 
3JHC and 3JCC coupling constants data for epothilone B in the absence of tubulin 
(see chapter 2) and is opposite to the one reported in the literature (Höfle et al., 
1996). 
The dihedral angle θ that complies with the ratio between the two CCR rates is –
45° ± 5°. We used the ratio of the two CCR rates, instead of the rates themselves, 
to determine the dihedral angle because this approach is independent from both 
the τc and the internal motion order parameter S2, if equal internal reorientation of 
all the CH vectors is assumed.  
The change in the θ dihedral angle from the gauche + conformation in the free 
form to the gauche – conformation in the bound form is supported by tr-NOE 
data. 
 38
The new experiment allows to determine X-Ca-Cb-Y dihedral angles by CCR rates 
when X is a proton and Y a methyl group. The method is broadly applicable to 












  Figure 3.4. Dependence of the two cross-correlated relaxation rates Γ (CH)22,(CH)3 and Γ 
(CH)23,(CH)3 on the dihedral angle θ(C2-C3-C4-C5). The two gray shadowed regions represent the 




3.2 The INPHARMA approach. 
 
3.2.1 The NMR experiment. 
The conformation of a ligand in the binding pocket of a macromolecular 
receptor can be accessed by NMR in solution by two approaches. If the molecular 
weight of the complex is of the order of 50 kDa or smaller and 13C/15N labelled 
receptor can be produced in vitro, a detailed three-dimensional picture of the 
ligand and of its interactions with the receptor binding pocket can be obtained 
with standard NMR methodology (Cavanagh et al., 1996). However, in other 
cases the macromolecular receptor is too large for NMR studies in solution or it 
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cannot be synthesized in vitro to introduce NMR active isotopes. In these 
instances, NMR can be applied to determine the receptor-bound conformation of 
the ligand, provided that the koff of the binding reaction is much larger than the 
relaxation constants of the ligand in the complex and the difference of the 
chemical shifts of the free and bound ligand forms (fast exchange regime). Under 
this condition, which implies a kD in the low micromolar to millimolar range, 
information on the ligand structure is derived from transferred-NOEs (tr-NOE) 
and transferred Cross-Correlated Relaxation rates (tr-CCRR). The determination 
of the receptor-bound conformation of the ligand leaves open the question of its 
orientation in the receptor binding pocket.  
The relative orientation of two competitive ligands weakly bound to a common 
receptor can be determined by the simple and novel approach that we propose 
here. A NOESY of a mixture of the two ligands in the presence of the common 
receptor is recorded. Under the fast exchange condition, and provided that the two 
ligands A and B bind competitively to the macromolecular receptor T, 
intermolecular tr-NOE peaks between the two ligands A and B can be observed in 
the NOESY spectrum. A NOE peak between a proton HA of ligand A and a proton 
HB of ligand B in the presence of the receptor T originates from spin diffusion 
involving a proton HT of the receptor. During the NOESY mixing time the ligand 
A binds to T and proton HA transfers its magnetization to proton HT (Fig. 3.5). 
Then the complex AT dissociates and B binds to T. The magnetization of HA, 
which had been transferred to HT, can now be transferred to HB, resulting in an 
intermolecular peak HA-HB. Clearly this peak can only exist if both HA and HB are 
close to HT in the AT and BT complexes, respectively. Therefore, a number of 
such intermolecular NOE peaks describes the relative orientation of the two 
ligands in the receptor binding pocket. Such interligand NOEs have never been 
observed so far and should not be mistaken for the interligand NOEs that occur 
for two ligands binding simultaneously in adjacent or partially overlapping 
binding pockets (London et al., 1992; London, 1999). Here, the two ligands A and 
B are never either close in space or bound to the protein simultaneously; instead, 
the two ligands bind to the protein competitively and consecutively and the 






Fig. 3.5. Schematic representation of the principle of the interligand NOEs observed between two 
competitive ligands A and B, binding consecutively to the same target T. When ligand A (in 
green) binds to the protein, magnetization is transferred from the proton HA of A to the proton HT 
of T. Subsequently, ligand A leaves the binding site and ligand B (in blue) binds to the target. The 
proton HB of B, situated close to HT, receives part of the magnetization transferred to HT  by HA of 
A. This results in a NOE peak between HA and HB , mediated by the proton HT, despite the fact 
that the two ligands do not bind the protein simultaneously and that HA and HB are never directly 
close in space.  
 
If the orientation of the ligand A in the binding pocket of T is known, the possible 
binding modes of the ligand B, resulting from docking calculations, can be ranked 
by evaluating their compatibility with the experimental interligand NOEs. The 
expected HA-HB intermolecular NOEs can be computed for each orientation of the 
ligand B in the BT complex and compared with the experimental ones. The 
structures that give rise to intermolecular NOEs in good agreement with the 
experimental ones are retained, the others rejected. We expect the new 
methodology, that we call INPHARMA (Interligand NOE for PHARmacophore 
MApping), to be useful to pharmaceutical research and ligand-target interaction 
studies, as it offers a rapid and easy way to determine the relative orientations of 





Fig 3.6 Structure of Epothilone A and Baccatin III. 
 
We apply the INPHARMA method to a mixture of epothilone A and baccatin III 
(Fig. 3.6) in the presence of tubulin. The complex Epo A – tubulin is only 
transiently formed during the mixing time of a NOESY experiment, and tr-NOEs 
can be observed for a 100:1 mixture of Epo A and tubulin, making the system 
suitable for application of the INPHARMA method (epothilone A = ligand B; 
tubulin = target T). A model of the complex of tubulin with paclitaxel is available 
by electron crystallography. Unfortunately paclitaxel is poorly soluble in water 
and therefore not suitable for NMR studies in solution. However, the precursor of 
paclitaxel, baccatin III (He et al., 2000), lacking the C-13 side-chain, is water 
soluble, binds to tubulin in a transiently-formed complex and delivers tr-NOE 
effects. Thus, although the biological activity of baccatin III is lower than that of 
paclitaxel, we chose baccatin III as ligand A for our experiments. To confirm that 
baccatin binds in the same pocket as paclitaxel, namely that it competes with 
epothilone for the taxane binding pocket, we evaluated the change in the tr-NOE 
rates of baccatin in presence of tubulin upon titration of epothilone. For a 
concentration ratio of epothilone A:baccatin of 0.67:1, the tr-NOE rates of 
baccatin decrease to 0.6 of their original value, confirming that the two ligands 
compete for the same binding pocket. 
We recorded NOESY experiments at different mixing times (20, 40, 70, 100 and 
200 ms) for a mixture of epothilone A (0.6 mM), baccatin III (0.6 mM) and 
tubulin (12μM) in D2O. Intermolecular NOE cross-peaks between the aromatic 
protons of baccatin III and several methyl groups of Epo A are clearly observable 




Fig. 3.7 NOESY spectrum of a mixture of tubulin, epothilone A, and baccatin III with 
concentrations of 12μM, 0.6 mM, and 0.6 mM, respectively. The spectrum has been acquired on a 
900 MHz spectrometer equipped with a cryoprobe with a mixing time of 70 ms. The blue and 
green peaks are intramolecular transferred NOE peaks for epothilone A and baccatin III, 
respectively. The red peaks represent the interligand transferred NOEs mediated by the protein 
protons. The numbering of the atoms corresponds to that of Fig. 3.5 (E stands for epothilone and B 
for baccatin). Bm,Bo and Bp indicate the protons in the meta, orto and para positions of the phenyl 
ring of baccatin, respectively. 
  
Nineteen intermolecular NOE peaks (Table 3.1) can be already observed in a 
NOESY experiment at 40 ms mixing time. The build-up curves of the intensities 
of seven of these NOE peaks (Fig. 3.8) show the characteristic damped parabolic 
shape for spin diffusion mediated NOE effects. Additional intermolecular NOEs 
become visible at 100 ms or higher mixing times. As a control, we recorded a 
NOESY spectrum of the mixture of Epo A and baccatin III in the absence of 
tubulin at 400 ms mixing time, which showed no intermolecular NOEs. Thus, we 
can conclude that the intermolecular NOE effects between Epo A and baccatin, 
observed in presence of tubulin, are mediated by protons of tubulin. In the next 
section I will describe how we interpret the interligand NOEs to obtain the 
binding mode of the two ligands to the protein. 
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Fig. 3.8 Build-up curves of seven out of the 19 most intense interligand transferred-NOE cross 
peaks, as assigned in the figure. The typical damped parabolic behaviour can be observed for all 
peaks, confirming that the interligand NOEs arise from spin-diffusion via the protein protons. The 
numbering of the atoms corresponds to that of Fig. 3.6 (E stands for epothilone and B for 
baccatin); Bm indicates the protons in the meta position of the phenyl ring of baccatin. 
 
We also measured intermolecular NOEs between EpoA and taxotere in the 
presence of tubulin. Taxotere is only purely soluble in water: the sample 
contained EpoA (0.5 mM), taxotere (0.05 mM), tubulin (3μM), 3 mM phosphate, 
3 mM calcium and ca. 0.7 mM sodium at pH 7.0 in D2O (95%) / DMSO (5%). 
We could observe intermolecular NOEs between several regions of the two 
compounds, confirming that EpoA binds in the same pocket as taxotere. However, 
due to the low concentration of taxotere, the interligand NOEs were too weak to 
be quantitatively interpreted.  
 
3.1.2 Computational approach for the evaluation of the interligand NOEs.  
Our approach to obtain a structural model of the complex between EpoA 
and tubulin consists of three steps: first, we generate 5000 models for each of the 
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two ligands complexed with tubulin and combine pairwise all models of the EpoA 
– tubulin complex with all models of the BacIII – tubulin complex; second, we 
calculate the theoretical intermolecular tr-NOEs between EpoA and BacIII for 
each of the 25 million pairs; third, we reject or retain pairs of structures depending 
on how well the calculated intermolecular tr-NOEs reproduce the experimental 
ones. We chose to use the soluble BacIII instead than the insoluble paclitaxel as 
reference ligand with known binding mode, under the assumption that the binding 
mode of BacIII to unpolymerized, soluble tubulin resembles that of paclitaxel to 
tubulin polymerized on Zn sheets and revealed by EC (Nogales et al., 1998). 
However, in the course of the project we had indications that the assumption of a 
common binding mode of baccatin and paclitaxel might not be confirmed. 
Therefore we generate 5000 docking model for the BacIII – tubulin complex in 
order to explore the conformational space of baccatin in the taxane binding pocket 
of soluble tubulin. From this point on, the INPHARMA method is used without 
knowledge of the binding mode of one of the two ligands. In the docking 
calculations we used the tubulin structure derived by electron crystallography 
(Nogales et al., 1998; Nettles et al., 2004), but we allowed both the backbone and 
the side-chains of the taxane binding pocket to be flexible, in order to explore a 
larger conformational space, which might be accessible in solution. For EpoA we 
used the tubulin-bound conformations derived by tr-NOEs and tr-CCRs in 
solution (Carlomagno et al., 2003b).  The orientation of epothilone in the binding 
site was not restricted in the docking calculations, which resulted in an extensive 
sampling of the taxane binding pocket. Among the 5000 docking models 
generated for the BacIII – tubulin complex, those models were retained, for which 
the aromatic ring of baccatin is located in one of the three pockets occupied by 
one of the aromatic rings of paclitaxel in the published electron crystallography 
structure (Nogales et al., 1998). This choice allows searching the taxane binding 
pocket for binding modes of baccatin to soluble tubulin which differ from the one 
of paclitaxel to polymerized tubulin, while maintaining the general profile of the 
interaction of taxanes with tubulin. 
Docking calculations. 5315 EpoA − β-tubulin and 5022 BacIII − β-tubulin 
complex models were generated with the HADDOCK protocol (Dominguez et al., 
2003) using the CNS program (Copyright © International Union of 
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Crystallography, Acta Cryst. D54, 905-921 1998). To improve the sampling of the 
conformational space of tubulin, seven and fourteen initial β-tubulin models were 
used for the EpoA – tubulin and the BacIII – tubulin complexes, respectively. 
These models included the electron crystallography (EC) derived structure of 
polymerized tubulin bound to paclitaxel (1JFF.pdb) (Nogales et al., 1998) and the 
EC-derived structure of polymerized tubulin bound to EpoA (1TVK.pdb) (Nettles 
et al., 2004). The remaining 5 and 12 tubulin models for the EpoA – tubulin and 
the BacIII – tubulin complexes, respectively, resulted from previous docking 
calculations of EpoA and BacIII to tubulin and belonged to complex models 
where the ligands are found in very different orientations in the binding pocket. 
 
Table 3.1: List of the intensities of the intermolecular NOEs between protons of  baccatin III 
and epothilone A in the presence of tubulin at four mixing times. B and E indicate baccatin and 
epothilone, respectively. B-o, B-m, B-p indicate the protons in the orto-, meta- and para- positions 
of the C2 benzoyl phenyl ring of baccatin. The NOE intensities are normalized relative to the 
diagonal peak intensity of proton A and multiplied by 104. 
 
                                              NOESY mixing times 
Proton A Proton B  40ms 70ms 100ms 200ms 
B-m E-21 8 14 26 68 
B-p E-21 9 10 25 81 
B-o E-21 4 12 19 60 
E-21 B-16 8 9 15 50 
E-21 B-17 5 11 17 65 
B-m E-27 5 16 24 70 
B-p E-27 4 17 23 75 
B-o E-27 3 10 22 65 
B-m E-22 5 13 20 57 
B-p E-22 3 10 14 61 
B-o E-22 5 10 16 50 
B-m E-23 4 9 19 50 
B-p E-23 0 7 18 53 
B-o E-23 4 8 15 43 
B-m E-25 4 15 19 66 
B-p E-25 7 14 21 72 
B-o E-25 3 12 21 57 
E-19 B-16 8 13 24 62 
E-19 B-17 10 16 23 85 
B-10 E-25 0 7 9 48 
B-3 E-22 0 7 14 49 
B-5 E-22 5 9 14 41 
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E-15 B-17 9 15 24 82 
E-17 B-17 12 21 25 78 
E-15 B-16 6 15 30 67 
B-5 E-24 0 0 9 31 
B-m E-24 3 13 19 49 
B-p E-24 0 9 11 56 
B-o E-24 3 7 14 44 
B-5 E-23 0 4 9 40 
B-2 E-23 0 4 9 17 
B-10 E-23 0 5 9 26 
B-13 E-27 0 6 19 64 
B-5 E-27 2 7 8 43 
B-2 E-27 0 7 7 35 
B-10 E-21 4 11 12 34 
B-13 E-21 0 7 9 31 
B-o E-12 4 3 9 21 
B-o E-13 0 3 4 24 
B-m E-7 0 3 6 16 
B-o E-7 0 3 4 15 
B-m E-15 0 0 6 22 
E-21 B-2 0 1 7 19 
B-5 E-17 0 0 5 13 
B-2 E-17 0 0 0 18 
B-m E-17 0 5 6 22 
B-p E-17 0 0 6 22 
B-o E-17 0 5 6 17 
B-m E-19 0 6 12 29 
B-o E-19 0 5 9 20 
E-15 B-o 6 16 28 69 
 
Increasing flexibility was allowed for the protein during the docking protocol. 
After a first stage of rigid docking, structural models were selected having the 
ligand close to the taxane binding pocket. In the following stages, we allowed the 
protein side chains in the binding pocket and subsequently also the loop backbone 
to be flexible. In the last water refinement step full flexibility of the protein was 
allowed and the complex was hydrated with a water layer of about 8Å. This 
procedure was designed to access conformational states of tubulin that could 
differ to some extent from the conformation of tubulin polymerized on Zn-
stabilized sheets.  
The conformations of EpoA and BacIII were kept rigid throughout the docking 
calculation. For EpoA we used the tubulin-bound conformation determined by 
transferred-NOEs (tr-NOE) and transferred cross-correlated relaxation rates (tr-
CCR). These data were complemented by the measurement of the C19-C18-C17-
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C16 torsion angle by the CH-CH dipolar-dipolar CCR rate between the C19-H19 
vector and the C17-H17 vector. As a consequence of the new CCR data, the C19-
C18-C17-C16 torsion angle was restrained to the range −40° - +40°. The tubulin-
bound conformation of BacIII was verified by tr-NOE data and was found to be 
equivalent to the conformation of the baccatin core of paclitaxel in the EC-derived 
structure (Nogales et al., 1998).  
The charges of both ligands were calculated in vacuo by MOPAC from Insight II 
(Stewart, 1990) using the MINDO/3 Hamiltonian (Bingham et al., 1995). As for 
the protein, implicit hydrogen bonding was introduced for hydrogen donors and 
acceptors of the ligands. The ligands non-bonded parameters were adapted to fit 
the PARALLHDG_5.3 parameter set from Michael Nilges (July 07, 2001 
University of California) as provided with HADDOCK 1.0.  
Intermolecular NOEs calculations. The peak volumes in the mixing time of a 
NOESY spectrum evolve according to the differential equation: 
dA(t)
dt
= − R + K( )⋅ A(t)                                         (Eq. 3.4) 
where  A denotes the square matrix of the peak volumes, R is the relaxation 
matrix and K the chemical exchange matrix (Ni, 1996). Solution of Eq. 3.4 leads 
to the matrix A(tm), which contains the intensities of all peaks in a NOESY 
spectrum with mixing time tm. The formal solution is  
A(tm) = exp[(R+K) tm] · A(0)                                  (Eq. 3.5)  
where A(0) contains the initial magnetization. 
We describe the system with a two-state kinetic model (Scheme 3.2), where we 
assume that the concentration of the free protein is negligible due to the large 
excess of ligands. Four chemical species are considered: free ligand A (EpoA), 
free ligand B (BacIII), complex TA (EpoA − tubulin) and complex TB (BacIII −  
tubulin).  





The relaxation matrix R  contains the relaxation rates between protons in the four 
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The bold lines group the sub-matrices corresponding to each one of the four 
species in the solution. The superindex of each 
s
xR indicates the species (either 
the free ligands or the complexes TA or TB) and the subindex indicates which 
protons of the species contribute to that sub-matrix. Thus, RB
B
describes the 
relaxation of the protons of ligand B in the free state and 
TB
BR the relaxation of 
the protons of ligand B when bound in the complex TB. Analogously, 
TB
TR  
describes the relaxation of the protein protons in the complex TB and 
RB,T
TB
contain the cross-relaxation terms between the protons of ligand B and the 
protons of protein T in the complex TB. 
The individual sub-matrices representing each of the four chemical species are 
symmetric square matrices of dimension Ns × Ns, where Ns is the number of 
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protons considered for each of the four different species s . To reduce the matrix 
sizes and be able to perform the calculation in a reasonable time, we considered 
only tubulin atoms within a given distance d from the ligand.  
The matrix K represents the kinetics of the species in equilibrium and has the 




 - k12[B] I    
 k12[TA] I   - k21[A] I  
- k21[TB] I  k12[B] I    




  k21[A] I  
   - k12[B] I  k21[A] I 
 
I indicates the identity matrix and [A], [B], [TA] and [TB] are the concentrations 
of the corresponding species.  
Structure selection criteria. The theoretical intermolecular NOEs between the 
two ligands EpoA and BacIII were calculated for each of the 26.7 millions pairs 
of docking models (5315 for the EpoA – tubulin complex and 5022 for the BacIII 
– tubulin complex) assuming a koff > 10000 Hz for both complexes. This lower 
bound of the koff was verified by relaxation dispersion experiments. To reduce the 
matrix sizes, we considered only tubulin atoms in a distance d < 8 Å  from the 
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ligand. By gradually increasing this limit, we verified that 8 Å is the optimal value 
to obtain precise interligand NOEs while keeping the calculation time at 
reasonable values.  
The theoretical intermolecular NOEs were compared with the experimental values 
by a linear regression algorithm. The best pair of models delivered a linear 
correlation coefficient R of 0.92. Three criteria were applied in the selection of 
pairs of models: first, the linear correlation coefficient has to exceed 0.86; second, 
the slope of the regression lines of the experimental vs. the calculated data must 
be confined between 0.3 and 1.4; third, the slope of the regression line of each 
NOE peak does not exceed two times the slope of the regression line of all the 
NOE peaks together. The second selection criterion considers that the calculated 
NOE intensities, normalized to the diagonal peak intensities, should have the 
same size as the experimental ones. The upper bound was set to 40%.  The lower 
bound allows the experimental NOEs to be 70% smaller than the calculated ones. 
The logic behind these criteria is based on the presence of internal motions, which 
could significantly reduce the experimental intermolecular NOEs. Internal 
motions cannot be simulated in the theoretical calculations, due to the lack of a 
satisfactory model for such a complex system. However, motion is not likely to 
increase the NOE by the same amount, which led us to set the upper bound of the 
slope to 40%. The presence of internal motion is also the likely explanation why 
the linear regression correlation coefficient does not exceed 0.92 for any pair of 
models.  
The 25 million pairs of models were clustered to facilitate the analysis. The 
pairwise RMSD of models belonging to the same cluster did not exceed 2 Å on 
EpoA heavy atoms after translation of their geometric center of mass into the 
origin of the coordinate system. After application of the selection criteria two 
families of pairs were considered further, pairs A and B. Pair A is represented by 
the EpoA – tubulin model of Fig. 4.5 and the BacIII – tubulin model of Fig. 4.9. 
Pair B was discarded due to the fact that the aromatic ring of baccatin in the 
BacIII – tubulin complex does not occupy any of the pockets where the aromatic 
rings of paclitaxel are found in the EC-derived model of the PTX – tubulin 
complex (Nogales et al., 1998). The orientation of the baccatin core also differs 
from those found in both the EC-derived model (Nogales et al., 1998) and the 
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REDOR/FRET-derived model (Li et al., 2000; Ivery & Le, 2003) of the PTX – 
tubulin complex. In summary, the binding mode of BacIII to tubulin in pair B 
contradicts the structural data available for the interaction of taxanes with tubulin 
and was not considered further.  
The EpoA – tubulin and BacIII – tubulin models of pair A were further refined 
through 230 ps of molecular dynamics, which improved the correlation coefficient 







4.1 The structure of the tubulin-bound epothilone. 
 
The conformation of epothilone A bound to tubulin was determined by 
NMR spectroscopy in aqueous solution by a combination of tr-NOEs and tr-CCR 
rates data (Carlomagno et al., 2003b). At the time we performed this work, this 
structure provided the first and only piece of experimental information on the 
active conformation of this class of microtubule stabilizers. In the meantime, the 
structure of tubulin assembled on bidimensional sheets stabilized by Zn and 
bound to epothilone was solved by electron crystallography at 3 Å resolution 
(Nettles et al., 2004). This structure is considerably different from the one derived 
by NMR in solution, as it will be discussed in more details in the next chapter. 
Leaving aside any consideration on the resolution of the EC structure, which 
might be too low to derive the conformation of a ligand of dimension 12 X 9 X 4 
Å, the physical state of tubulin is different in the two studies, indicating that 
epothilone might bind to tubulin in a polymerization state – dependent manner. In 
this chapter I describe the results of our NMR study of the bioactive conformation 
of epothilone A in solution, while the differences with the EC derived structure 
are discussed in Chapter 5.  
Transferred nuclear Overhauser enhancement (tr-NOE) and transferred cross-
correlated relaxation (tr-CCR) methods have been employed to unravel the 
conformation of epothilones in complex with tubulin (see chapters 2 and 3). 
Fortunately, the kinetic and thermodynamic properties of the complex between 
epothilone A and tubulin are in the desirable range for tr-NOE and tr-CCR 
experiments, as indicated by the negative sign of the NOE cross peaks in a 100:1 
mixture of epothilone A with tubulin. The tr-NOE and tr-CCR data are in 
agreement with a kD in the range of 100 μM. Both epothilone A and B, the two 
major naturally occurring epothilone variants, displace 3H-paclitaxel from tubulin 
(Ki equals 1.4 μM and 0.71 μM for epothilone A and epothilone B, respectively) 
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(Kowalski et al., 1997), indicating that the tubulin binding sites of the epothilones 
and paclitaxel overlap. In our NMR system, the observation of extensive 
interligand NOEs between epothilone and taxotere with the INPHARMA method 
confirms the binding of the two drugs to the same binding pocket. 
A crucial provision for the structural investigation of the epothilone-tubulin 
complex in solution is the prevention of tubulin polymerization in microtubules. 
Electron microscopy and gel electrophoresis show that substitution of Mg2+ with 
Ca2+ (Solomon, 1977) and D2O as solvent (Chakrabarti, 1999) are sufficient to 
prevent tubulin polymerization. In this conditions and in the absence of both 
EpoA tubulin exists as a mixture of higher molecular weight aggregates of the α,β 
− dimers, as observed by electron microscopy (EM) (Fig. 2.2A) and size-
exclusion chromatography. The tubulin “aggregates” are disordered polymers, and 
no microtubules or ordered polymers are formed. The addition of a large excess of 
EpoA (12μM tubulin and 500 μM EpoA) promotes polymerization of tubulin in 
the form of tubules sheets (Fig. 2.2B). The NMR derived tubulin-bound 
conformation of EpoA refers to the “aggregate” form of tubulin. The average 
correlation time τc of the tubulin “aggregates” is approximately 1.3 μs, which 
roughly corresponds to 15 protein dimers. The small percentage of EpoA bound to 
the tubules sheets does not contribute to the observed NMR signal, because EpoA 
binds strongly to the microtubules (and consequentely to the tubules sheets) (Buey 
et al., 2004) and disappears from the NMR spectrum. In agreement with this 
consideration we do not observe any change in the EpoA NOE signals with time, 
while the microtubules sheets precipitate out of solution in a few days. Moreover, 
the average correlation time τc of the tubulin-bound epothilone observed in the 
NMR spectra is approximately 1.3 μs, which roughly corresponds to 15 protein 
dimers, while the microtubules sheets observed in the EM images contain several 
hundreds of dimers. The average correlation time of 1.3 μs is thus incompatible 
with the hypothesis that the microtubules sheets measurably contribute to the 
observed NMR signal. 
The relevance of determining the binding mode of EpoA to tubulin “aggregates” 
is evident, as the EM images prove that epothilones are able to induce the 
formation of ordered tubulin polymers (Fig. 2.2B) by binding to the disordered 
“aggregates” (Fig. 2.2A). Moreover unpolymerized tubulin is always present in 
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the form of “aggregates” (Fig. 2.2A), underlying the biological importance of 
such disordered polymers in the conformational equilibrium of tubulin.  
The tubulin bound conformation of epothilone A resulted from the analysis of 
both tr-NOEs and tr-CCR rates data. The NOESY spectra of EpoA in the presence 
and in the absence of tubulin are shown in Fig. 4.1. A comparison of the two 
spectra shows that the NOEs observed for the EpoA - tubulin mixture generate 
from the tubulin-bound form of epothilone. 46 inter-proton distance restraints 
were derived from transferred NOE experiments. To filter out spin-diffusion 
mediated peaks, only those signals, which were present with opposite sign to the 
diagonal peaks in a transferred ROESY experiment, were taken into account. 
 
         A          B 
 
 






























Fig. 4.1. NOESY spectra at 300 ms mixing time for epothilone A in D2O (a) and for the mixture 
epothilone A – tubulin 100:1 in D2O (b). The change in sign of the NOE peaks from positive 
(negative grey countours, τc < 1.12/ωH) in A) to negative (positive black contours, τc > 1.12/ωH) in 
B) proves that the NOE signals of the mixture epothilone A – tubulin B) are dominated by the 
contribution of the bound form of epothilone. C) Epothilone with atom numbering; R = H for 
epothilone A and R = CH3 for epothilone B. 
 
Seven dihedral angle restraints were obtained by measuring CH-CH dipolar-
dipolar and CH-CO dipolar-CSA transferred CCR rates for 60-70% 13C labeled 
epothilone A. The tr-CCR experiments were indispensable to obtain a unique 
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description of the bound conformation, as more than one structure of the 
macrolide ring is compatible with the same H-H distance set (NOE intensities). 
The seven tr-CCR rates defined the torsion angles O11-C1-C2-C3, C1-C2-C3-C4 
(Fig. 4.2), C2-C3-C4-C5, C5-C6-C7-C8, C12-C13-C14-C15, C13-C14-C15-O11 
and C14-C15-C16-C17.  
 
Fig. 4.2 Summary of the CCR rates that were measured to determine the tubulin-bound 
conformation of EpoA and of the dihedral angles that were derived from these tr-CCR rates. 
 
The tubulin-bound conformation of epothilone A is shown in green in Figure 4.3 
and is compared with the free (unbound) conformation of epothilone A 
determined by X-ray crystallography (Rihs, G.  and Walter, H.R. unpublished 
results), which is shown in gray. We choose to compare the tubulin-bound 
conformation of epothilone with the X-ray structure and not with the solution 
structure available in CD2Cl2, because of the extensive flexibility of epothilone in 
solution in the absence of tubulin (Taylor & Zajicek, 1999). However, the most 
populated conformer in solution is indeed very similar to the X-ray conformer. 
The position of the thiazole nitrogen (blue in Fig. 4.3) and 3-OH (red in Fig. 4.3), 
which are important for the delineation of a pharmocophore model, change 
significantly upon binding. 
A comparison of the torsion angles of epothilone A in the tubulin-bound (green in 
Fig. 4.3) and in the free (gray in Fig. 4.3) conformation (Table 1) reveals two 
major changes: the first occurs in the region O1-C6 and the second affects the 
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orientation of the thiazole ring with respect to the C16-C17 double bond. In the 
lower region of the macrocycle both cross-correlated relaxation rates and NOE 
data define the conformational change of the dihedral angle C2-C3-C4-C5, which 
switches from a gauche+ to a gauche− conformation, while the variations of the 
dihedral angles O1-C1-C2-C3 (+ anti-periplanar to − anti-clinal) and C3-C4-C5-
C6 result from the adjustment of the macrocycle to the modified torsion around 
the C3-C4 bond. The observed conformational change in the O1-C6 region of the 
ring primarily affects the position of the protons at C2, H2 and H2a, and of the 
3OH group. The two protons at C2 move towards the inner part of the ring. At the 
same time the oxygen attached to C3, which points to the inside of the macrocycle 
in the free conformation, moves by 3.8 Å towards the exterior (i.e. it now points 
away from the macrocycle).  
Neither the dihedral angle C5-C6-C7-C8, determined by tr-CCR, nor the C10-C15 
region exhibit any significant conformational change upon binding to tubulin. The 
latter finding corroborates a recent study where the conformation of the 
macrocycle in the epoxide region is investigated using analogues of epothilone B 
and D (Taylor et al., 2003). 
 
 
Fig. 4.3 Comparison of the tubulin-bound conformation of epothilone A in aqueous solution 
(green, this study) with the free conformation determined by X-ray crystallography (gray). The 
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structures can be viewed in stereo. Hydrogen atoms have been removed for clarity. The 
conformational change that occurs in the C1-C5 region is clearly visible, and it is associated with a 
significant shift in the position of the 3-OH group (in red). A second key feature of the bound 
structure is the 180º degree change in the orientation of the side chain, which liberates the nitrogen 
(in blue) of the thiazole ring from the bulky Me 27 group and makes it accessible to hydrogen 
bond donors.  
 
The second significant change between the free and tubulin-bound conformations 
of epothilone occurs in the side-chain bearing the thiazole ring. The dihedral angle 
C16-C17-C18-C19 changes from an anti-periplanar to a syn-periplanar 
conformation. This finding is substantiated by a strong NOE signal between the 
protons of Me27 and H19 together with a significant weakening of the NOE 
between H17 and H19 compared with that observed for epothilone A in aqueous 
solution and in the absence of tubulin. The eclipsed rotamer is energetically 
disfavored due to the steric hindrance between Me27 and H19. However, in this 
conformation the nitrogen of the thiazole ring becomes more accessible for 
potential hydrogen bond formation with protein functional groups or with water, 
which may more than offset an intrinsically disfavored epothilone side-chain 
conformation. 
 
4.2 The binding mode of epothilone to soluble tubulin. 
 
In this work we derived a structural model for the binding mode of EpoA to 
tubulin in solution (Fig. 4.4) by using a combination of the novel INPHARMA 
methodology (Sanchez-Pedregal et al., 2005) and molecular modeling. Briefly, 
the INPHARMA methodology relies on the observation of inter-molecular tr-
NOEs between two ligands binding competitively and consecutively to the same 
binding site of a common target protein (see Chapter 3). These NOEs are 
exclusively mediated by spin-diffusion through protons of the protein and are 
therefore dependent on the binding mode of each of the two ligands to the protein. 
An accurate and quantitative evaluation of such effects leads to the determination 
of the binding mode of the ligands to the protein.As the experimental system 
consists of two ligands binding competitively and mutually exclusively to tubulin, 
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we describe the system with a pair of structural models, one for the EpoA - 
tubulin and one for the BacIII - tubulin complexes.  
 
Table 1. Comparison of the dihedral angles of the tubulin-bound conformation and the free 
conformation of epothilone A. The values given for the tubulin-bound conformation result from 
averaging over the 10 lowest energy conformations. The values given for the free conformation 
result from crystal structure analysis of epothilone A in methyl-tert. butylether (CH3OC(CH3)3) 
solvate.[30] This conformation as well as crystal packing is nearly identical to that of epothilone B[2] 
although the two compounds crystallize from different solvents. 
 






C1-C2-C3-C4 −152.5° ± 0.2° 165.4° 
C2-C3-C4-C5 −51.7° ± 0.1° 73.0° 
C3-C4-C5-C6 −43.0° ± 1.8° −75.9° 
C4-C5-C6-C7 156.4° ± 0.5° 145.6° 
C5-C6-C7-C8 −70.0° ± 0.8° −64.0° 
C6-C7-C8-C9 −74.8° ± 0.3° −79.2° 
C7-C8-C9-C10 164.1° ± 0.8° 159.0° 
C8-C9-C10-C11 −171.9° ± 0.4° 176.8° 
C9-C10-C11-C12 −178.0° ± 0.4° 174.8° 
C10-C11-C12-C13 −129.2° ± 0.5° −112.8° 
C11-C12-C13-C14 4.1° ± 0.1° −1.9° 
C12-C13-C14-C15 76.3° ± 0.1° 93.9° 
C13-C14-C15-O1 −62.6° ± 1.0° −156.9° 
C14-C15-O1-C1 179.5° ± 0.5° 159.6° 
C15-O1-C1-C2 176.3° ± 1.3° 174.2° 
O1-C1-C2-C3 −124.3° ± 1.2° 156.7° 
C14-C15-C16-C17 −129.7° ± 1.3° −118.5° 
C15-C16-C17-C18 180.0 ° ± 0.2° 176.0° 






   
Fig. 4.4. Stereo views of the model of the EpoA – tubulin complex that best reproduces the 
experimental interligand NOEs in combination with the BacIII – tubulin complex of Fig. 4.8. In 
panel A, the solvent accessible surface colored by the electrostatic potential of tubulin is shown. In 
panel B, the thiazole ring of epothilone (white, C; red, O, blue, N and yellow, S) interacts with the 
aromatic ring of H227, while the 7-OH is situated close to T274 and R282. The H1 helix of tubulin 
is colored in red, the H2 helix in yellow. The hydrophobic stretch C8-C12 of epothilone is directed 
towards the hydrophobic floor and lower right side of the binding site. The aliphatic side chain of 
R276 entertains hydrophobic contacts with the EpoA side chain, while the guanidinium group 
interacts face-to-edge with the thiazole ring and enjoys a favorable electrostatic interaction with 
the negatively charged side chain of D224. 
 
After application of selection criteria used to evaluate the agreement between the 
calculated and experimental NOEs in each pair of EpoA – tubulin and BacIII  –
 tubulin complex models (see Chapter 3 for details), one family of model pairs 
was uniquely identified. The representative model of the EpoA – tubulin complex 
in this family that uniquely satisfies the experimental intermolecular tr-NOEs is 
shown in Fig. 4.4 and represents the NMR-determined binding mode of EpoA to 
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soluble tubulin. We can exclude that the recently published EC-derived binding 
mode of EpoA to tubulin (Nettles et al., 2004) is present in solution, as this model 
provides a very poor agreement between calculated and experimental 
intermolecular tr-NOE data in combination with any of the 5000 binding modes of 
BacIII. As it will be discussed below, the complex displayed in Fig. 4.4 provides a 
good explanation of the SAR data obtained for epothilone analogues and gives an 




Fig. 4.5. Stereo view of the superposition of the NMR-derived EpoA (green) binding mode and 
EC-derived paclitaxel (light blue) binding mode to β-tubulin (Nogales et al., 1998): The thiazole 
ring of EpoA roughly overlaps with the C3’ benzamido phenyl of paclitaxel. Additionally, the 3-
OH of EpoA is close to the 1’-CO and 2’-OH of paclitaxel. 
 
Most importantly, the pharmacophore of the NMR-derived binding mode of EpoA 
to tubulin partially resembles that of the EC-derived binding mode of paclitaxel 
(Nogales et al., 1998) (vide infra), with the addition of a few intermolecular 
interactions that are unique to the EpoA – tubulin complex. This is in contrast to 
the EC-derived model of the EpoA – tubulin complex (Nettles et al., 2004), where 
no common feature is observed between the pharmacophores of EpoA and 
paclitaxel.  
The position of the thiazole ring in the NMR-derived structure of the Epo A – 
tubulin complex is close to that of the C3’-benzamido phenyl in the PTX – tubulin 
complex (Fig. 4.5). The thiazole ring is involved in aromatic - aromatic 
interactions with the ring of H227 (Fig. 4.4Β). The thiazole and the histidine rings 
are stacked in a face-to-face orientation, though rather tilted, at an angle of ca. 
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30°. This result is in good agreement with the observation that the protonated 
histidine rings usually interact with tryptophane rings in a face-to-face orientation 
in protein hydrophobic cores (Sumanta et al., 1999).   
The intermolecular contacts involving the hydroxyl group on the C7 of EpoA 
represent a unique feature of the EpoA – tubulin complex. In our model the 
positively charged side chain of R282 entertains extensive electrostatic contacts 
with the polarized C7-OH of EpoA (Fig. 4.6). This interaction locks the side chain 
of R282 in an optimal position for forming a H-bond with the side chain of T274, 
thereby stabilizing a specific conformation of the tubulin M-loop, which might be 
relevant for microtubule stabilization. The involvement of T274 and R282 in this 
network of electrostatic interactions justifies the loss in the activity of epothilones 
in cell lines containing either the T274I or the R282Q mutation (40-fold and 57-
fold activity loss, respectively) (Giannakakou et al., 2000). This pattern of 
electrostatic interactions is exclusively observed in the EpoA – tubulin complex 
and is not present in the PTX – tubulin complex, as confirmed by the higher 
tolerance of paclitaxel to the T274I and R282Q mutations (Giannakakou et al., 
2000).  
The aliphatic side chain of R276 entertains hydrophobic contacts with the EpoA 
side chain, while the guanidinium group interacts face-to-edge with the thiazole 
ring and enjoys a favorable electrostatic interaction with the negatively charged 
side chain of D224. This contact, together with the electrostatic interaction of the 
C7-OH with R282 and the aromatic-aromatic interaction of the thiazole ring with 
the H227, locks the position of the helix H7 with respect to the M loop. As I will 
discuss in chapter 5 the role of EpoA as bridging molecule between the helix H7 
and the M loop of tubulin is relevant to the biological function of the drug. 
The epoxide oxygen of EpoA is not involved in extensive protein – ligand 
interactions, in agreement with the high activity of the unsaturated analogues 
EpoC and EpoD. The EpoA stretch C9-C12 enjoys hydrophobic interactions with 
the leucine-rich floor of the protein pocket including P272, L273, L284 and L369 
(Fig. 4.7). The epoxide ring is situated at the entrance of the hydrophobic pocket 
hosting F270; however, epothilone does not enter this pocket, as opposed to 
paclitaxel, which locates its C2-benzoyl phenyl close to F270. In accord with the 
NMR-derived structural model of the EpoA – tubulin complex, epothilones retain 
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their activity in cell lines exhibiting the F270V mutation, while the activity of 
paclitaxel is decreased by 27-fold (He et al., 2001). 
 
  
Fig. 4.6. Interactions of the 7-OH of EpoA with R282 and T274 of tubulin. Electrostatic 
interactions between the guanidinium group of the arginine and the EpoA 7-OH define a 
conformation of the M-loop, which favors the formation of a H-bond between R282 and T274. 
 
  
Fig. 4.7 Stereo view of the model of the EpoA – tubulin complex of Fig. 4.4, which shows the 
hydrophobic interactions of the EpoA stretch C9-C12 with the leucine-rich floor of the binding 
pocket including P272, L273, L284 and L369. The epoxide ring is situated at the entrance of the 
hydrophobic pocket occupied by F270. 
 
The model of the BacIII – tubulin complex that provides a good fit of the 
experimental interligand NOEs with the EpoA – tubulin complex model of Fig. 
4.4, is shown in Fig. 4.8. In contrast to our expectation, the baccatin binding mode 
obtained by the EC-derived PTX – tubulin complex (Nogales et al., 1998) after 
removal of the side chain on C13 does not fit the experimental interligand NOE 
data in combination with any of the EpoA – tubulin complex models (R ≤ 0.75). 
Instead, docking models where baccatin places the C2 benzoyl phenyl ring in the 
pocket occupied by the C3’ phenyl in the PTX – tubulin complex, close to F270, 
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are consistent with the INPHARMA data. The orientation of the baccatin core in 
the BacIII – tubulin complex of Fig. 4.8, however, is similar to the one proposed 
for the PTX – tubulin complex on the basis of FRET and REDOR data (Li et al., 
2000; Ivery and Le, 2003). The fact that the binding mode of baccatin to tubulin 
differs from the one of paclitaxel is not surprising, considering that baccatin lacks 
the C3’ benzamido phenyl, which plays a fundamental role in the determination of 
the binding mode of paclitaxel to tubulin by interacting with H227. It should be 
noted that our model of the BacIII – tubulin complex explains the enhanced 
activity of 2-m-azido baccatin by invoking the interaction of the azido group with 
the guanidinium group of R320 (Ivery & Le, 2003). However, we do not exclude 
that 2-m-azido baccatin might have a binding mode that differs from that of 
baccatin, as allowed by the broad and flexible tubulin binding pocket and in 




Fig. 4.8 Model of the BacIII – tubulin complex that best reproduces the experimental interligand 
NOEs in combination with the EpoA – tubulin complex of Fig. 4.4. The orientation of the baccatin 
core differs from the one observed in the EC-derived model of the PTX – tubulin complex 
(Nogales et al., 1998) and is similar to that proposed on the basis of FRET and REDOR data (Li et 
al., 2000; Ivery and Le, 2003). The C2 benzoyl phenyl is situated in the hydrophobic pocket 
defined by F270 and L369, where paclitaxel places the C3’ phenyl in the EC-derived complex 








5.1 The structure of the tubulin-bound epothilone. 
 
The tubulin bound conformation of epothilone derived by NMR is solution 
(Fig. 4.3) is consistent with the wealth of chemical modification data available for 
this class of compounds. The SAR data available for epothilones indicate that the 
C4-C8 region and the side-chain are critical for binding.  
The hydroxyl group attached to C3 is one of the biologically most relevant sites. 
The inversion of the stereochemistry at C3 results in a considerable loss of 
potency in the induction of tubulin polymerization (Nicolaou et al., 1997). On the 
other hand, α,β-unsaturated (trans double bond between C2 and C3) analogs of 
epothilones A and B are almost as active as the natural products. A very recent 
report by G. Vite also showed that the replacement of the hydroxyl group at C3 
with a cyano moiety leads to a compound that retains high biological activity 
(Reguiero-Ren et al., 2002). In the epothilone free conformation this OH group 
points towards the inner part of the ring and its oxygen atom is not easily 
accessible for the formation of external hydrogen bonds; conversely, in the 
tubulin-bound conformation the 3OH group points outwards, which potentially 
makes the oxygen a better acceptor of hydrogen bonding from tubulin side-chains. 
This observation is consistent with chemical modification data which underline 
the importance of the stereochemistry at C3 and therefore of the position of the 
3OH group. On the other hand, the fact that α,β unsaturated epothilone analogues 
are almost as active as the natural compound indicates that the OH group is not 
crucial for  binding to tubulin.  
The second profound conformational change observed upon binding of epothilone 
to tubulin concerns the orientation of the thiazole side–chain, which undergoes a 
180º rotation around the C17-C18 bond to liberate the nitrogen of the thiazole ring 
from the hindrance of the methyl group C27. It might be speculated that the 
nitrogen is now better available for hydrogen bond formation with a tubulin side-
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chain. The potential role of the nitrogen as hydrogen bond acceptor is 
corroborated by chemical modification data: the tubulin polymerization activity is 
retained upon substitution of the thiazole ring with a 2-pyridyl moiety, while the 
incorporation of 3 or 4-pyridyl residue causes a reduction in the biological activity 
(Nicolaou et al., 2000). However, substitution of the thiazole ring with a phenyl 
ring, lacking any H-bond acceptor, does not have any effect on the ability of 
epothilone to induce tubulin polymerization (Altmann, private communication), 
but is detrimentous only for the cellular activity of the drug. Taken together these 
facts do not support the relevance of an hydrogen bond, involving the N of the 
thiazole ring as acceptor, in the binding mode of EpoA to tubulin. Moreover, the 
electron distribution in heterocycles is complex and their interaction with other 
aromatic rings includes additional options than H-bonds, not disregarding 
solvation effects. In fact, NOESY spectra acquired for EpoA in water al low 
temperature and in absence of tubulin indicate that the dihedral angle C16-C17-
C18-C19is in conformational equilibrium between the syn-periplanar and the 
anti-periplanar conformation. The presence of an H-bond between the nitrogen of 
the thiazole ring and tubulin side-chains could not be confirmed in the NMR 
derived model of the epothilone – tubulin complex (vide infra). 
SAR data on epimers of 14-methyl EpoB and EpoD show that the R configuration 
for EpoB and the S configuration for EpoD retain most of the biological activity 
while the respective S and R configurations are inactive (He et al., 2000; Taylor et 
al., 2004). In agreement with these data, 14-methyl EpoB with S configuration at 
the C14 could not adopt the NMR-derived bioactive conformation due to steric 
hindrance with the Me27 and the H10 proton. Analogously, introduction of a 
methyl group at the C10 with S configuration leads to inactive EpoC, as expected 
from the steric clash of this additional methyl group with the protons at the C2.  
The (E)-9,10-dehydro- and (E)-10,11-dehydro- analogues have been found to 
retain the biological activity of epothilone (Taylor et al., 2003; Rivkin et al., 
2003), in agreement with the trans disposition around the C9-C10 and C10-C11 
torsion angles of the NMR-derived bioactive conformation. 
Recently, the structure of tubulin bound to EpoA, assembled into two-dimensional 
sheets stabilized by Zn2+ ions, was derived by electron crystallography (Nettles et 
al., 2004). Interestingly, the tubulin-bound structure of epothilone A derived by 
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electron crystallography contradicts the NMR derived conformation of the 
compound bound to soluble tubulin (Fig. 5.1). Several dihedral angles, which 
were determined for the tubulin-bound conformation of EpoA by tr-CCR rates in 
the NMR study, strongly differ in the two conformations.  
 
Fig. 5.1 Comparison of the tubulin-bound conformation of EpoA derived by electron 
crystallography (in red) (Nettles et al., 2004), for tubulin assembled in two-dimensional sheets 
stabilized by zinc, and that derived by NMR (in blue) (Carlomagno et al., 2003b), for soluble 
tubulin. The yellow bonds are those for which the torsion angles were determined by tr-CCR rates. 
The two conformations conspicuously differ. 
 
However, in both conformations the 3OH points towards solution and the N of the 
thiazole side chain is not buried between the two methyl groups at C27 and C21.  
The discrepancy between the two conformations can be explained by invoking the 
dependence of the conformation and the binding mode of EpoA on the assembly 
state of the protein. Such interplay is likely to be mediated by the conformation of 
the M loop, which undergoes a defined change between the aggregate form, 
present in the NMR experiments, and the polymeric form which is found in Zn2+-
stabilized sheets. Here, the M-loop is involved in lateral contacts with the helices 
H12 and H5 of a second β unit of tubulin (Nogales et al., 1998) (antiparallel 
assembly of the protofilaments). It should be noted that the lateral contacts of 
tubulin in Zn2+-stabilized sheets differ substantially from those of the biologically 
relevant assembly state, i.e. the microtubules. In the latter, the tubulin 
protofilaments are arranged parallel and the lateral contacts are found between the 
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M loop of one β subunit and the S1-H2 loop (Fig. 1.1) and H3 helix of the other β 
subunit (Li et al., 2002).  
In this work, we have studied the binding mode of epothilone to soluble tubulin. 
With the help of NMR data and electron micrographs (Fig. 2.2. and Section 4.1) 
we have demonstrated that epothilone binds indeed to non-microtubular soluble 
tubulin to induce formation of elongated ordered polymers even in absence of 
Mg2+ and GTP. Therefore, the conformation derived here can be considered the 
first member of a series of different structures along the tubulin polymerization 
pathway of the epothilone – tubulin complex. It should be underlined that the EC-
derived model cannot be conciliated with the NMR structural data, which allows 
us to exclude that this structure is populated in solution. The “aggregate”, non-
microtubular form of soluble tubulin is observed in micrographs of ligand-free, 
unpolymerized tubulin and to a lesser extent in micrographs of microtubules (Diaz 
& Andreu, 1993), which underlies the functional relevance of such disordered 
polymers in the conformational equilibrium of tubulin. The structure of epothilone 
bound to soluble tubulin, as well as the model of the epothilone – tubulin 
complex, represents the first functional step in the cascade of conformational 
change events, which lead to the formation of hyper stable microtubules. 
 
5.2 The binding mode of epothilone to soluble tubulin. 
 
The NMR-derived structural model for the EpoA – tubulin complex 
explains well the SAR data available on epothilones. We show this by discussing 
the most significant chemical modification data. 
Replacement of the thiazole ring by various types of substituted pyridine rings is 
well tolerated (Nicolaou et al., 2000); a simple phenyl group in place of the 
thiazole ring does not have a significant effect on the tubulin polymerizing 
activity of epothilone but causes a decrease of the epothilone activity of ca. one 
order of magnitude in cells (Altmann et al., 2000). A pyridine ring linked at 
position 2 is considerably preferred over a pyridine rings linked at position 3 or 4. 
These data were interpreted as an indication that the nitrogen of the thiazole ring 
accepts a H-bond from tubulin side chains. However, the electron distribution in 
heterocycles is complex and not predictable with simple models. Moreover, the 
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fact that a phenyl ring in place of the thiazole does not affect the tubulin 
polymerizing activity in a test-tube suggests that the nirogen of the thiazole ring 
might be important for the transport of epothilone into the cells and not for its 
binding to tubulin. In our complex no H-bond is formed between the nitrogen of 
the thiazole ring and the side chains of tubulin. Instead, the two proton-bearing 
nitrogens of the histidine ring are situated above the sulphur and the nitrogen of 
the thiazole ring respectively. This allows a favorable interaction between the 
delocalized charge of the His ring and the π orbital of the thiazole ring, which has 
a higher electron density at the sites of the S and N. Any perturbation of the 
position of the sulphur or nitrogen atoms results in a less favorable interaction. In 
addition, our model preserves a favorable contact between the aromatic rings of 
the histidine and the thiazole, which are in a tilted face-to-face orientation with 
respect to each other (Fig. 4.4), as often observed for protonated histidine rings in 
protein cores (Samanta et al., 1999). 
Substitution of the methyl group C21 of the thiazole ring with small polar or 
apolar substituents is well tolerated, while introduction of large substituents on 
C20 leads to inactive epothilones (Nicolaou et al., 1998; Höfle et al., 1999). In 
our model bulky substituents on C20 would distort the position of the side chains 
in the H1 helix and in the H2-B3 loop, thus disturbing the overall structure (Fig. 
4.4). 
Inversion of the stereochemistry of C3 is detrimental for biological activity 
(Nicolaou et al., 1997), while a cyano group in place of the hydroxyl group is well 
tolerated (Regueiro-Ren et al., 2002), as is a trans C2-C3 double bond. In our 
model, the 3-OH group is not involved in close contacts with the protein. 
Inversion of the stereochemistry of C3, however, might destabilize the bioactive 
conformation of EpoA, due to steric clash of the 3-OH group with the proton H6. 
A trans C2-C3 torsion angle is required for function, as confirmed by the 
biological activity of (E)-2,3-dehydro epothilone. Additionally, we observe that in 
the EC-derived structure of the PTX – tubulin complex, paclitaxel places the 
hydrophilic carbonyl and hydroxyl groups of the C1’-C2’ stretch in about the 
same position as the 3-OH of EpoA (Fig. 4.5), without any evident contacts with 
tubulin (Nogales et al., 1998). It has been proposed that paclitaxel stabilizes the 
lateral contacts of the β subunits by mimicking the binding of the eight extra 
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residues of the M-loop present in the α subunit. Binding of paclitaxel converts the 
hydrophobic binding site into a hydrophilic surface, similarly to the α subunit, 
where the backbone carbonyls of the inserted residues are presented on the 
surface. The possibility that the significance of the 3-OH group of EpoA resides in 
the generation of a hydrophilic protein surface, similar to that of the α subunit, 
remains to be investigated. 
Ligand – protein interactions at the C7 site are confirmed by SAR data, which 
indicate that simultaneous inversion of the stereochemistry of C6 and C7, as well 
as removal of the methyl group at C8, causes a considerable loss of activity 
(Nicolaou et al., 1998). In our model inversion of C7 would seriously disturb the 
H-bond network around R282 and T274, which represents a fundamental 
interaction of EpoA with the M-loop (Fig. 4.6). Additionally, inversion of the C6 
would prevent EpoA from assuming its active conformation, due to steric 
hindrance between the methyl group at C6 and the H2 and H9 protons. Finally, 
the lack of the methyl group at the C8 would eliminate the positive hydrophobic 
interactions of EpoA with both L284 and L369 (Fig. 4.7). 
          
           A                                                              B 
          
Fig. 5.2 Comparison of the EC derived model of the epothilone – tubulin complex (panel A) with 
the NMR derived model of the same complex (panel B).  
 
Most importantly, our model accommodates very well the activity data for 
epothilones with structural modification on C12.  EpoB, with a methyl group on 
C12, is more active than EpoA. Small apolar substituents on C12 are in general 
well tolerated, as they would be placed in the hydrophobic pocket hosting F270 






cannot be easily accommodated in this pocket, as reflected by the lower activity of 
such modified epothilones (Nicolaou et al., 1998). 
The NMR-derived model of the EpoA – tubulin complex differs from the EC-
derived one (Fig. 5.2). Four are the major differences between the two models, in 
addition to the divergent conformation of the bound epothilone (Fig. 5.1).  
First, in the EC derived model the nitrogen of the thiazole side chain of epothilone 
makes a H-bond with the aromatic ring of H227 (Fig. 5.2A), while in the NMR 
derived model the N22 of epothilone is not involved in H-bonds with the protein 
side chains. However, our model preserves a favorable contact between the 
aromatic rings of H227 and the thiazole of EpoA, situated face-to face to each 
other, as opposed to the EC-derived model, where the two aromatic rings are 
situated edge-to-edge, in an orientation seldom observed in protein cores 
(Samanta et al., 1999). Moreover, on the basis of the EC derived model, one 
would predict a conspicuous loss of the tubulin polymerizing activity of 
epothilones bearing a phenyl instead of a thiazole ring in the side-chain. 
Contrarily, substitution of the thiazole ring by a phenyl ring has been found to 
affect only the activity of epothilone in cells, while the induction of tublin 
polymerization in a test-tube is comparable for wild-type and modified 
epothilones. 
Second, in the EC derived model the 3OH of EpoA could entertain a H-bond with 
the carbonyl of T274 (Fig. 5.2), while in the NMR derived model the 3OH of 
epothilone is not involved in H-bonds with the protein side chains. However, the 
importance of the 3OH hydroxyl group in tubulin binding is not confirmed, as 
(E)-2,3-dehydro epothilone, lacking the 3OH group, possesses a high biological 
activity. The drop in activity of epothilones with inverted stereochemistry at C3 
could be related to the inability of such mutant epothilones to assume a trans 
conformation for the C2-C3 torsion angle, which seems to be required for 
function. 
Third, the EC-derived model does not explain the higher activity of EpoB vs. 
EpoA, as substituents on C12 would be projected towards solution, thus making 
no additional contacts with the protein side chains. In contrast, in our model 
substituents on C12 would be placed in the hydrophobic pocket hosting F270 and 
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L369 and left empty by EpoA, which provides a rationale for the higher activity 
of EpoB vs. EpoA.  
Fourth, in contrast to the NMR-derived complex, the EC derived model does not 




Fig. 5.3. Superposition of the straight (green) and bent (red) conformations of tubulin. Epothilone 
is shown in the taxane binding pocket in the binding mode of Fig. 4.4. GDP is shown in magenta. 
 
The existence of two models for the EpoA – tubulin complex, which have been 
derived from different experimental data, suggests that the binding mode of EpoA 
to tubulin might depend on the tubulin polymerization state. The NMR-derived 
complex contains tubulin in the soluble state, namely in the functionally relevant 
state of the protein before polymerization. The EC-derived complex contains 
tubulin in the polymerized state on Zn-stabilized sheets, which are however never 
found in cells and therefore artificial. Future efforts aimed at the verification of 
the influence of the polymerization state of the protein on the binding mode of 
MSAs are essential to understand how microtubule-stabilizing drugs control 
tubulin function. 
Recent work of the Knossow and Nogales laboratories (Ravelli et al., 2004; Wang 
& Nogales, 2005) suggests that microtubules stabilization occurs via straightening 
of the curvature at the α and β units interface in protofilaments (Fig. 1.2). In 
particular a 2.5 Å translation of the helix H7, which drags along the H6-H7 loop 
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and the helix H6, is the major player in determining the curvature at the interface 
between heterodimers (Fig. 1.2) (Ravelli et al., 2004). These authors propose that 
GDP and GTP regulate microtubules stability by influencing the equilibrium 
between the straight (green in Fig. 5.3) and bent (red in Fig. 5.3) tubulin 
conformation. When GTP is bound the H7 lever helix is pushed towards its 
straight conformation through interaction of the nucleotide with the N-terminal 
end of this helix. We propose that epothilone regulates microtubules stability by 
the same mechanism but operating from the other side of the H7 helix. When 
epothilone binds tubulin, it acts as a linker between the H7 helix and the M loop, 
thereby pulling the H7 helix in the direction of the M loop, namely in the 
conformation assumed in the straight form of tubulin (Fig. 5.3). We propose that 
the direct contact of the M-loop residue R278 with the H7 residue D224, mediated 
by epothilone, and the interactions of epothilone with the H7 residue H227 and 
the M-loop residues R284 and T274, lock the relative position of the H7 helix and 
the M-loop, thereby stabilizing the straight conformation even in absence of GTP. 
This model provides a rationale for the mechanism of action of the drug. 
In conclusion, our data establish a relationship between the functional mechanism 
of epothilone and its binding mode to tubulin. The differences between the 
structure of the EpoA − tubulin complex in solution and in Zn-stabilized sheets 
and the incompatibility of the EC-derived structure with the NMR data in solution 
underlines the importance of accessing structural data for the EpoA − tubulin 
complex in the different polymerization states. We expect our results to be helpful 
for the development of improved therapeutic molecules, based on the existence of 





A novel pharmacophore for peptide toxins interacting 






1.1 The biological system. 
 
Potassium (K+) channels are a very diverse group of proteins that are key 
elements for a variety of different physiological functions, including the electrical 
excitability of cells (Hille, 2001).  During evolution a great variability of peptide 
toxins targeting different K+ channels have been evolved by several venomous 
organisms including snakes, spiders and scorpions.   
Despite the lack of any obvious structural homology, unrelated toxins that interact 
with voltage activated K+ channels, including charybdotoxin from a scorpion, 
BgK from a sea anemone and dendrotoxin from snakes, share a common 
structural feature. A dyad motif, composed of a lysine and a hydrophobic amino 
acid residue, usually a phenylalanine or a tyrosine is the key player in the binding 
to the target K+ channel (Stampe et al., 1994; Dauplais et al., 1997; Savarin et al., 
1998; Gilquin et al., 2002; Srinivasan et al., 2002). The lysine residue of this 
functional dyad has been proven to penetrate the K+ channel pore, thereby 
occluding it (Miller, 1995; Eriksson & Roux, 2002; Gao & Garcia, 2003). In 
particular, the dyad motif is present in all the diverse peptides that interact with 
the voltage-gated Kv1 subfamily of K+ channels, such as the Shaker channel from 
Drosophila (Dauplais et al., 1997; Savarin et al., 1998; Gilquin et al., 2002; 
Srinivasan et al., 2002; Rauer et al., 1999; Jacobson et al., 2000). Therefore, it 
was hypothesized that all peptidic toxins targeting Kv1 channels possess a 
common pharmacophore, centered on a functional dyad.  
The venoms of the marine cone snails are known to contain different families of 
peptides, the so called conotoxins, which target ligand gated and voltage gated ion 
channels with great specificity. These cysteine-rich peptides are classified into 
groups based on their structural scaffolds and target specificity (Terlau & Olivera, 
2004).  κ-conotoxin PVIIA (κ-PVIIA), a Shaker K+ channel blocker (Terlau et al., 
1996; Shon et al., 1998) was the first K+ channel-targeted conotoxin to be 
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characterized. Although structurally unrelated to other known K+ channel 
blockers, κ-PVIIA shares the common feature of a functional lysine/hydrophobic 
residue dyad (Jacobson et al., 2000).  Recently, the group of H. Terlau at the 
University of Lübeck described a novel Conus peptide ligand, κM-conotoxin 
RIIIK (κM-RIIIK), that blocks the Shaker K+ channel in a state-dependent 
manner. By using Shaker channel mutants with single residue substitutions it was 
shown that κM-RIIIK interacts with the pore region of the channel. Introduction 
of a negative charge at residue 427 (K427D) greatly enhances the affinity of κM-
RIIIK, whereas substitutions at the residues F425 and T449 strongly reduced toxin 
affinity. The teleost homolog of Shaker, the trout TSha1 K+ channel is the highest-
affinity target of κM-RIIIK yet identified (Ferber et al., 2003).  The 24 amino 
acids sequence of κM-conotoxin RIIIK contains three positively charged residues 




Fig. 1.1 Sequence alignment of κM-conotoxin RIIIK to other M-superfamily peptides and κ-
conotoxin PVIIA. O = 4-hydroxyproline;  # denotes an amidated C-terminal amino acid. 
 
The absence of an aromatic side chain raised the intriguing question about the 
presence of the lysine/hydrophobic dyad motif in κM-RIIIK. If a functional dyad 
is present a non-aromatic residue must be the hydrophobic counterpart of the 
positively charged lysine. However, it is conceivable that κM-RIIIK binds the 
TSha1 K+ channel with a novel, not yet identified pharmacophore.  
κM-RIIIK shares the same disulfide connectivity with other conotoxins belonging 
to the M-superfamily (Fig. 1.1). μ-conotoxins GIIIA and GIIIB are Na+ channel 
blockers, while   ψ-conotoxins PIIIE and PIIIF are antagonists of the nicotinic 
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acetylcholine receptor. The similarity in the cysteine bridge schema of the three 
peptides, despite their completely different functions, poses the challenging 
question if the pharmacological selectivity of these peptides is based on general 
differences in the overall three-dimensional shape or on subtle differences in the 
charge and hydrophobic side-chain distribution on the surface of the peptide.  
 
1.2 The question we ask 
 
In this work we combine systematic mutational analysis, NMR structural 
analysis, thermodynamic mutant cycle analysis and docking calculations to 
answer the following questions: 
1. Which amino acids of κM-RIIIK are essential for channel binding and does the 
petide contain a functional dyad? 
2. Is there any structural similarity between κM-RIIIK and the other peptide of the 
M-superfamily μ-GIIIA and GIIIB and ψ-PIIIE and PIIIF, which have a different 
pharmacological profile? Is there any structural similarity between κM-RIIIK  and 
κ-PVIIA with the same activity spectrum? 
3. With which pharmacophore does κM-RIIIK bind the TSha1 K+ channel? Are 
the intermolecular recognition features similar in the κM-RIIIK/K+ channel 
complex and in the μ-GIIIA/Na+ channel complex? 
4. Are the several hydroxyproline residues present in κM-RIIIK of any 
significance for channel binding? 
 
1.3 Significance of the work  
 
The structural/functional study conducted here has a broad significance 
because κM-RIIIK is at the unique intersection between structural similarity and 
similar target specificity. We will show that κM-conotoxin RIIIK binds the K+ 
channel TSha1 with a novel binding mode, which is not centered on a functional 
dyad. The intermolecular interactions, involving the channel loops and the toxin 
positively charged side chains, identified in this work, are of general importance 
in determining the selectivity of peptidic toxins for ion channels. 
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We will provide direct evidence that κM-conotoxin RIIIK and κ-conotoxin 
PVIIA, which both inhibit the same K+ channel subtypes, are both structurally 
divergent and mechanistically dissimilar. In contrast, κM-conotoxin RIIIK is 
structurally highly similar to genetically related conotoxins (i.e., μ-conotoxin 
GIIIA and ψ-conotoxin PIIIF), which have a completely different target 
specificity (K+ channels, Na+ channels, Ach receptors). Additionally, we will 
show that the binding mode of κM-RIIIK to the TSha1 channel closely resembles 
that of μ-conotoxin GIIIA to the NaV1.4 Na+ channel. This observation 
demonstrates that the two conotoxins have developed a similar scaffold and 
binding geometry to their respective targets, while the pharmacological selectivity 
is determined by the exact charge distribution and three-dimensional shape. This 
provides a potential framework for understanding both molecular convergence 









Peptide synthesis. Synthetic conotoxin κM-RIIIK was produced by solid-
phase peptide synthesis for structure determination by NMR spectroscopy. 
Peptides were synthesized manually on a methylbenzhydrylamine resin (2g) 
(Stewart et al., 1976) (substitution was 0.2-0.4 meq./g).  The following side chain 
protected Boc-amino acids were used: Hypro (Bzl), Cys(Mob), Asn(Xan), 
Arg(Tos), Lys(Cl-Z), Ser(Bzl),Tyr(Br-Z), His(Tos), Glu(Chx).  Most peptide 
couplings were mediated for 1 h by diisopropylcarbodiimide in CH2Cl2 or N-
methylpyrrolidone in the presence of HOBt and monitored by the qualitative 
ninhydrin test of Kaiser (Kaiser et al., 1970). Couplings including and following 
hydroxyproline were achieved using 3 equivalents (eq.) of protected amino acids 
(based on the original substitution of the resin) preactivated in NMP with 2.9 eq 
TBTU, 6 eq. HOBt and 9 eq. DIPEA.  Boc removal was achieved with TFA (60% 
in CH2Cl2, 1% m-cresol) for 10 min.  After deblocking, the resin was washed 
with methanol followed by successive washes with triethylamine (10% in 
CH2Cl2), methanol, triethylamine, methanol and CH2Cl2.  The completed peptide 
was then cleaved from the peptido-resin (weight gain varied between 1.5 to 2.0 
grams) by HF containing the scavengers anisole (10% v/v) and methyl sulfide 
(5% v/v) for 90 min at 0 °C.  The deprotected and cleaved peptide was 
precipitated in ether with 1% mercaptoethanol and separated from the spent resin 
by filtration after dissolution in aqueous 0.1% TFA and 60% acetonitrile.  The 
major and desired component was isolated using preparative reverse phase HPLC 
using an acetonitrile gradient in 0.1% TFA-water.  The fractions containing the 
desired peptide (300-400 mL) were combined and degassed with argon for 5 min.  
A buffer solution (500-600 mL) made of distilled water, 9.6 g (0.1 mol) 
ammonium carbonate, 100 mg EDTA (0.27 mmol), 250 mg of Cysteine.HCl (1.6 
mmol) and 250 mg of Cystine (1.05 mmol) and 100 mL acetonitrile was also 
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degassed using argon and added to the reduced peptide solution (300-400 mL); 
the pH (ca 8.8) was immediately adjusted to 8.2 with glacial acetic acid.  The 
clear solution was stirred under argon for 16 hrs at room temperature.  The folding 
was followed by HPLC and generally completed within a few hours. 
After the folding was completed, the reaction mixture was acidified with TFA, 
diluted with the same volume of water, then loaded to a preparative HPLC (Miller 
& Rivier, 1998) cartridge (5 cm × 30 cm) packed in the laboratory with reversed-
phase 300Å Vydac C18 silica (15-20 μm particle size).  The peptides eluted with a 
flow rate of 100 mL/min using a linear gradient of 1% B per 3 min increase from 
the baseline % B (eluent A = 0.25 N TEAP pH 2.25, eluent B = 60% CH3CN, 
40% A).  All peptides were subjected to a second purification step carried out 
with eluents A = 0.1% TFA in water and B = 60% CH3CN/40% A on the same 
cartridge using a linear gradient of 1% B per min increase from the baseline % B.  
Analytical HPLC screening of the purified fractions was performed on a Vydac 
C18 column (0.46 x 25 cm, 5 μm particle size, 300 Å pore size) and a 0.1% TFA 
solvent system.  The fractions containing the product were pooled and subjected 
to lyophilization.  The final yield for these purified peptides was about 5-25% (20-
120 mg). 
Characterization of analogues.  The purity of the final peptides was determined 
by analytical RP-HPLC performed with a linear gradient using 0.1 M TEAP pH 
2.5 as eluent A and 60% CH3CN/40% A as eluent B on a Hewlett-Packard Series 
II 1090 Liquid Chromatograph connected to a Vydac C18 column (0.21 x 15 cm, 5 
μm particle size, 300 Å pore size), Controller Model 362 and a Think Jet printer.  
Capillary zone electrophoresis (CZE) analysis was performed as described earlier 
(Miller & Rivier, 1998). Peptides are more than 90% pure by HPLC and CZE in 
most cases.  Mass spectra (MALDI-MS) were measured on an ABI-Perseptive 
DE-STR instrument.  The instrument employs a nitrogen laser (337 nm) at a 
repetition rate of 20 Hz.  The applied accelerating voltage was 20 kV.  Spectra 
were recorded in delayed extraction mode (300 ns delay).  All spectra were 
recorded in the positive reflector mode.  Spectra were sums of 100 laser shots.  
Matrix alpha-cyano-4-hydroxycinnamic acid was prepared as saturated solutions 
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in 0.3% trifluoroacetic acid in 50% acetonitrile.  The observed monoisotopic (M + 
H)+ values of each peptide corresponded with the calculated (M + H)+ values. 
1D NMR spectra were used to prove the structural integrity of the alanine 
analogues which showed a profound reduction in the binding affinity. For these 
mutants (L1A, R10A, K18A and R19A) only local chemical shift changes are 
observed, indicating that the overall structure is conserved.  
Molecular biology. The original DNA clone of the Shaker-related K+ channel 
(TSha1), from CNS of rainbow trout (Oncorhychus mykiss), was kindly provided 
by Prof. Dr. G. Jeserich, University of Osnabrück, Germany). In vitro site-
directed mutagenesis of TSha1 was performed following standard procedures 
(Ishii et al.,1998; Sambrook & Russel, 2001) and according to manufacturer 
protocols when commercial kits were used. The vector used throughout this study 
was pSGEM (3118 bp), a modified version of pGEMHE, which was a generous 




NMR analysis. The sample was prepared by dissolving 2.4 mg of the 
peptide in 300 μl of 90% H2O/10% D2O, pH 3.5. and measured at 25 °C. A pH of 
3.5 was chosen because of the lower solvent exchange rate of the HN protons. No 
substantial difference was observed in the relative chemical shifts of the HN peaks 
when raising the pH to 6.5 or lowering the temperature to 5 °C, indicating that the 
structure of the peptide does not vary significantly among the different conditions.  
An additional peptide sample for the measurement of N-HN dipolar couplings was 
prepared by dissolving 2.4 mg peptide in 14 μl pentaethylene glycol monododecyl 
ether (C12E5) and 317 μl of a 10% D2O/H2O mixture (Rückert & Otting, 2000).  
The nematic phase formed after adding 2 μl n-Hexanol and vigorous mixing. 
Resonance assignment and structural restraints were obtained by conventional 
NMR methods for unlabelled peptide chains (Wüthrich, 1986).  NOESY (Jeener 
et al., 1976) with mixing times of 100 ms and 350 ms, DQF-COSY (Rance et al., 
1983), TOCSY (Braunschweiler & Ernst, 1983), 15N and 13C HSQC (Bax et al., 
1990) NMR spectra were collected on Bruker-Avance 600 and 700 MHz 
spectrometers. 
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Solvent exchange rates of the HN protons were measured by adding 300 μl pure 
D2O to 2.4 mg of κM-conotoxin RIIIK. Eight TOCSY experiments were 
performed after 0h, 1h, 2h, 4h, 8h, 16h, 22h and 36h. After adding D2O the 
following HN protons were still observable: Cys4, Ser6, Leu9, Arg10, Val14, 
Cys17, Lys18, Asp20 und Cys23. 
N-HN residual dipolar couplings were measured in a ω1-coupled HSQC 
experiment for 2.4 mg of κM-conotoxin RIIIK dissolved in the nematic phase 
described above. 
All spectra were processed with the Bruker XWIN-NMR software package 
(Bruker Instruments, Rheinstetten, Germany) and further analyzed with the 
FELIX 2000 software package (MSI, San Diego, CA).  Cross-peak volumes were 
calculated by integration of all data points in a rectangular region, which was 
manually defined for each peak.  
Structure calculations.  The distance restraints were classified on the basis of 
peak intensity in a NOESY spectrum with mixing time of 100 ms with lower and 
upper bounds of 1.0-2.5 Å (strong), 2.5-3.5 Å (medium) and 3.5-5.0 Å (weak).  
Very weak restraints with an upper bound of 6.0 Å were obtained from the 
NOESY experiment with mixing time of 350 ms. A correction of 0.5 Å was added 
to the upper bounds of restraints involving pseudoatoms for methyl groups. 
Backbone H-bonds were not included in the structure calculation. 
All structure calculations were performed using an extended version of the X-
PLOR 3.851 software package (Brünger, 1993). The initial extended conformer 
was subjected to a simulated annealing protocol consisting of four steps: an initial 
65 ps high-temperature phase at 2000 K was followed by a first cooling phase, 
where the temperature was lowered to 1000 K in steps of 50 K, then by a second 
cooling phase, where the temperature was lowered to 100 K, and by a final energy 
minimization step. A total of 237 NOE-derived distance restraints were applied 
with soft-square potential and a force constant of 50 kcal·mol-1·Å-2. The 
stereospecific assignment of the protons of 16 methylene groups was obtained by 
means of a routine of the simulated annealing protocol, where the two H atoms 
are repetitively swapped and the configuration that best fits the experimental 
restraints is retained. For the remaining methylene groups either only one 
resonance was observed for both protons or the experimental data were not clearly 
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indicative of a single stereospecific assignment. Restraints involving not 
stereospecifically assigned CH2 protons were treated with the floating chirality 
assignment procedure of X-PLOR. A total of seventeen dihedral angles restraints 
from 3J(HN,Hα) and twelve dihedral angles restraints from 3J(Hα,Hβ) coupling 
constants were included in the calculation.  
A hundred structures were calculated and the thirteen structures with the lowest 
energy  were used for statistics.  This ensemble of thirteen structures satisfied the 
criteria of no NOE violations >1.0 Å and no dihedral angle violations >5°. 
Electrophysiological measurements. The oocyte expression system was used to 
study the effects of the wild type and the isoforms of κM-RIIIK. Oocyte 
preparation and RNA injection was performed as described by Jacobson et al. 
(Jacobson et al., 2000).  Whole-cell currents were recorded under two-electrode 
voltage-clamp control using a Turbo-Tec amplifier (npi electronic, Tamm, 
Germany).  The intracellular electrodes were filled with 2M KCl and had a 
resistance between 0.5 and 1.2 MΩ.  Current records were low-pass filtered at 1 
kHz (-3db) and sampled at 4 kHz.  The bath solution was normal frog Ringer’s 
containing (in mM):  115 NaCl, 2.5 KCl, 1.8 CaCl2, 10 Hepes, pH 7.2 (NaOH).  
All electrophysiological experiments were performed at room temperature (19-22 
°C).  Toxin-containing solutions were applied by a Gilson pipette directly into the 
bath chamber. 
The IC50 values of M-RIIIK and the corresponding analogs were calculated from 
the reduction of whole cell currents at a test potential of 0 mV obtained from 
oocyte expressing either TSha1 or the different Shaker isoforms according to IC50 = 
fc / (1-fc) * [Tx], where fc is the fractional current and [Tx] is the toxin 
concentration.  Data are given as mean ± S.D. For wild type toxin dose-response 
measurements where performed as well, resulting in an almost identical IC50 value 
(see Fig. 3.3). 
The two-electrode voltage clamp technique (TEVC) in the Xenopus oocyte 
heterologous expression system was used to investigate the affinities of the toxin 
mutants for the different channel mutants. The calculation of the interaction free 
energy (ΔΔG) from the electrophysiological data was performed as described 
earlier (Jacobson et al., 2000).  
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Docking calculations.  The model of the TSha1 channel was obtained by 
homology to the crystal structure of the KcsA channel (Doyle et al., 1998) with a 
procedure similar to that described by Eriksson and Roux to obtain the Shaker 
channel model (Eriksson & Roux, 2002). A large number of spatial restraints, 
extracted from the KcsA pdb file (1BL8), were optimised using the program 
MODELLER v.6.2 to generate similarity-based models of TSha1 (Sali & Blundell, 
1993). The ideal fourfold symmetry of the tetrameric channel was imposed on all 
the models. Of the one hundred generated model, the one with the lowest 
MODELLER restraint energy was kept and refined by energy minimization with 
the program CNS solve 1.1 (Brünger et al., 1998), using the "proteinallhdg" 
forcefield.  
The docking protocol was based on a similar procedure as that used by Eriksson 
and Roux (Eriksson & Roux, 2002). 875 docking models of the complex between 
the TSha1 channel model structure and the NMR structure of κM-conotoxin RIIIK 
were generated with the program CNS solve 1.1 (Brünger et al., 1998) and using 
mutant cycle derived intermolecular distance restraints. In the thermodynamic 
double mutant cycle analysis, two interacting molecules A and B are mutated at 
specific sites a and b to give two molecules A* and B*. The binding free energies 
ΔG for the wild-type, single and double mutant complexes A-B, A*-B, A-B* and 
A*-B* are combined to obtain the interaction free energy ΔΔGint = [ΔG(A*-B*)-
ΔG(A*-B)]-[ΔG(A-B*)-ΔG(A-B)]. The ΔΔGint is a measure of the non-additivity 
of the mutantions a* on A and b* on B and reveals a direct interaction of the sites 
a and b (Ranganathan et al., 1996; Schreiber & Fersht, 1995). In this study the 
ΔΔG values of Fig. 3.7 were translated into intermolecular distances as follows: a) 
2 KJ/mol < ΔΔG ≤ 3 KJ/mol corresponds to a very weak intermolecular distance 
(d) restraint between sites a and b (4 Å < d < 6 Å); b) 3 KJ/mol < ΔΔG ≤ 4 KJ/mol 
corresponds to a weak intermolecular distance restraint (3.5 Å < d < 5.5 Å); c)  4 
KJ/mol < ΔΔG ≤ 5.5 KJ/mol corresponds to a medium distance restraint (2.5 Å < 
d < 4.5 Å); ΔΔG > 5.5 KJ/mol corresponds to a strong distance restraint (1.5 Å < 
d < 3.5 Å). If a and b are polar or charged residues, the minimum distance 
between the heavy atoms of the polar or charged groups has to fulfil the 
intermolecular distance restraint; for non-polar residue pairs the minimum 
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distance between all heavy atoms of the side chains is used. Due to the fourfold 
symmetry of the TSha1 channel we used ambiguous distance restraints: the 
distance dij between a residue of the toxin (i) and a residue of the channel (j) is 
described as: 
                                             
dij = Min(||ri-rjA||, ||ri-rjB||, ||ri-rjC||, ||ri-rjD||) 
 
where A, B, C and D are the four identical subunits of TSha1. 
To avoid redundant identical complexes all distances from the residue R10 of κM-
RIIIK were assigned to the subunit A of the channel. The NMR structure of κM-
conotoxin RIIIK shows that R10 and K18 are on opposite sides of the peptide: to 
ensure that the toxin is stretched over the pore, we impose that K18 is close to the 
extracellular loop of the channel unit opposite to that in contact with R10 (unit C). 
A total of sixteen distance restraints were used: three very weak (V376-L1, M375-
O15, E348-R19), three weak (E348-L1, M375-L1, E348-R10, five medium (E354-
L1, P349-L1, E348-K18, E354-R19, S351-R19) and five strong (E354-R10, 
P349-R10, S351-R10, E354-K18, P349-R19). An additional distance restraint was 
added between the N-terminus NH3+ of the toxin and any electronic acceptor of 
the channel, following the dramatic decrease in the toxin affinity upon acetylation 
of the terminal amine (Al-Sabi et al., 2004). All distances were restrained with a 
harmonic potential. 
The docking protocol consisted of a series of short torsion angle MD trajectories. 
In the first step of the simulated annealing protocol the temperature was increased 
to 1000 K (500 steps of 10 fs for a total of 5 ps); during this phase the Van der 
Waals radius of the atoms is decreased from 1 to 0.1. In the second step the 
temperature is slowly lowered to 300 K (1000 steps of 15 fs for a total of 15 ps) 
and the Van der Waals radius is increased from 0.1 to 1. At the beginning of the 
trajectories, the toxin was positioned randomly to a distance of 15 Å from the 
channel. All docking trajectories were started with different initial conditions by 
changing the initial velocities and the initial orientation of the toxin with respect 
to the channel pore axis. During the simulated annealing the electrostatic energy 
was turned on towards the end of the dynamics. A continuum solvent model was 
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used with a dielectric constant ε = 12 (Eriksson & Roux, 2002). The distance 
restraint force was fixed to 300 kcal mol-1 Å-2 during the dynamics.  
Flexibility was allowed for the conformation of the toxin backbone of the amino 
acids 1-3 and of all the toxin side chains. The N-terminus backbone of the peptide 
was allowed to change conformation with respect to the NMR structure following 
the observation that this region is highly flexible in solution (Al-Sabi et al., 2004). 
The peptide backbone of residues 4-24 was restrained with an harmonic potential 
based on the root-mean-square deviation from the NMR structure with a force of 
500 kcal mol-1 Å-2. This allows rotation and translation of the toxin with respect to 
the channel, while keeping the overall folding close to the experimentally 
determined one. The conformation of the trans-membrane helices of the channel 
was kept fixed, the backbone of residues 336-386 was restrained to that of the 
initial model with an harmonic potential and a force of 300 kcal mol-1 Å-2, while 
the side-chains of residues 336-386 were allowed full flexibility.  
The MD were followed by 6 cycles of 500 steps of energy minimizations where 
the backbone restrain function was turned off and the distances restraints were 
decreased to 75 kcal mol-1 Å-2. During the minimization the electrostatic potential 
was turned on. 
The trajectories were analysed using the g_cluster module of the GROMACS 3. 1. 
program (Berendsen et al., 1995; Lindahl et al., 2001) The clusters were 
generated using distances RMSD with the gromos method (Daura et al., 1999) 
and a cutoff of 0.2 nm. The RMSD used to define the clusters is an intermolecular 
RMSD containing distances between toxin residues L1, S6, R10, O13, O15, K18, 
R19 and amino acids E348, P349, E354, G371 and V376 of the turret and pore 











3.1 The NMR structure of conotoxin κM-RIIIK; similarities to μ- and ψ-
conotoxins.  
 
The three dimensional structure of conotoxin κM-RIIIK (Fig. 3.1) was 
determined from a total of 237 NOE-derived distance restraints, 17 backbone 
dihedral angle restraints and 12 side-chain dihedral angle restraints. 100 structures 
were generated using the simulated annealing protocol of the X-PLOR program 
(Brünger, 1993), including NMR-derived structural restraints (Table 3.1).  
κM-RIIIK is relatively flexible in aqueous solution.  The r.m.s. deviation of the 13 
structures with lowest energy (Fig. 3.1) versus the mean is 1.62 Å for the 
backbone atoms and 2.74 Å for all heavy atoms.  The region 1-11 is relatively 
disordered, while the C-terminus region 12-24 is well defined with a backbone 
r.m.s.d value of 0.78 Å.  The flexibility of the peptide in the region 1-11 is 
confirmed by the higher values of the 1H-13C heteronuclear NOEs of the Cα-Hα 
vectors in the N-terminus part of the peptide as compared to those in the C-
terminus part, as well as by the significantly reduced values of the N-HN dipolar 
couplings in the region 3-11.  Most of the φ and ψ angles are in allowed regions of 
the Ramachandran plot, but only 37% lie in the most favored region.  This 
indicates the presence of non-canonical or distorted structural elements, brought 
about by the three disulfide bridges and the four hydroxyprolines.  The ω dihedral 
angle for all hydroxyprolines were found to be trans on the basis of NOEs and 
13Cβ/γ chemical shifts. 
The overall form of κM-RIIIK is that of a disk with dimensions 15 x 13 Å. The 
three dimensional structure of κM-RIIIK (Fig. 3.2A, red ribbon) is very similar to 
that of the Na+ channel blockers μ-conotoxins GIIIA and GIIIB (Fig. 3.2A, blue 
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ribbon) in the C-terminal region 12-24 (27-29).  The three peptides have the same 
disulfide connectivity, which was independently confirmed by direct chemical 
analysis of partially reduced intermediates of κM-RIIIK (J. Rivier, unpublished 
results). In the C-terminal half of the peptide, a γ turn between Cys12 to Val14 is 
followed by a short distorted right-handed helix between Hyp15 and Lys18.  The 
tail of the peptide contains a final 310 helix turn between Asn20 and Cys23.  The 
presence of these structural elements is confirmed by the slow solvent exchange 
kinetics of the amide protons of Val14, Cys17, Lys18, Asn20 and Cys23.  On the 
other hand, the structure of κM-RIIIK significantly differs from that of μ-GIIIA in 
the flexible region 1-11.  The N-terminal region of μ-GIIIA consists of very tight 
turns (2-5 and 5-8) which position the N-terminal tail in the opposite direction with 
respect to the C-terminus (Fig. 3.2B). Conversely, the N-terminal region of κM-
RIIIK consists of an extended tail until Cys4 followed by a wide loop between 
Cys5 and Leu11.  In conotoxin κM-RIIIK the N-terminal tail protrudes into 
solution almost perpendicular to the flat surface of the peptide and to the C-
terminal end (Fig. 3.2B). 
 
 
Fig. 3.1 Superimposition of the 13 lowest energy structures of κM-conotoxin RIIIK. The region 1-
11 presents a high degree of flexibility, while the region 12-24 is well defined. 
 
Recently, the three-dimensional structures of two ψ-conotoxins, ψ-PIIIE and ψ-
PIIIF, antagonists of the nicotinic acetylcholine receptor, have been solved in 
solution by NMR (Fig. 3.2A,B green ribbon) (Van Wagoner & Ireland, 2003; Van 
Wagoner et al., 2003).  The disulfide bond pattern of these small peptides is 
homologous to that of both κM-RIIIK and μ-GIIIA, although their natural receptor 
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belongs to a different superfamily, the ligand-gated ion channels.  The fold of the 
C-terminal part of ψ-PIIIF is similar to that observed for both κM-RIIIK and μ-
GIIIA, with two helical turns involving the last three cysteine residues.  However, 
the N-terminal part of ψ-PIIIF, which consists of well defined β turns, differs in 
structure from both κM-RIIIk and μ-GIIIA.  The series of β turns, that structurally 
differentiate the N-terminus of ψ-PIIIF from the wide flexible loop of κM-RIIIK, 
place the N-terminal tail perpendicular to the flat surface of the peptide (Fig. 3.2B), 
similar to κM-RIIIK but unlike μ-GIIIA. Although well defined turns are situated 
in homologous positions in μ-GIIIA and ψ-PIIIF, the geometry of these turns is not 
the same, bringing about the difference in the positioning of the N-terminus in the 
two toxins.  Furthermore, unlike conotoxins κM-RIIIK and μ-GIIIA, ψ-PIIIF has 






Fig 3.2 A) Comparison of the structures of κM-conotoxin RIIIK (red ribbon), μ-contoxin GIIIA 
(blue ribbon; pdb entry: 1TCG.pdb) and ψ-conotoxin PIIIF (green ribbon; pdb entry: 1JLP.pdb). 
The N-terminus is on the left side and the C-terminus on the right side for each peptide. The 
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structure of the three peptides is very similar in the C-terminal part, while the N-terminal part 
shows conspicuous differences. B) same as in A) after rotation of 90º. This orientation was chosen 
to highlight the different position of the N-terminal tail in the three peptides. 
 
The cysteine bridges in the three peptides show substantial differences in 
conformational flexibility. The two Cys bridges 4-17 and 5-22 are quite disordered 
in κM-RIIIK and average between a R and a S conformation, probably as a 
consequence of the mobility of the loop 5-11 (χ2 = −60º for all Cys).  Conversely, 
the corresponding cysteine bridges in μ-GIIIA, ψ-PIIIF are well defined. The 
disulphide bridge 12-23 of κM-RIIIK deserves a particular comment.  The Hβ 
resonances of Cys12 are degenerate and the HN signal is extremely weak, which 
indicates conformational averaging on a ms time scale.  Such resonance 
broadening had been observed before for the corresponding Cys10 of μ-GIIIA and 
μ-GIIIB.  The observation that the HN resonance of Cys10 sharpens at lower 
temperature motivated the structural analysis of μ-GIIIA and μ-GIIIB at 10 ºC 
(Hill et al., 1996; Lancelin et al., 1991; Wakamatsu et al., 1992); in contrast we do 
not observe any sharpening of the HN resonance of Cys12 by changing the 
temperature from 25 ºC to 5 ºC.  In κM-RIIIK the Cys bridge 12-23 shows 
conformational averaging between a R and a S conformation (χ1 = -60º for Cys 23; 
the χ1 of Cys12 cannot be determined due to the degeneracy of the Hβ protons), 
similarly to the corresponding disulphide bridge in ψ-PIIIF (Van Wagoner et al., 
2003). Conversely, in μ-GIIIA the Cys bridge 10-21 assumes only one well-
defined conformation at 10 ºC, despite the observed broadening of the HN 
resonance of Cys10 at 25 ºC.  The flexibility of the 12-23 disulphide bridge and its 
homologs in ψ-PIIIF and μ-GIIIA at room temperature is potentially of 
mechanistic importance, as it allows for conformational changes upon binding to 
the receptor.  
The three conotoxins κM-RIIIK, μ-GIIIA and ψ-PIIIF share a common cysteine 
bridge pattern and a similar folding of the C-terminal part of the polypeptide chain, 
despite the large diversity in the receptor specificity. We speculate that the 
structural difference at the N-terminus of the polypeptide chain, the degree of 
conformational flexibility and the different charge distribution in the three-





Restraints for calculation 
      Total NOE restraints                                                           237 
          Intraresidue                                                                     155 
          Sequential                                                                        51 
          Long range                                                                      31 
          Dihedral angle restraints 29 
Restraint violations (mean and s.d.) 
      Distance restraints ≥ 0.3 Å(2)  0.20 ± 0.02(2) 
      Dihedral angle restraints ≥ 5.0 deg  0.02 ± 0.02 
      Coupling constant restraints ≥ 0.5. Hz 0.24 ± 0.1 
Deviation from idealized geometry 
      Bonds (Å) 0.002 
      Angles (deg) 0.48 
      Dihedrals (deg) 1.73 
Energies (kcal mol-1) 
      Restraint energy 19 ± 6 
      Total energy 52 ± 7 
Ramachandran statistics (%) 
      Most favored 37.2 
      Additionally allowed 55.8 
      Generously allowed 5.8 
      Disallowed 1.3 
R.m.s. deviation from mean structure (Å) 
      Backbone atoms 1.62 
      All heavy atoms 2.74 
(1)Structure statistics refers to an ensemble of 13 structures with the lowest energy 
from 100 calculated structures. 
(2)No distance restraint was violated more than 1.0 Å. 
 
Conotoxins κM-RIIIK is structurally unrelated to conotoxin κ -PVIIA, despite the 
fact that the two peptides have overlapping binding sites within the pore region of 
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Shaker K+ channel, as indicated by the loss of activity upon mutations of F425 and 
T449 for both conotoxins κM-RIIIK and κ-PVIIA (Shon et al., 1998; Ferber et al., 
2003). The secondary structure elements are very different, with the three 
dimensional structure of conotoxin κ-PVIIA mainly consisting of two large loops 
stabilized by a triple stranded β-sheet. A weak similarity can be recognized in the 
overall shape, which resembles a disk for both peptides. Moreover, as in 
conotoxins κM-RIIIK, extensive flexibility was found for two of the three 
disulphide bridges of conotoxin PVIIA.  
 
3.2 Mutational analysis.   
 
We synthesized analogs of κM-RIIIK containing alanine substitutions at 
each amino acid position except for the cysteines. All analogs were synthesized 
manually and characterized using RP-HPLC, CZE and mass spectrometry. The 
affinity of the alanine isoforms was functionally assayed by two-electrode voltage 
clamp measurements using Xenopus oocytes expressing the trout TSha1 K+ 
channel, the cloned K+ channel isoform with the highest affinity for κM-
conotoxin (IC50 of about 70 nM) identified so far, which is reversibly blocked by 
the toxin (Fig. 3.3).  The results of these assays are shown in Table 3.2. 
For six amino acids (O2; S6; L7; L9; O21; T24) the alanine substitution resulted in 
an IC50 value within 5-fold of the wild-type κM-RIIIK. We note that some 
substitutions (O2A, S6A, L7A) cause a bigger change in the IC50 value than others 
(L9A, O21A, T24A), indicating that although these residues are not dominant 
determinants for binding they may slightly contribute to the interaction with the 
TSha1 channel. 
Alanine mutations of seven (S3, N8, L11, O13, V14, O15, N20) residues exhibited 
an intermediate behavior, with IC50 values higher than 5-fold, but less than 16-fold 
of the wild-type IC50.  Interestingly, S3, L11, O13, V14, O15 and N20 are located 





Fig. 3.3  κM-conotoxin RIIIK reversibly blocks TSha1 mediated currents. A) 
Whole cell currents recorded from oocytes expressing TSha1 K+ channels upon 
depolarization to 0 mV are shown before (control), after addition of 1 μM of κ-
conotoxin RIIIK and after subsequent wash with NFR, indicating the reversibility 
of the block of the toxin. The holding potential was −100 mV.  B) Dose-response 
curve for the block of TSha1 current by κM-RIIIK at a test potential of 0 mV 
(total number of experiments = 12 with n between 4 and 11 for the different toxin 
concentrations indicated). The IC50 from these measurements is 70 ± 11 nM which 
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is almost identical to the value from the fractional currents measurements (see 
Table 3.2). The Hill coefficient was close to 1.   
 
Table 3.2. 
IC50 values for Tsha1 K+ block of κM-RIIIK and analogs 
 
κM-RIIIK IC50 ± SD N IC50mutant/IC50W
WT 73 ± 34 7 1 
L1A 3180 ± 300 6 44 
O2A 210 ± 40 3 3 
S3A 760 ± 280 6 10 
S6A 240 ± 80 3 3 
L7A 310 ± 100 6 4 
N8A 420 ± 140 3 6 
L9A 90 ± 20 3 1 
R10A 4220 ± 860 7 58 
L11A 970 ± 300 6 13 
O13A 510 ± 170 6 7 
V14A 1130 ± 390 5 15 
O15A 850 ± 180 3 12 
K18A 3920 ± 1300 6 54 
R19A 1530 ± 710 9 21 
KR1819RK 180 ± 100 7 2 
N20A 430 ± 70 3 6 
O21A 130 ± 30 3 2 
T24A 120 ± 50 3 2 
 
As shown in Fig. 3.4, mutations of four other residues (L1, R10, K18 and R19) 
resulted in a major reduction of the affinity for TSha1 K+ channels (Table 3.2).  
The IC50 of these analogs are increased by more than 20-fold indicating an 
important role of these amino acids in receptor binding.  Interestingly, the affinity 
of the double mutant K18R-R19K to the Tsha1 K+ channel is close to wild-type, 
indicating that the positive charge is important at both positions, but the specific 
nature of the side chain is not critical for the interaction with the TSha1 K+ 
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channel. Somewhat surprisingly for a peptide blocking K+ channels, these four 
critical residues are distributed at various sites of the molecule (Fig 4.1).  
Furthermore, the structure of κM-RIIIK does not provide any evidence of the 
existence of a hydrophobic/positively charged amino acid dyad, as Leu1, the most 
important hydrophobic residue for binding, is more than 6 Å apart from any 




Fig. 3.4. Mutations of the residues L1, R10, K18 and R19 results in isoforms of κM-conotoxin 
RIIIK with low affinity to TSha1 channels. Whole cell currents recorded from oocytes expressing 
TSha1 K+ channels before and after addition of the κM-RIIIK isoform are shown. Notice the 
apparent slowing of activation of the currents in the presence of R10A, K18A and R19A 
illustrating the re-equilibrium of toxin binding to the open state. The pulse protocol was as in Fig. 
3.3. The vertical bars represent 2 μA. 
 
The alanine walk identified Leu1 as the only hydrophobic residue that 
substantively affects binding of κM-conotoxin RIIIK to the TSha1 channel.  The 
solution structure determined by NMR indicates that Leu1 is too far from any 
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positively charged residue to serve as the hydrophobic component of a dyad, a 
conserved motif in otherwise divergent K+ channel-targeted toxins.  However, the 
fact that the N-terminal region (amino acids 1-11) is flexible leads to some 
reservations regarding this conclusion. In other toxins, the hydrophobic component 
of the dyad is most commonly an aromatic residue, while a lysine plays the role of 
the positively charged component; this lysine occludes the extracellular opening of 
the ion channel pore. Thus, if the Leu1 is part of a functional dyad that forms 
following a conformational change upon binding the receptor, it is reasonable to 
predict that the substitution of the leucine with an aromatic amino acid can be well-
tolerated and perhaps even leads to an increase in binding affinity.  In order to test 
this hypothesis, we evaluated the effect of various substitutions for Leu1 on the 
interaction of κM-RIIIK with the TSha1 channel (Table 3.3). 
 
Table 3.3. 
Mutations of L1 affect the binding affinity of κM-RIIIK to the TSha1 K+ channel. 
 
κM-RIIIK IC50 ± SD n IC50mutant/IC50WT 
WT    73 ± 34 7 1 
L1A          3180 ± 300 6 44 
Ac-L1    7630 ± 760 6 104 
L1E    56500 ± 27670 5 774 
L1H  5430 ± 790 4 74 
L1I    1380 ± 1000 5 19 
L1M  340 ± 110 5 5 
L1K    950 ± 270 4 13 
L1R  190 ± 10 3 3 
L1F    5260 ± 1420 4 72 
L1Y  12300 ± 1920 3 168 
 
In contrast to what was predicted on the basis of the dyad hypothesis, both a 
phenylalanine (the most common amino acid as the hydrophobic half of the dyad) 
and a tyrosine substitution for Leu1 caused a greater apparent decrease in affinity 
(>100-fold) than the L1A substitution (~40-fold).  Unexpectedly, the replacement 
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of Leu by a positively charged amino acid (e.g., the L1R and L1K mutations) had a 
smaller effect on the affinity for the TSha1 channel (2- and 12-fold, respectively) 
than the L1A mutant. Introducing a negative charge (L1E) or blocking the positive 
charge (N-acetylated κM-RIIIK) causes a drastic fall in affinity (>500- and >100-
fold, respectively). 
The data of Table 3.2 and 3.3 do not support the involvement of Leu1 in a dyad. 
This result, together with the structural data that indicate that Leu1 is not close to 
any positively charged side chain, allows us to conclude that this leucine does not 
serve as the hydrophobic component of a dyad. 
 
3.3 Mutant cycle analysis. 
 
 We have performed a mutant cycling analysis to identify which amino 
acids of κM-RIIIK interact with specific residues in the vestibule of the ion 
channel pore of TSha1. For this purpose we have generated several mutants of 
TSha1 with single amino acids changes in the pore region of the channel, where 
κM-RIIIK is likely to interact (Ferber et al., 2003). Figure 3.5A shows the 
alignment of the amino acid sequences of the pore region of TSha1 and Shaker 
together with the one of KcsA, for which a high resolution structure is available 
(Doyle et al., 1998). Several mutations within this area have been constructed and 
functionally assayed using the Xenopus expression system and 2-electrode 
voltage-clamp experiments. The addition of 1 μM of κM-RIIIK leads to different 
reductions of the measured currents at a test potential of 0 mV for wild type and 
mutated ion channels (Fig. 3.5B), demonstrating that the affinity of the peptide for 
the mutated channels is reduced. For M375K channels, hardly any block can be 
observed at this toxin concentration. This indicates a very low affinity of the toxin 
for the mutated channel, which was estimated to be about 10 μM (kD ≈ 76 nM for 
the wild type channel). The changes in the affinity for the different channel 
mutants are summarized in Table 3.4 and confirm that κM-RIIIK is indeed 
interacting with the pore region of the channel. 
The relative changes induced by the different mutations are summarized in Fig. 
3.6. The mutations E348S, P349K, S351K, M375L and V376T led to a 2-fold 
reduction in the affinity of κM-RIIIK. Interestingly the mutation E348K did not 
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have a significant effect, despite the drastic change in the electrostatic properties 
of the side chain. The mutations E354K and E354Q resulted in a decrease of the 
affinity of 6-fold and 4-fold respectively. The mutation M375I resulted in a much 
stronger affinity change than M375L (12-fold vs. 2 fold), while the most dramatic 










Fig. 3.5. Selected site-directed mutations on the pore region of TSha1 K+ channels. A. The amino 
acid alignment of the pore region of the Shaker and TSha1 K+ channels (S5-S6 linker) and the 
corresponding region of KcsA bacterial K+ channel (M1-M2). B. Whole-cell currents recorded 
from oocytes expressing TSha1 mutant channels before and after addition of the κM-RIIIK WT 
are shown. Notice the apparent slowing of activation of the currents in the presence of toxin 
illustrating the re-equilibrium of toxin binding to the open state (Ferber et al., 2003). The dashed 





IC50 values for TSha1 mutant K+ block of kM-RIIIK WT. 





(0 mV) nM 
 
n 
WT 76 ± 10 9 
E348S 110 ± 30 4 
E348K 50 ± 10 3 
P349K 130 ± 20 3 
S351K 160 ± 10 4 
E354K 490 ± 110 3 
E354Q 270 ± 30 4 
S366T NF -- 
M375K 10730 ± 2460 3 
M375L 140 ± 40 3 
M375I 1360 ± 70 5 
V376T 120 ± 20 3 
V376H LE -- 
V376S NF -- 
V376E NF -- 
V376K NF -- 
 
To investigate which amino acids of the TSha1 channel pore interact with specific 
amino acids of κM-RIIIK, we measured the affinity of several toxin mutants to 
different ion channel mutants. In this analysis we concentrated on the amino acid 
residues of the toxin which had been shown to be functionally relevant (L1, R10, 
K18, R19). The IC50 values for the different combinations of channel and toxin 
mutations are summarized in Table 3.5, while Fig. 3.7 shows the corresponding 
changes in binding energy (ΔΔG) values. Assuming that a ΔΔG-value of 2 kJ/mol 
indicates that the distance between the two mutated residues is less than 6 Å 
(Schreiber & Fersht, 1995), the data of Fig. 3.7 indicate a quite complex network 
of interactions between the toxin and amino acids from different domains of the 
ion channel target. R10, K18 and R19 have the largest interactions with residues 
E348, P349, S351 and E354 of the turret and pore helix regions of the K+ channel, 
thus excluding that any of the positively charged side-chains penetrates the 
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channel pore. Instead, the positively charged residues interact with the loops of 




Fig. 3.6 Influence of single point mutations in the pore region of TSha1 on κM-RIIIK binding. The 
bar diagram shows the affinity of κM-RIIIK to the individual channel mutants normalized to 
























Fig. 3.7 Summary of mutant cycle analysis. Coupling energy (ΔΔG ± SE) between TSha1 mutants 
and analogs of κM-RIIIK representing important residues for binding (L1, R10, K18 and R19). 
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ΔΔG values exceeding 2.0 KJ/mol indicate coupling interaction within 6 Å distance. L1A mutant 
(empty bars), L1I (gray-filled bars), R10A (net-filled bars), K18A (diagonal-stripped bars), R19A 
(horizontal-stripped bars) and K18R/R19K (mosaic-filled bars). All numbers represent the means 
of 3-6 independent determinations. ΔΔG are taken as absolute values. 
 
3.4 The docking models.  
 
The mutant cycling data have been used as intermolecular distance 
restraints in docking calculations with the aim of obtaining a model for the 
complex of  κM-RIIIK with the TSha1 channel. The structure of  κM-conotoxin 
RIIIK, determined in aqueous solution by NMR, was docked to the model 
structure of the TSha1 channel, using the distance restraints derived from the 
mutant cycle analysis, as described in Chapter 2. According to what observed by 
Eriksson and Roux for the Ag2Tx - Shaker complex (Eriksson & Roux, 2002), we 
find that one or two distance restraints are insufficient to achieve a selection 
among the different orientations of the toxin with respect to the channel pore. 
Therefore, we chose to use all the available distance restraints in the docking 
calculations. The 875 generated models can be subdivided into 4 clusters, which 
have been numbered from I to IV according to increasing total energy (Fig. 3.8). 
90% of the generated models belong to Cluster I, which also contains the structure 
with the lowest energy; 6 % of the models belong to Cluster II, 3% to Cluster III 
and 1% to Cluster IV. No intermolecular distance restraint violations are found in 
Cluster I and II while all structures of Cluster III and IV  violate the distance 
restraints E354-R19 and M375-L1, respectively. The backbone conformation of 
the toxin is well defined in all four clusters (toxin backbone RMSDs are 1, 1.4, 
1.1 and 1 Å in cluster I, II, III and IV, respectively). The conformation of the 
toxin backbone is quite close to the one determined by NMR in Cluster I (RMSD 
of 1.4 Å), while it deviates the most in Clusters III (RMSD of 2.5 Å). The toxin 
conformations of Cluster II and IV have RMSD values to the NMR determined 
conformation of 1.8 and 1.6 Å, respectively. 
The details of the atomic interactions for the lowest energy structure of each 




Fig. 3.8. The four models for the complex κM-conotoxin RIIIK – TSha1 K+ channel. The 
backbone of the toxin is represented in blue (cluster I), green (cluster II), yellow (cluster III) and 
magenta (cluster IV). The toxin deeply interacts with only three units of the channel. In cluster I, 
units A, B and C are involved in electrostatic and hydrophobic contacts with toxin side chains; in 
cluster II, III and IV, units A, C and D contact the toxin side chains. 
 
Cluster I: The positively charged side chain of R10 of  κM-RIIIK is located in a 
negatively charged pocket of the extracellular loop of unit A of the TSha1 channel 
defined by the carbonyls of P349, E350 and S351 and by the side chains of E348, 
S351 and E354 (Fig. 3.9). The strong interaction of R10 with E354 accounts for 
the decreased affinity of   κM-RIIIK to the Shaker channel, where the 
homologous position to E354 is occupied by a lysine. The positively charged side 
chain of K18 is surrounded by the backbone carbonyls of P349, E350, S351 and 
the side chains of E348, S351 and E354 of unit C, while the R19 interacts with the 
negatively charged side chain of E354 and with the backbone carbonyl of S351 of 
unit C (Fig. 3.9). The electrostatic interactions of R10, K18 and R19 anchor the 
peptide to the channel loops stretching it over the channel pore. The interactions 
of L1 with the channel unit B are both electrostatic and hydrophobic (Fig. 3.9). 
The positively charged N-terminus is situated among the backbone carbonyl of 
E348 and the side chains of Q352 and E354, justifying the consistent decrease in 
affinity for the N-acetylated toxin; the hydrophobic side chain packs against the 
side chains of E350 and Q352 and contacts the methyl groups of M375 and V376. 
Cluster II: The positively charged side-chain of R10 contacts the backbone 
carbonyls of P349, E350 and S351 and the side chains of E348 and E354 of unit 
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A, similarly to cluster I. K18 interacts with the backbone carbonyls of P349, E350 
and S351 and with the side-chains of E348, S351 and E354 of unit C; R19 
contacts the side-chain carbonyls E354 of the same unit C. As for cluster I, the 
electrostatic interactions of the side-chains of R10, K18 and R19 with loop 
residues of unit A and C stretch the peptide over the channel pore. In cluster II, L1 
is situated close to the loop residues of unit D, unlike in cluster I, where L1 
contacts the extracellular loop of unit B (Fig. 3.8). The positively charged N-
terminus group contacts the side chains of Q352 and E354, while the Leu side 
chain has hydrophobic contacts with P349. The distance between the side chain of 




Fig. 3.9 Stereo picture of model I, showing the details of the electrostatic and hydrophobic 
interactions of the toxin with the channel. The amino acids E348, S351 and E354 of unit A (in 
magenta) are in deep contact with the amino acid R10 of the toxin; the same amino acids  E348, 
S351 and E354 of unit C (in yellow) contact the side chains K18 and R19 of the toxin, while 
amino acids E350, Q352, M375 and V376 of unit B (in green) interact with the charged N-
terminus and with the hydrophobic side chain of the toxin L1. 
  
Cluster III: As in the Cluster I and II, the positively charged side chain of R10 
interacts with the backbone carbonyls of P349, E350 and S351 and with the side 
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chain carbonyl of E354 of unit A. The amino group of K18 is situated in a pocket 
formed by backbone carbonyls of P349, E350 and S351 and by the side chain of 
E354 of unit C, while R19 contacts the backbone carbonyls of P349 and E350 and 
the side chain of E354 of unit D. The distance between the negatively charged 
side chain of E354 and the positively charged side chain of R19 is larger than in 
cluster I and II. The positive charge of the arginine side chain is surrounded by 
several backbone carbonyls and a serine side chain of the toxin itself. L1 is 
situated close to the extracellular loop of unit D. The positively charged N-
terminus weakly interacts with the backbone carbonyl of E354; the hydrophobic 
leucine side chain packs against Pro349 and S351, while the distance to M375 and 
V376 is larger than in cluster I. 
Cluster IV: The backbone carbonyls of Pro349 and E350 and the side chain of 
E354 of unit A interact with R10 as in all other models. The side chains of E348, 
Q352 and E354 of unit C surround K18, while R19 stretches over towards the 
backbone carbonyls of E348 and P349 and the side chains of E348 and E354 of 
unit D. The positively charged N terminus of L1 interacts with the side chain of 
E354 of unit D, while the Leu side chain only contacts the side chain of Q352 and 
is further from M375 than in any other cluster. 
In all four clusters the positively charged side chain of R10 is situated in a 
negatively charged pocket of unit A defined by the backbone carbonyl of the 
stretch 348-351 and by the side chain carbonyls of E348 and E354. This reflects 
the high ΔΔG values observed upon introduction of a positive charge in position 
349, 351 and 354 and explains the higher affinity of the toxin for the TSha1 
channel as opposed to the Shaker channel, where a lysine is found in the 
homologous position to E354. The atomic interactions of K18 with loop residues 
348-354 are very similar to those of R10. Thus, the two positively charged side 
chains of R10 and K18 serve as anchors to very similar negatively charged 
pockets of the channel extracellular loops and pore helix. An additional anchor is 
represented by R19 that tightly interacts with the side chain of E354. However, 
R19 can interact either with the same unit as K18 (unit C), as in Cluster I and II or 
with the neighbouring unit, as in Cluster III and IV, depending on the 
conformation of the R19 side chain. This heterogeneity is observed also for 
structures belonging to the same cluster (1% of the structures of Cluster I and 20% 
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of the structures of Cluster II). The mutant cycling data and consequently the 
docking models show that R19 is in closer proximity to the side chain of P349 
than K18 (ΔΔG = 6.31 kJmol-1 for the R19A-P349K mutation and 1.67 kJmol-1 
for the K18A-P349K mutation).  
More complex are the interactions of L1. Mutant cycling data point to the 
existence of contacts between L1 and E348, P349, E354, M375 and V376. The 
distance restraints with P349 and E354 are classified as medium and are reflected 
in electrostatic contacts of the positively charged N-terminus of L1 with the side 
chain carbonyl of E354. The hydrophobic contacts of L1 are different in the four 
models: the weak distance restraints with M375 and V376 are best satisfied in 
Cluster I and II, where L1 reaches M375 and V376 the closest.  
Given its small size,  κM-RIIIK cannot interact with the extracellular loops of all 
four units.  In all four clusters the toxin contacts three out of four units of the K+ 
channel. In model I, unit A, B and C are binding the toxin, while in model II, III 
and IV unit A, C and D are involved in contacts with the peptide (Fig. 3.8). 
According to the NMR studies, the toxin has a discoid shape: in model I the flat 
surface of the disc is out of the plane defined by the four channel loops, while in 
model II, III and IV the toxin is flattened on the channel like a pancake. Although 
the toxin contacts only three of the four units, the accessibility for a potassium ion 
























































































































































































































































































































































































































































































































































































































































































































































































4.1 The mutational analysis and the NMR structure of κM-conotoxin RIIIK. 
 
 The solution conformation of κM-conotoxin RIIIK differs substantially 
from that of κ-conotoxin PVIIA, the only other structurally characterized 
conotoxin that interacts with the K+ channels. While the two conotoxins share 
common binding sites on the Shaker K+ channel, they dramatically differ in the 
disulphide bond pattern, secondary structure elements and charge distribution.  
κM-conotoxin RIIIK is encoded by a gene belonging to the M-superfamily, while 
κ-PVIIA belongs to the O-superfamily.  The latter superfamily includes ω-
conotoxins, which are targeted to voltage-gated Ca2+ channels.  The most well-
characterized member of the M-superfamily is μ-conotoxin GIIIA, an extremely 
specific blocker of the Nav1.4 voltage-gated Na+ channel subtype. The structure of 
κM-RIIIK is much more similar to that of μ-GIIIA than to that of κ-PVIIA. 
Clearly, the shared class III Cys pattern of kM-RIIIK and μ-GIIIA is the dominant 
determinant of the overall structure. Despite the structural similarity, κM-RIIIK 
and μ-GIIIA show no overlap in the pharmacological specificity at all. 
The structural divergences between κM-RIIIK and κ-PVIIA pose the intriguing 
question of whether the mechanism of the K+ channel conductance block of the 
two toxins significantly differs. Despite their differences in size, amino acid 
sequence, structure and biological origin, all other well characterized toxins (e.g 
dendrotoxin from snakes, various scorpion and sea anemone toxins), including κ-
PVIIA, share a number of convergent features. The key amino acid determinants 
for the interaction with the K+ channel are localized on one side of the toxin 
surface and the pharmacophore is based on a hydrophobic/positively-charged 
amino acid dyad motif. Encouraged by the similarity in the mechanisms of 
interaction with the K+ channels of structurally and phylogenetically different 
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peptides, we had expected κM-conotoxin RIIIK to fit in the common framework 
and to interact with K+ channels with a dyad-based pharmacophore.  
Conversely, the structural and mutational analyses described above indicate that 
κM-RIIIK does not fit the established paradigm.  κM-RIIIK is a relatively flat disc-
shaped molecule in which important amino acid determinants for binding are not 
clustered on the toxin surface into a clearly defined pharmacophore (Fig. 4.1).  
Most importantly, κM-RIIIK does not appear to have a dyad motif composed of a 
hydrophobic amino acid and a lysine residue. Our conclusion that a dyad does not 
exist is based on two types of experimental data. First, the structure shows no 
hydrophobic residue within 6 Å of a positively charged residue.  Second, we found 
that substitutions of aromatic residues for Leu1, the functionally most important 
hydrophobic amino acid in κM-RIIIK, are even less well tolerated than Ala.  
Furthermore (and most unexpectedly), substitution of a positive amino acid gave 
an affinity close to the wild-type peptide. In fact, the Leu1 substitution with the 
smallest effect on the affinity of the peptide is an arginine (L1R) and not isoleucine 
(see Table 3.3). An affinity similar to the substitution L1R was observed for the 
methionine substitution (L1M). Since methionine is a smaller residue than arginine 
and on the other hand the lysine substitution (L1K) leads to a bigger reduction in 
the affinity of the peptide than L1R, it is likely that a combination of size-
dependent hydrophobic and electrostatic interactions involving the first residue of 
this peptide are important for binding to the channel. Taken together all these 
results are completely inconsistent with Leu1 being the hydrophobic partner in a 
dyad. Interestingly, the dyad hypothesis has been challenged by Mouhat et al. 
(Mouhat et al., 2004), where it is shown that the functional dyad K24-Y33 of the 
scorpion toxin Pi1 is not indispensable for recognition and binding to the voltage-
gated Kv1.2 potassium channel. This conclusion, drawn from the observation of a 
partial but specific current reduction after application of the mutant [A24,A33] – 
Pi1, lacking the functional dyad, confirms our results and opens the way to 
considering different possible mechanisms for the interaction of toxins with K+ 
channels. 
κM-RIIIK, the Na+ channel blocker μ-GIIIA and the non-competetive antagonist 
of nicotinic acetylcholine receptors ψ-PIIIF all share a common Class III Cys 
pattern.  The structural features of the three peptides are very similar towards the 
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C-terminus where all three conotoxins are folded in two distorted helical turns 
(Fig. 3.2). However, towards the N-terminus the three peptides show substantial 
differences both in structure and dynamics.  While μ-GIIIA and ψ-PIIIF have a 
well-defined backbone folded in a series of turns, κM-RIIIK is highly flexible in 
the region 1-11.  It should be emphasized that the flexibility of the peptide is not an 
artifact due to poor structural restraints but an intrinsic dynamic feature of the 
molecule, as confirmed by the averaged values of the 3J(HN,Hα) couplings, the 
small values of the HN dipolar couplings and the higher values of the heteronuclear 
13C-1H NOEs in this region. We suggest that the differences in the three-
dimensional form, provided by the structural heterogeneity at the N-terminus, and 
in the surface charge distribution are an important determinant of target selectivity. 
 
A                                                       B 
          
 
Fig. 4.1 A) Map of the functionally important residues of κM-conotoxin RIIIK on the three-
dimensional structure. To visualize the different changes in the affinity observed for the 
corresponding alanine mutants the residues are color-coded. red: alanine substitution increased the 
IC50 of κM-RIIIK by more than 20-fold (L1, R10, K18 and R19); yellow: alanine substitution 
affect the affinity by more than 5-fold but less than 16-fold (S3, N8, L11, O13, V14, O15, N20): 
green: all the rest. B) same as in A) but from the opposite side.    
 
The localization of the functionally critical amino acids on the three dimensional 
structure of κM-RIIIK is shown in Fig. 4.1. The four most important residues (L1, 
R10, K18 and R19) and the seven residues of medium importance are well 
distributed across the whole molecule, as opposed to the commonly found 
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structural motif for K+ channel blockers that contains a dyad of a positively 
charged and an hydrophobic residue.  The separation of key residues in κM-RIIIK 
resembles μ-GIIIA more than other K+ channel-targeted toxins.  However, all 
functionally relevant residues can be localized on a surface of 12 x 9 Å (Fig. 4.1A) 
with the most important residues (in red) being situated at the edges and the 
residues of medium relevance (in yellow) in the middle of the surface.  On the 
opposite side of the peptide (Fig. 4.1B), no residue seems to be essential for 
function. 
 
A        B 
 
C       D 
   
 
Fig. 4.2 Electrostatic surface potential for κM-conotoxin RIIIK (A,B) and μ-contoxin GIIIA 
(C,D). The orientation of κM-conotoxin RIIIK is the same as in Fig. 4.1. Intense blue(red) regions 
correspond to a charge of +1.0(−1.0) or greater. The surface potential was calculated with the 
AvgCharge algorithm of MOLMOL 2k.2. 
 
The charge distributions on the surfaces of κM-RIIIK, μ-GIIIA and κ-PVIIA are 
substantially different.  In κM-RIIIK, most of the positive charges are distributed at 
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the edges of the peptide face containing the functionally essential amino acids (Fig. 
4.2A). It is noteworthy that in κM-RIIIK all determinants for binding contain a 
positive charge, and that all positively-charged residues are necessary for binding. 
This ring of positive charges could be used as an anchor to residues of the K+ 
channel loops.  In μ-GIIIA and κ-PVIIA, the distribution of both charges and 
binding-determinant residues on the peptide surface is more homogeneous than in 
κM-RIIIK. In μ-GIIIA, however, a ring of positive charges could be similarly 
identified at the height of R19 and R1 (Fig. 4.2C,D).  In contrast to κM-RIIIK, a 
functionally highly relevant residue in μ-GIIIA, R13, sticks out from the surface 
defined by this ring and is probably projected into the channel pore.  In κM-RIIIK, 
no additional positively charged residue sticks out from the surface defined by the 
ring of positively charged residues L1, R10, K18 and R19.  This observation, 
together with the fact that κM-conotoxin RIIIK lacks a functional dyad, does not 
support the model of a positively charged side chain occluding the channel pore.  
On the contrary, the even distribution of L1, R10, K18 and R19 at the edges of the 
peptide face containing all functionally relevant residues suggests that conotoxin 
κM-RIIIK may block the channel by covering the pore as a lid. This 
pharmacophore model represents a novel mechanism of K+ channels block that has 
not been found in any other K+ channel-targeted peptide characterized to date. 
Mouhat et al. (Mouhat et al., 2004) demonstrate the presence of a basic ring in 
scorpion toxin Pi1 that might be similar to the one described here, indicating that a 
similar pharmacophore has been independently evolved by cone snails and 
scorpions. Mutation and docking data reveal the importance of a cooperative 
electrostatic interaction of the basic residues of this ring in scorpion toxin Pi1 with 
side chains of the turret region of the channel. These results reinforce our 
proposition of a different model of peptide-channel interaction that is not centered 
on a functional dyad.  
 
4.2 Mutant cycle analysis and docking model.  
 
We have performed docking calculations using the mutant cycling data as 
intermolecular distance restraints with the aim of obtaining a model for the 
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complex of  κM-RIIIK with the TSha1 channel. The structure of  κM-conotoxin 
RIIIK, determined in aqueous solution by NMR, was docked to the model 
structure of the TSha1 channel, using the distance restraints derived from the 
mutant cycle analysis. As described in 3.4, the generated models can be 
subdivided into 4 clusters, which have been numbered from I to IV according to 
increasing total energy  (Fig. 3.8).  
To discriminate between the four models, we analysed the location of the 
functionally relevant residues of the toxin with respect to the channel pore (Fig. 
4.3). The mutational analysis identified L1, R10, K18 and R19 as being 
fundamental for binding to the K+ channel (red in Fig. 4.3); S3, N8, L11, O13, 
V14, O15 and N20 resulted to be of medium importance (yellow in Fig. 4.3), 
while mutations of O2, S6, L7, L9, O21 and T24 to alanine did not significantly 
reduce the activity of the toxin (grey in Fig. 4.3). Model I is in very good accord 
with the mutational data (Fig. 4.3A). All functionally relevant residues, with the 
exception of N8, are facing the channel pore or are in contact with the loops, 
while no residue that is unessential for function strongly interacts with the 
channel. The only grey residue facing the channel pore is A16, for which no 
mutational data are available. Model II fits the mutational data worse than model 
I. Three residues of medium importance for binding (S3, N8 and L11) are not in 
contact with the channel while the C terminus of the toxin, whose side chain was 
found to be irrelevant for binding, is contacting the loop of unit C (Fig. 4.3B). In 
model III the residues 21-24 at the C terminus of the toxin are involved in several 
contacts with units C and D, while the stretch 11-15, which contains several 
residues of medium importance for function, points towards solution (Fig. 4.3C). 
In model IV, the C terminus of the toxin deeply penetrates the channel and a great 
portion of the residues that are unimportant for binding interacts with the protein 
(Fig. 4.3D).  
The fact that a whole stretch of functionally relevant toxin residues (residues 11 to 
15) is not in contact with the channel in model III and IV cannot be taken as the 
sole argument to exclude these models, as mutations at this site might destabilize 
the overall structure of the toxin. However, it is rather improbable that amino 
acids profoundly interacting with the protein (stretch 21-24) can be mutated to 
alanine without influencing affinity.  All in all the mutational analysis data are 
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severely contradicted by models III and IV, allowing us to exclude them as valid 
representations of the complex between κM-RIIIK and the TSha1 channel. Model 
II is retained as this stage, as it does not contradict the mutational data as 




Fig. 4.3. Filling space representation of κM-conotoxin RIIIK in the four clusters (Cluster I-IV in 
panels A-D), showing the mutational data obtained by systematic alanine substitution in color 
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code: the functionally most relevant residues are represented in red (L1, R10, K18 and R19); the 
residues of medium importance for binding (S3, N8, L11, O13, V14, O15 and N20) are shown in 
yellow, while the residues that are irrelevant for binding (O2, S6, L7, L9, O21 and T24) are in 
grey. Two orientations are provided for each of the four models: from the side (left panel) and 
from the top (right panel) of the channel. 
 
To further discriminate between cluster I and II, we analysed which part of the 
toxin is in close proximity to the selectivity filter. For different toxins, which 
interact with voltage gated K+ channels, there is evidence that a positively charged 
side chain occludes the channel pore. This positively charged amino acid is part of 
the functional dyad, together with an amino acid containing a hydrophobic side 
chain, usually a tyrosine. In our previous work, we demonstrated that  κM-
conotoxin RIIIK does not possess a functional dyad. Moreover, as a result of the 
mutant cycling analysis, all positively charged amino acids interact with the turret 
or pore helix regions of the channel and therefore cannot penetrate the channel 
pore. Which toxin residues are then facing the channel pore in our models? In 
model I the O15 is very close to the selectivity filter of units C and B and the 
hydroxyl oxygen at the Cγ is at a hydrogen bond distance (2.8 Å) from the 
carbonyl of the G373 of the selectivity filter of unit B (Fig. 4.4A). In model II the 
O13 is in proximity of the selectivity filters of unit A and D, but makes no tight 
direct contact with them (Fig. 4.4B). To distinguish between the two models, 
mutant cycle data involving the residues of the GYG selectivity filter would be 
required. This is unfortunately not feasible as any mutation of residues in the 
selectivity filter destroys the channel activity. Nevertheless, model I and model II 
can be distinguished by considering the distance of O13 or O15 from the amino 
acid V376 of the TSha1 channel. While in model I O15 is expected to be closer to 
V376 (of unit C) than O13, in model II both O13 and O15 are at a similar distance 
from V376 of unit D and C, respectively. The mutant cycle analysis performed 
using TSha1 V376T resulted in a ΔΔG of 0.6 kJmol-1 for O13A and of 2.51 kJmol-
1 for O15A, which reflects the geometry of model I much better than that of model 
II. To obtain further evidence for the interaction of O15 with the amino acids of 
the selectivity filter we assayed the affinity of the O15R and O15K mutants, 
following the idea that a positive charge should be well tolerated but the bulky 
arginine should not be easily accommodated in proximity of the tight channel 
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pore. The affinity of the mutant O15K for the wild type TSha1 channel was found 
to be 430 ± 20 nM (n = 4) against a value of 930 ± 160 nM (n = 3) for the mutant 
O15A. This indicates that a positive charge in position 15 is preferred to the 
absence of any polar group, as would be expected if the side chain of O15 
interacts with the carbonyls of the selectivity filter. On the other hand O15R binds 
the channel with a kD of  2940 ± 540 nM (n = 4), suggesting that O15 is situated 
close to the channel pore where there is no space to accommodate the bulky 
arginine side chain.  Although these data do not prove directly the interaction of 
O15 with residues of the selectivity filter, they strongly support it. 
 
 
Fig. 4.4 Interactions of the residues O13 and O15 of κM-conotoxin RIIIK with the selectivity filter 
of the channel. In the two panels A and B model I and II are shown, respectively. The two 
representations differ for a rotation of about 180º around the channel axis to allow for a better 
visualization of O15 in the two models. A) Model I: the Cγ-OH group of O15 is close to the 
selectivity filter of unit B and C and in H-bond distance from the carbonyl oxygen of G373 of unit 
C. B Model II: both O13 and O15 are close (< 5Å) to the selectivity filter of unit C and D, but no 
specific interaction can be identified. 
 
Model I provides a novel pharmacophore for the interaction of toxin peptides with 
K+ channels that best explains the mutational and mutant cycle data for the  κM-
RIIIK – TSha1 complex. The peptide is anchored to the extracellular loops of 
three out of the four channel units via a basic ring provided by the side chain of 
R10, K18, R19 and the protonated N-terminus of L1, and no positively charged 
residue occludes the channel pore.  
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Unlike several other peptides that target voltage activated K+ channels,  κM-
conotoxin RIIIK does not contain a functional dyad of a hydrophobic and a 
positively charged side chain, which was proposed to be the minimal functional 
core for K+ channel blocking peptides (Dauplais et al., 1997; Savarin et al., 1998; 
Gilquin et al., 2002; Srinivasan et al., 2002). The dyad model has been recently 
challenged by Mouhat et al. (Mouhat et al., 2004), who demonstrated by 
mutational analysis and docking calculations that a functional dyad is not strictly 
required for binding of the scorpion toxin Pi1 to the voltage-gated Kv1.2 
potassium channel. Instead, a basic ring of four positively charged side chains was 
proposed to be a fundamental recognition element by the residue D355 of each of 
the four Kv1.2 α-subunits. Similarly, we find that four positively charged residues 
of  κM-conotoxin RIIIK are involved in electrostatic interactions with loop and 
pore helix amino acids of three subunits of the TSha1 channel. Residue E354 of 
different units is involved in contacts with all four positively charged residues of 
the peptide. This amino acid distinguishes the TSha1 channel, which is the highest 
affinity target of κM-RIIIK (IC50 = 76± 10 nM), from other channels of the same 
family, as for example the Shaker (IC50 = 1.2 μM) (Ferber et al., 2003), where the 
homologous position is occupied by a lysine (K427), and Kv1.2 (IC50 = 400 nM) 
(Ferber et al., 2004) where the homologous position is occupied by a neutral 
proline (P359). Our model suggests that E354 is a fundamental recognition 
element for  κM-RIIIK binding to the TSha1 channel. However, the complete lack 
of affinity for κM-RIIIK shown by other members of the Kv1 family (Ferber et 
al., 2003), which, like Kv1.2, contain an uncharged amino acid at position 359, 
indicates that channel amino acids other than P359 play a comparably important 
role in toxin recognition. For the toxin it is reasonable to hypothesise that the 
spatial distribution of the positive charges of the basic ring exerts a fundamental 
role in channel recognition and provides a solid framework for the high selectivity 
of the K+ channel-blocking toxins among the diverse targets. 
As shown in the NMR-derived solution structure of the peptide, the basic ring 
defined by L1, R10, K18 and R19 separates the peptide in two faces: all 
functionally relevant residues, identified by systematic alanine mutations, cluster 
on one face, which is in contact with the channel in model I. 
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The mutant cycle analysis excludes that one of the positively charged side chains 
of κM-RIIIK penetrates the channel pore, as they all interact with amino acids of 
the extracellular loop and pore helix. In model I the Cγ-hydroxyl of O15 tightly 
interacts with the carbonyl of G373 of the unit C selectivity filter. It has been 
proposed that the carbonyls of the selectivity filter are major players in the 
coordination of K+ ions at the entrance of the channel pore (Doyle et al., 1998). 
Dehydration of the ions must occur at the selective filter, as a hydrated K+ is too 
large to enter the channel pore. By acting as electron donors, the carbonyls of the 
selectivity filter replace the water molecules usually associated with K+ ions in 
solution, thus compensating for the large energetic penalty of the dehydration 
process. A H-bond between the Cγ-hydroxyl of O15 would block one of the 
selectivity filter carbonyls, seriously disturbing the energetic of the K+ 
dehydration process.  
A thorough analysis of the binding mode of various scorpion toxins to diverse K+ 
channels (Rodriguez de la Vega et al., 2003, Xu et al., 2004) revealed three 
possible binding modes, which involve different faces of structurally similar 
toxins: the internal binding mode, where residues of the turret region, pore helix 
and selectivity filter of the channel are involved; the intermediate mode, involving 
residues of the turret region; the external mode, which involves residues far away 
from the selectivity filter. In the intermediate and external binding modes no 
functional dyad is observed on the peptide site. This analysis, triggered by the 
observation that the scorpion toxin BmTx3 can block both A-type K+ and HERG 
currents (Huys et al., 2004) using different functional faces, confirms the existence 
of different binding modes of peptidic toxins to K+ channels, some of which do not 
involve a direct obstruction of the pore by a positively charged side chain. The 
mutant cycle data and the docking model I prove the interaction of κM-RIIIK 
residues with amino acids in the turret and pore helix regions and to some extent 
also with the selectivity filter. In the classification of Rodriguez de la Vega et al. 
(Rodriguez de la Vega et al., 2003), the position of the toxin in the κM-RIIIK – 
TSha1 channel complex resembles the internal binding mode best. However, the 
side chain of O15 does not completely occlude the channel pore, as the lysine of 
the functional dyad, but rather disturbs the charge distribution at the selectivity 
filter by involving one of the carbonyls in a H-bond.  
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Despite the entirely different pharmacological specificity and many differences in 
the amino acid sequence, κM-conotoxin RIIIK shows striking structural 
similarities to μ-conotoxin GIIIA, which specifically blocks Nav1.4 Na+ channels. 
κM-conotoxin RIIIK and μ-conotoxin GIIIA belong to the same phylogenetic 
family and share a common pattern of cysteine bridges. Interestingly, O15 of κM-
conotoxin RIIIK is at the homologous position of R13, the Na+ channel pore 
occluding residue in the peptide sequence of μ-conotoxin GIIIA. This fact, 
together with the high structural similarity of the two toxins, suggests that κM-
conotoxin RIIIK and μ-conotoxin GIIIA might block K+ and Na+ channels, 
respectively, with a similar geometry. However, being the O15R mutant of κM-
RIIIK inactive on Nav1.4 sodium channels (data not shown), additional 
parameters must be involved in determining the selectivity of the two peptides for 
Na+ or K+ channels. Similarly to κM-RIIIK, a ring of positively charged side 
chains can be identified on μ-GIIIA as well. Most likely the overall shape of the 
two peptides and the charge distribution of the basic ring are key determinants for 











1.1 The biological system. 
 
The TAR-RNA. The trans-activating region (TAR) RNA of the human 
immunodeficiency virus (HIV) is a particularly attractive example of the RNA-
based drug discovery process. The formation of full-length viral transcripts 
requires the interaction of the TAR-RNA (Scheme 1.1) with the transcriptional 
activator protein, Tat (Frankel, 1992). Shortly after promoter clearance, RNA 
polymerase II stalls at the TAR-RNA site due to the action of the negative 
elongation factor. The Tat/TAR complex recruits the positive transcription 
elongation factor complex (P-EFTb), which activates the RNA polymerase II 
stalled at the TAR-RNA site and enables viral replication (Wei et al., 1998; 
Garber et al., 1998). Disruption of the Tat/TAR interaction inhibits the production 
of complete viral transcripts, as the P-EFTb complex cannot bind the TAR-RNA 
in the absence of the Tat-protein (Wei et al., 1998). Thus, the interaction of the 
TAR-RNA with both the Tat-protein and the P-EFTb complex represents an 
appealing target for anti-viral therapy.  
The TAR-RNAs from HIV-1 and HIV-2 differ in the size of the bulge, which 
comprises three nucleotides (UCU) in the HIV-1 and two nucleotides (UU) in the 
HIV-2. Both TAR-RNAs recognize the Tat-protein in a similar manner. Of 
critical importance is the U23 nucleotide in the TAR bulge and the (G26-C39) and 
(A27-U38) base pair in the upper stem (Cordingly et al., 1990; Roy et al., 1990; 
Weeks & Crothers, 1991). Mutational analysis have shown that U23 is the only 
essential nucleotide for the TAR-Tat interaction (Weeks & Crothers, 1991; 
Churcher et al., 1993). The other bulge nucleotides (two in the HIV-I TAR and 
one in the HIV-II TAR-RNA) can be freely substituted, even with a non-
nucleotide linker (Churcher et al., 1993; Sumner-Smith et al., 1991) and merely 
act as spacers. NMR studies of the HIV-2 TAR-RNA in complex with 
argininamide, a mimetic of the Tat-protein, suggest the formation of a base triple 
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between U23, A27 and U38, which helps widen the major groove of the upper 
stem and makes it more accessible to the incoming argininamide (Brodsky & 
Williamson, 1997; Puglisi et al., 1992).  
The subunit cyclin T1 (CycT1) of the P-EFTb complex binds the Tat/TAR 
complex contacting directly the transactivation domain of the Tat-protein and the 
loop of the TAR-RNA (Zhu et al., 1997; Mancebo et al., 1997). Mutational 
analysis revealed G32 and G34 of the hexanucleotide loop of the TAR-RNA to be 
crucial for CycT1 binding, while the presence but not the nature of the nucleotide 
in position 35 is relevant for complex formation (Richter et al., 2002). 
Additionally, the formation of a transient base pair between C30 and G34 has 
been suggested to favor the binding of the CycT1 subunit of the P-TEFb complex 
to the Tat-TAR complex (Richter et al., 2002). 
Given the relevance of the TAR-RNA as a potential therapeutic target, much work 
has been directed towards the synthesis and screening of small organic 
compounds, which selectively bind to the TAR-RNA, thereby inhibiting the 
Tat/TAR binding event. As a result of these studies, a number of small molecules 
have been found to interact with the TAR-RNA inhibiting viral transcription in 
HeLa cells (Arzumanov et al., 2001; Mischiati et al., 2001; Kaushik et al., 2002).  
Interaction of the TAR-RNA with aminoglycosides. The cationic antibiotics of 
the aminoglycoside family bind to several RNA motifs by specifically recognizing 
their three-dimensional structure (Hermann & Westhof, 1998). In particular, they 
have been proven to exert an inhibitory effect on the binding of the Tat-protein to 
the TAR-RNA (Mei et al., 1995 and 1998, Wang et al., 1998; Hamy et al., 1998). For 
the HIV-1 TAR-RNA, brownian dynamics simulations have identified three “hot-
spots”, which are more prone to be targeted by cationic antibiotics because of 
higher electro negativity in these pockets. The predicted pockets are on top of the 
U31-GG-G34 loop, in the U23-C-U25 bulge and in the major groove of the lower 
stem (Hermann & Westhof, 1999). Polycationic aminoglycosides are predicted to 
simultaneously interact with the lower and upper stem regions, thus inhibiting the 
binding of Tat or Tat-derived  peptides (Hermann & Westhof, 1999). The 
structural basis of the interaction of the TAR-RNA with aminoglycosides has 
been described for neomycin B by NMR (Faber et al., 2000): neomycin B binds 
the TAR-RNA in the minor groove of the lower stem, which results in an 
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“allosteric” inhibition of Tat binding to TAR-RNA caused by a reduction of the 
major groove volume in the upper stem. Interestingly, to date aminoglycosides 
have not been found to compete with Tat for binding the bulge region of the TAR-
RNA, as it has been proven for other small organic molecules possessing an 
aromatic scaffold and one or more guanidium groups (Davis et al., 2004). 
                     
1 HIV II TAR-RNA 
Scheme 1.1  
Aminoglycosides are valuable instruments to study the structural basis of RNA 
recognition and function inhibition by cationic organic molecules. However, their 
use as RNA-targeting drugs is impeded by several drawbacks, such as low 
specificity, high toxicity and increasing development of resistance  (Wilson & Li, 
2000; Michael & Tor, 1998; Mingeot-Leclercq & Tulkens, 1999). These 
considerations underline the continuous need for new compounds that share an 
aminoglycosidic scaffold but can be easily derivatized to obtain drug leads with a 
better pharmacological profile. The group of Prof. Kirschning at the University of 
Hanover ha conducted a program directed towards the synthesis of a new class of 
aminoglycoside analogues (Kirschning & Chen, 1999; Kirschning & Chen, 2000; 
Chen & Kirschning, 2002). These potential RNA ligands consist of aminodeoxy 
hexoses and the corresponding cyclitols. Aminocyclitols do not contain the 
chemically and enzymatically labile acetal group (glycosidc bond), which make 
them particularly attractive targets. This class of aminoglycoside ligands is unique 
in the fact that they are easily synthesized via metathesis olefination and can be 
derivatized straightforwardly. Dot blot analysis, the results of which have been 
discussed in a previous publication (Kirschning et al., 2004), point out that the 
cyclic neooligoaminodeoxysaccharide (Scheme 1.1) has a much greater binding 
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affinity to the TAR-RNA in comparison to its linear counterparts. The 
aminoglycoside analogues can be obtained as 13C and 15N labelled derivatives at 
reasonable costs for NMR studies (Jaunzems et al., 2004).  
Here we present the structure of the HIV-2 TAR-RNA bound to the cyclic 
neooligoaminodeoxysaccharide 1 (Scheme 1.1). The structural analysis conducted 
here reveals attractive features in the interaction of this ligand with the TAR-
RNA. The aminoglycoside analogue 1 binds to two sites of the TAR-RNA: the 
bulge and loop regions on the major groove side of the upper stem and the minor 
groove of the lower stem. Like argininamide, 1 contacts the crucial residues of the 
TAR-RNA bulge required for Tat binding. This is in contrast to natural 
aminoglycosides, like neomycin B, which interact exclusively with the minor 
groove of the TAR-RNA lower stem (Faber et al., 2000). Additionally, we detect 
extensive contacts of 1 to the A35 of the dynamic hexanucleotide loop, in 
agreement with digestion experiments, indicating protection of the loop guanines 
upon addition of the ligand to the TAR-RNA. The NMR studies conducted on 
both free and argininamide-bound TAR failed to reveal the presence of well-
structured elements in the hexanucleotide loop of the TAR-RNA (Brodsky & 
Williamson, 1997; Colvin et al., 1993; Jäger & Tinoco, 1993); however, the 
relevance of the loop size and of the G32 and G34 functional groups for the 
formation of the Tat/TAR/CycT1 complex (Richter et al., 2002) suggests that the 
hexanucleotide loop assumes a well-defined structure when interacting with the P-
TEFb complex. Our structural investigation of the TAR-RNA in complex with 1 
indicates that the TAR-RNA loop can indeed interact with cofactors through the 
looped-out nucleotide in position 35. Upon binding the cofactor, the loop becomes 
more ordered, and the functional groups N7 and O6 of G34 are situated at 
reasonably well-defined positions in the major groove of the upper stem. The 
structural stabilization of the hexanucleotide loop upon binding of a cofactor to 
A35 could represent a general mechanism by which the Tat protein pre-orders the 
loop for the binding of CycT1 to the G32 and G34 residues. Thus, the 
simultaneous targeting of both the bulge and the loop of the TAR-RNA by 
positively charged molecules should result in a more efficient inhibition of both 
the Tat-protein and the P-TEFb complex binding to the TAR-RNA. The 
aminoglycoside analogue 1 binds to the TAR-RNA with a Kd in the μmolar range; 
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however, the easy addition of functional groups on the sugar skeleton makes this 
structure an attractive starting point for the design of TAR binders with improved 
thermodynamic properties, contacting both the bulge and loop functional “hot 
spots”.  
 
1.2 The questions we ask. 
 
Here we perform a structural investigation of the aminoglycoside 
analogue 1 in complex with the HIV-2 TAR-RNA (Scheme 1.1) by NMR in 
solution. This work aims to answer the following questions: 
1. Does 1 bind the TAR-RNA in the bulge region, thereby directly competing 
with the protein Tat for the same binding site? 
2. Does 1 contact residues of the hexanucleotide loop of the TAR-RNA?  
3. In case 1 binds also to the loop of the TAR-RNA is this binding mode 
significant to understand the principle of the binding of CycT1 to the same loop? 
4. Which are the principles of RNA recognition by 1? Are there any specific 
hydrogen bonds between the charged amino groups of 1 and the phosphate 
backbone of the RNA? 
5. Are the 2’-hydroxyl groups of the RNA riboses involved in cofactor 
recognition? 
Question 5 can only be answered if precise structural information on the 
orientation of the proton of the 2’-OH group is available. However, the orientation 
of the 2’-OH proton has so far escaped structural investigation both by X-ray and 
NMR in solution. Thus, we set out to develop an NMR-based approach, which 
could reveal the conformation around the H2’-C2’-O2’-OH torsion angle. The 
new methodology and the results obtained for the HIV-2 TAR-RNA in absence of 
cofactors are presented and discussed in Chapter 5, where we address the role of 
the 2’-hydroxyl group in the stabilization of RNA secondary structure and in 
supporting an ordered network of H-bonds in the minor group of A-form helical 
RNA. Unfortunately, due to the low concentration of the sample of the TAR-
RNA/1 complex (< 0.3 mM), the new methodology could not be reliably applied 
to this system. However, the approach described in Chapter 5 will be very 
valuable to understand the function of the 2’-hydroxyl group in cofactor binding, 
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when sample concentration of the order of 1 mM can be reached. Indeed, such 
studies are being conducted in our laboratory for the TAR-RNA bound to Mg2+ 
ions. 
 
1.3 Significance of the work 
 
RNA molecules are able to switch among different conformations, 
depending on different factors like the pH, temperature and salt concentrations. 
These local or global conformational changes can be triggered by cofactors 
binding and are required for the biological function. Small positively charged 
molecules, such as polyamines, aminocyclitols or aminoglycosidic scaffolds can 
capture specific three-dimensional folding motifs of nucleic acids, thereby either 
blocking the RNA in a biologically inactive conformation or directly competing 
with the binding of proteins and cofactors necessary for the biological function. 
Understanding the principle of the interaction of RNA with cationic antibiotics 
represents a major step towards the design of specific RNA binders. The TAR-
RNA and its interaction with the Tat protein and the CycT1 unit of the P-EFTb 
complex are key elements in the control of HIV viral replication and constitute 
attractive targets for anti-viral therapy. The structural work conducted here, and in 
particular the novel structural insights obtained for the hexanucleotide loop of the 
TAR-RNA, contribute to a better understanding of the multiple possibilities of 
RNA recognition by positively charged molecules and indicate a new direction for 
the design of improved TAR binders, which inhibit the interaction of the TAR-








NMR spectroscopy. NMR experiments were acquired using a 0.3 mM 
sample of 13C/15N labeled HIV-2 TAR-RNA dissolved in either D2O or H2O/D2O 
(90/10), containing 50 mM phosphate buffer at pH 6.4.  Compound 1 was titrated 
in concentrations varying from 0.3 mM to 30 mM. The chemical shift changes of 
the resonances of both the base C5/C6/C8 and H5/H6/H8 and the sugar C1’ and 
H1’ atoms of the RNA were monitored during the titration in HSQC spectra (Bax 
et al., 1990). Standard NMR methods were employed to assign both the free and 
the aminoglycoside-bound TAR-RNA (Hu et al., 1998; Wijmenga & van Buuren, 
1998). The experiments were acquired at 600, 700 and 800 MHz. The non-
exchangeable base and sugar proton resonance were assigned with the aid of 3D 
HCCH-COSY-TOCSY (Hu et al., 1998)  and 3D 13C-HSQC-NOESY 
experiments acquired in D2O. Exchangeable imino proton resonances were 
assigned from 2D NOESY spectra in H2O. Low concentration of the sample 
hampered the stereospecific assignment of H5’/H5’’ and hence contacts to them 
were treated as ambiguous restraints. Presence of imino-imino proton peaks and 
NOE interactions that suggested stacking led us to impose hydrogen bond base 
pairing restraints on G16-C46, G17-C45, C18-G44, C19-G43, A20-U42 and G21-
C41 in the lower stem and G26-C39, A27-U38, G28-C37 and C29-G36 in the 
upper stem. Absence of the imino proton peak of U40 even at lower temperatures 
indicates disruption of the A22-U40 base pair in the complex. However, the 
presence of several NOEs between U40 and C39 (protons H6 to H6, H5 to H2’, 
H5 to H3’ and H6 to H3’ respectively) and U40 and C41 (protons H2’ to H5 and 
H3’ to H5, respectively) indicates that U40 is not bulged-out but remains between 
C41 and C39. Thus, weak hydrogen bonding between U40 and A22 was imposed 
in the initial phase of the calculations to ensure that U40 does not move out of the 
helix. The hydrogen bonding restraint between U40 and A22 was released during 
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the refinement step. Intermolecular NOEs from the TAR-RNA to the ligand were 
assigned from a 3D 13C-edited / 12C-filtered HSQC-NOESY spectrum in D2O 
(Leupin et al., 1990, Zwahlen et al., 1997), where the NOEs between the 13C-
labeled RNA and the unlabeled aminoglycoside could be selectively observed. 
The ligand being in fast exchange between the free and bound forms, no 
intramolecular NOE restraints could be derived for the aminoglycoside in the 
complex.  
RNA intramolecular NOEs were derived from a 3D 13C-HSQC-NOESY and from 
a base-selective high-resolution 3D 13C-HSQC-NOESY (Brutscher et al., 1991) 
with mixing time of 100 ms, while a mixing time of 200 ms was used to measure 
the intermolecular NOEs in the 3D 13C-edited / 12C-filtered HSQC-NOESY 
experiment. 
The sugar pucker was defined as either C2’ endo or C3’ endo depending on the J 
coupling constants between H1’ and H2’ derived from a 2D-HCCH-E.COSY 
spectrum (Schwalbe et al., 1994). The sugar pucker was restrained to C2’ endo for 
J > 8 Hz and to C3’ endo for J < 3 Hz coupling. Because of the low sample 
concentration, the quality of the experiments involving the backbone phosphate 
was very poor and no 3JHP coupling constant could be measured to prove the 
backbone dihedral angles.  
15N-labeled aminoglycoside (Jaunzems. et al., 2004) was mixed with unlabeled 
TAR-RNA to attempt the measurement of H-bond mediated JNP couplings, which 
would have confirmed the presence of hydrogen bonding between the amino 
groups of the aminoglycoside and the phosphate backbone of the RNA. The J-
quantitative method (Vuister & Bax, 1993) was used to measure the JNP couplings 
in a H-N two-dimensional correlation. Unfortunately, no hydrogen bond mediated 
JNP coupling could be detected for this sample. The 15N chemical shift of the 
amino group confirmed that all four groups of 1 are protonated in the NMR 
buffer. The resonances of the amino protons of 1 could not be observed due to fast 
exchange with the solvent.  
T1 relaxation times for the base C8/C6 carbons were measured in 13C-1H 
correlations using relaxation delays of  5, 10, 20, 30, 40, 60, 80, 100, 120, 160, 
200, 300, 400, 600, 800 and 1200 ms.  
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The simultaneous presence of the negatively charged RNA and 10-fold excess of 
positively charged ligand deterred us from using phages or bicelles to attempt 
alignment of the RNA-ligand complex. Instead, we measured residual dipolar 
couplings (RDC) by making use of the fact that at high magnetic fields, RNA 
helices are sufficiently aligned to generate measurable field-induced dipolar 
couplings. The field-induced RDCs (fiRDCs) linearly scale with the square of the 
field strength. We measured the 1H-13C splitting (J+D) of the C2H2, C6H6, C8H8 
and C1’H1’ at 600, 700 and 800 MHz. The dipolar couplings at 800 MHz were 
derived by linear fitting of the three values and extrapolation to zero magnetic 
field to obtain the value of J. Only those RDCs were employed during the 
refinement procedure, which showed a linear relationship to B02 within the 
experimentally determined error limits (37 RDCs in total, excluding the two-base 
bulge, loop and the two terminal residues). 
The high values of the residual dipolar couplings and T1 values considerably 
longer than those of the free-TAR indicated that the TAR/1 complex dimerizes. 
No intermolecular NOEs between two RNA molecules in the dimer was observed 
in a 3D 13C-edited / 12C-filtered HSQC-NOESY spectrum in D2O and in a 3D 13C-
edited/12C/14N-filtered HSQC-NOESY in H2O for a sample consisting of 150 μM 
13C/15N labelled RNA,150 μM unlabelled RNA and 3 mM ligand. 
Structure calculations. The NOE peaks from the 3D 13C-HSQC-NOESY, 3D 
13C-edited/ 12C-filtered HSQC-NOESY and 2D NOESY spectra in H2O or D2O 
were converted to appropriate distance restraints classified into three categories 
corresponding to weak, medium and strong, with upper distance bounds of 3, 4 
and 5 Å respectively. Very weak NOEs to exchangeable protons or very weak 
intermolecular NOEs were allowed an upper bound of 6.0 Å. 
All chemical shifts of the nucleotides in the lower stem (16-21 and 41-46) but the 
C1’ of G43 did not significantly change upon binding of compound 1, indicating 
that the A-form conformation of the lower stem, found in the free form (Aboul-ela 
et al., 1996) is conserved. Typical sequential NOEs confirmed the presence of A-
form helix in this region. Therefore, very loose dihedral angle restraints, within a 
range of ±60° of the standard A-form values, were imposed for the α, β, ζ and ε 
backbone angles in the lower stem of the TAR-RNA. 
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Restrained molecular dynamics (rMD) combined with energy minimization in 
XPLOR-NIH (Schwieters et al., 2003) was employed to obtain the final ensemble 
of structures of the TAR/neooligoaminodeoxysaccharide complex. The dna-rna-
allatom.par (Parkinson et al., 1996) parameter set was used for the RNA, while a 
modified force field was employed for the ligand with parameters for bond, angle, 
improper and non-bonded terms assembled from the updated parameter files for 
carbohydrates in XPLOR-NIH. The restraints used in the calculations comprised a 
total of 447 NOEs for the RNA (320 intranucleotide and 127 internucleotide 
NOEs), 55 intermolecular NOEs, 44 experimental dihedral angle restraints 
defining the ribose pucker for 22 nucleotides, 41 non-experimental dihedral angle 
restraints defining the backbone angles α, β, ζ and ε in the lower stem, 72 H-bond 
restraints defining 10 base pairs for stretches 16-21, 41-46 and 26-29, 36-39 and 
10 restraints defining the planarity of the base pairs.  
Definition of the overall geometry of the complex. The chemical shift mapping 
and the intermolecular NOEs identified three regions for the binding of the 
aminoglycoside analogue 1 on the TAR-RNA: in the bulge and loop regions on 
the side of the upper stem major groove and in the minor groove of the lower stem 
(Fig. 3.1). Furthermore, the dipolar coupling data and the relaxation indicate that 
the RNA dimerizes. The presence of only one set of resonances for the complex 
and the absence of NOEs between the two RNA molecules in the dimer, suggest 
that the dimer is symmetric and that the RNA dimerizes through one or more 
aminoglycoside molecules. The dipolar coupling data are compatible with a dimer 
where the two upper or lower stems are roughly parallel to each other while the 
other two stems diverge, forming an angle of about 60° with the other stem in the 
same RNA molecule. Four possible scenarios can satisfy these constraints (Fig. 
2.1): a) three molecules of 1 bind to the loop, the bulge and lower stem of the 
TAR-RNA and the RNA dimerizes with the two upper stems parallel to each 
other; b) three molecules of 1 bind to the loop, the bulge and lower stem of the 
TAR-RNA and the RNA dimerizes with the two lower stems roughly parallel to 
each other; c) one molecule of 1 binds to the upper stem major groove contacting 
both the bulge and the loop of the TAR-RNA, while a second molecule binds to 
the lower stem minor groove and the RNA dimerizes with the two upper stems 
parallel to each other; d) one molecule of 1 binds to the upper stem major groove 
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contacting both the bulge and the loop of the TAR-RNA, while the second 
molecule contacts the lower stem minor groove of the TAR-RNA; the RNA 
dimerizes with the two lower stems roughly parallel to each other. Structure 
calculations according to the first, and third scenarios resulted in very high 




Fig. 2.1 Schematic representation of the association of TAR with the aminoglycoside analogue 1  
and of dimer formation. (A) three molecules of 1 bind to the loop, the bulge and the lower stem 
minor groove and the RNA dimerizes with the two upper stems parallel to each other; the lower 
stems point in opposite directions. The magnetic susceptibility tensor predicted for such an 
arrangement of the helical elements is in agreement with the experimentally determined dipolar 
coupling tensor. (B) Three molecules of 1 bind to the loop, the bulge and the lower stem minor 
groove and the RNA dimerizes with the two lower stems parallel to each other; the upper stems 
point in opposite directions. Also in this case the predicted magnetic susceptibility tensor is in 
agreement with the experimentally determined dipolar coupling tensor. (C) one molecule of 1 
binds to the upper stem major groove contacting both the bulge and the loop of the TAR-RNA, 
while a second molecule binds to the lower stem minor groove; the RNA dimerizes with the two 
upper stems parallel to each other. (D) one molecule of 1 binds to the upper stem major groove 
contacting both the bulge and the loop of the TAR-RNA, while the second molecule contacts the 
minor groove of the lower stem of the TAR-RNA; the RNA dimerizes with the two lower stems 
parallel to each other. 
 
Therefore, only the second and fourth scenarios were found to be consistent with 
the observed intermolecular NOEs. However, the second scenario, which includes 
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five aminoglycosides molecules binding to two RNA units can be excluded due to 
the following reasons: a) A35 is the only residue of the loop showing NOEs to 1, 
indicating that the binding of 1 to this residue must be part of a more complex 
network of interactions; b) chemical shifts data indicate that 1 binds to the bulge 
and the loop of RNA with the same Kd, suggesting cooperative binding to both 
sites; c) smaller cyclic analogues or linear analogues of 1 do not show any 
detectable binding to the TAR-RNA (Kirschning et al., 2004), indicating the 
relevance of a cooperative binding to multiple sites; d) entropic contribution 
strongly disfavor the second case with respect to the fourth. Therefore, the case of 
Fig. 2.1B was not considered further. 
Definition of the upper stem binding site. The first binding site, comprising the 
bulge, the upper stem major groove and the loop of the RNA was accurately 
defined using the following procedure. Due to the four-fold degeneracy of the 
resonances of the aminoglycoside analogue 1, intermolecular NOEs between the 
RNA and 1 cannot be assigned to a defined sugar or linker unit. Full ambiguity 
among the four possibilities results in non-convergent structures at the upper stem 
binding site. Therefore an accurate procedure was used to define the 
intermolecular NOEs, covering all reasonable possibilities that are not equivalent 
by symmetry. The sugars and linkers of compound 1 were numbered from 1 to 8 
clockwise to define a ring consisting of sugar 1, linker 2, sugar 3, linker 4, sugar 
5, linker 6, sugar 7 and linker 8. We constructed seven different intermolecular 
NOE templates as described in Fig. 2.2. Although the resonances of 
aminoglycoside analogue 1 show a four-fold symmetry, the symmetry of the 
chemical structure is only two-fold. Therefore, the initial seven sets of 
intermolecular NOEs, shown in Fig. 2.2, were duplicated by shifting both the 
sugar and the linker numbering by one unit (sugar 1? sugar 3, linker 2 ? linker 
4, etc.). This resulted in seven sets of intermolecular NOEs plus two numbering 
schemes, totaling fourteen combinations. The rmsd of the upper stem binding site, 
formed by the aminoglycoside analogue 1 and the RNA nucleotides A22, U23, 
U25 and A35, and the rmsd of the whole complex, excluding the loop residues, 
were evaluated for the energetically most favorable 20 structures in all fourteen 
calculations before the final refinement with the fiRDC data.  
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The upper stem binding site of the complex converged the best for the seventh set 
of intermolecular NOEs with both numbering schemes. The numbering of the 
sugars and linkers showed in Scheme 1.1 delivered the best result with an rmsd 
value of 2.15 Å for the upper stem binding core and 1.75 Å for the whole complex 
excluding the loop. The average rmsd value for the remaining thirteen calculations 
was 3.0 Å for the upper stem binding core and 2.25 Å for the whole complex. 
Thus, the seventh set of intermolecular NOEs and the numbering scheme of 
Scheme 1.1 were used to determine the structure of the complex. Some of the 
ambiguities in the seventh intermolecular NOEs data set were further released by 




Fig. 2.2 Pictorial representation of seven intermolecular NOEs data sets used in the structure 
calculations to define the upper stem binding site. Two assignments were considered for NOEs 
stemming from A35: i) either to sugar 1 and linker 2 (lower row) or ii) to sugar 1 and linker 8 
(upper row). For NOEs stemming from the bulge residues A22, U23 and U25, three alternatives 
were devised: a) A22, U23 and U25 contact sugar 5 and linkers 4 and 6 (first column); b) A22, 
U23 and U25 contact sugars 3 and 5 and linker 4 (second column);  c) A22 and U23 contact sugar 
5 and linkers 4 and 6, while U25 contacts sugar 3 and linkers 2 and 4 (third column). Combination 
of the two possibilites for NOEs from A35 with the three for the bulge yields  six sets of NOEs. In 
the seventh set (right), NOEs stemming from A35 were assigned to sugar 1 and linker 8; those 
stemming from U25, to sugar 3 and linkers 2 and 4; those stemming from U23, to sugars 3 and 5 
and linker 4; those stemming from A22, to sugar 5 and linker 4 or 6. When a residue contacts two 
ligand moieties equivalent by symmetry (e.g. linkers 4 and 6), those restraints were treated as 
ambiguous in the structure calculation. Additionally, other seven NOE sets were created by 
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rotating the aminoglycoside macrocycle 90º counter-clockwise to account for its two-fold 
symmetry. 
 
As the contacts between the aminoglycoside analogue 1 and the upper stem, bulge 
and loop of the TAR-RNA are much more extensive than those with the second 
binding site in the lower stem minor groove, a first round of structure calculations 
focused on the determination of the intermolecular recognition in the upper stem 
binding site only. 150 structures were subjected to 22 ps of restrained Molecular 
Dynamics (rMD) at 1000K during which the force constants of the NOE (50.0 
kcal/mol Å2), dihedral angle restraints (300.0 kcal/mol deg2), angles, impropers 
and Van der Waals were increased to their full value. After this MD step, we 
chose 125 structures out of 150, which had total energy lower than 700 kcal/mol. 
These structures were subjected to three rounds of MD of 3 ps each at 1000K, 
600K and 400K. 700 steps of Powell minimization were performed between each 
MD step (Jucker & Pardi, 1995). All force constants were kept at their maximum 
values. After the high temperature step, hydrogen bond restraints between U40 
and A22 were released. At this stage 50 structures were chosen with total energy 
< 600 kcal/mol and NOE violation energy < 100 kcal/mol. These structures were 
subjected to a refinement protocol consisting of 20000 steps of 1 fs dynamics at 
500K, 300K, 150K, 50K and 10K. The protocol ended with 2000 steps of Powell 
minimization. Only repulsive energy terms were employed for the Van der Waals 
forces at each stage and no electrostatics was used during any part of the structure 
generation, annealing and refinement. At each subsequent stage of dynamics 
(simulated annealing and refinement), the number of violations and the energy 
decreased suggesting that the experimental restraints are well satisfied in the 
structures. 
The 50 structures were subjected to a final refinement with the incorporation of 
fiRDCs to validate the shape and conformation of the complex. In this final 
refinement protocol the attractive Lennard-Jones potential term was switched on. 
The force constant for the dipolar coupling energy term was 1.5 kcal mol-1Hz-2. 
An accurate estimate of the magnitude and rhombicity of the alignment tensor 
cannot be obtained from the powder pattern if only C-H dipolar couplings for base 
and C1’-H1’ ribose vectors are available; hence we performed a grid search 
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wherein the dipolar coupling energy term was evaluated as a function of the 
alignment tensor. A systematic grid search for the optimal values of Dzz and R 
was performed sampling values of Dzz between 5 and 10 in 1 Hz steps and 
rhombicity between 0.1 and 0.65 in 0.05 steps. Examination of the dipolar 
coupling energy profiles revealed a minimum for Dzz = 7 Hz and R = 0.55; thus, 
this tensor was employed during refinement (Varani et al., 2005). The correlation 
coefficients of the experimentally determined fiRDCs versus the calculated 
fiRDCs and the Q factors of the final structures were calculated using DipoCoup 
(Meiler et al., 2000). The final structures were viewed and analysed using 
MolMol (Koradi et al., 1996).  
Definition of the second binding site and dimer structure. The contacts of the 
aminoglycoside analogue 1 with the lower stem minor groove are defined by the 
intermolecular NOEs of 1 with G43-H1’ and G44-H4’. Due to steric reasons, 
these NOEs were assigned to the same sugar and linker units of 1.  
A second aminoglycoside molecule was docked to the minor groove of two 
TAR/1 molecules, predisposed by rigid body dynamics in the correct orientation 
to satisfy the geometry defined by the dipolar coupling data. The docking was 
performed by MD simulation in explicit water solvent and was guided by the 
NOEs of 1 to G43-H1’ and G44-H4’. The heating stage consisted of 200 steps of 
2fs dynamics at 100, 200, 300,500 and 600K. This was followed by refinement at 
600 K for 6ps. Then, the molecule was allowed to cool to 25 K in temperature 
steps of 25 K with 200 steps of 3fs dynamics at each temperature. The 
calculations ended with 200 steps of Powell minimization. 
RNase digestion experiments. 5’-32P labeled HIV-2 TAR-RNA (Scheme 1.1) 
was digested with both RNase T1 (G-selective) and RNase A (selective for U and 
C) in presence of the aminoglycoside analogue 1 at 4 ºC. The concentration of the 
RNA was 10 μM, while the concentration of compound 1 varied from 0.1 μM to 
10 mM for the digestion with RNase T1 and with RNase A. All experiments were 
performed in autoclaved Eppendorf reaction vessels. Extreme precaution has been 
taken to avoid RNAse contamination. After the reaction, the mixture was loaded 
onto a 20% denaturing polyacrylamide gel. 
PACE experiment. The stechiometry of the binding of the TAR-RNA to 1 was 
verified using the PACE technique (Cilley & Williamson, 1997). A series of lanes 
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containing different concentration of the aminoglycoside (0, 1, 2, 5, 7, 10, 20, 70, 
100, 200 and 500 μM) were poured with the gel rotated by 90°, as described by 
Cilley and Williamson. The total concentration of 5’-32P labeled RNA was 10 μM. 
D represents the retardation distance of the RNA at each aminoglycoside 
concentration. The function (D-DF)/(DB-DF), where DB and DF are the retardation 
distances of the RNA completely bound to the aminoglycoside (concentration of 1 
= 500 μM) and in the absence of the aminoglycoside, respectively, is plotted 
against the aminolycoside concentration in the gel (Fig. 3.3). The data where 
fitted assuming the following scenarios: a)  one molecule of the TAR-RNA binds 
one molecule of 1; b) one molecule of the TAR-RNA binds two molecules of 1 
with the same Kd; c) two molecules of the RNA bind one molecule of 1; d) one 
molecule of the TAR-RNA binds two molecules of 1 with different Kds; e) one 
molecule of the TAR-RNA binds one molecule of 1; subsequently the TAR/1 
complex dimerizes; f) two molecules of the RNA bind one molecule of 1; 
subsequently two molecules of 1 are recruited by the dimer for a total of two RNA 
molecules and three molecules of 1 (case of Fig. 2.1D). As shown in Fig. 3.3, the 
scenario f) optimally fits the experimental data, confirming the dimer geometry 




The TAR-RNA used for the NMR experiments was obtained by in-vitro 
transcription using T7-polymerase expressed and purified in house. 15N/13C 
labeled NTPs were purchased by Spectra Stable Isotopes. The RNA was purified 
by gel electrophoresis. 20 ml transcription reaction yielded ca. 5 mg of pure RNA. 
The aminoglycoside analogue 1 was obtained by chemical synthesis as described 







3.1 NMR experiments and dipolar coupling analysis.  
 
C1’/H1’, C5/H5, C6/H6 and C8/H8 RNA resonances were monitored 
upon titration of the ligand in concentration ratios varying from 1:1 to 1:100. 
Significant chemical shift changes were observed up to a 10-fold excess of the 
ligand (3 mM) over the RNA (0.3 mM). The chemical shift mapping identifies 
A22, U23 and loop nucleotides G32, G34 and A35 as the sites being most affected 
by the binding of the aminoglycoside analogue 1 (Fig. 3.1). In agreement with this 
observation, binding of ligand 1 protects both loop sites G32-G34 and C30 from 
digestion with RNase T1 and with RNAse A, respectively (Fig. 3.2). However, 
digestion at G21 site is enhanced at high ligand concentration, suggesting that the 
A-form helical structure is disrupted between G21 and A22 (Fig. 3.2B).  
 
A       B 
 
                 
 
Fig. 3.1 (A) Superposition of the base region of a C-H correlation for the HIV-2 TAR-RNA free 
(black) and in complex with the aminoglycoside analogue 1 (red). The acquisition dimensions 
were 128 points (C) and 2048 points (H); each spectrum was acquired for a total of 5 hours on a 
600 MHz Bruker AVANCE spectrometer. The most significant chemical shifts changes upon 
binding of the TAR-RNA to 1 are observed either for the base or for the ribose C and H 
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resonances of A22, U23, G26, G32, G34 and A35 (rendered in red in panel (B)). More modest 
chemical shift changes are observed for G21, U25, G28, C29, U31 G33, G36 and G43 (rendered in 
light blue in panel (B)). 
 
The intermolecular NOESY spectrum reveals intimate contacts of ligand 1 with 
A22, U23, U25 and A35. The atypical C8/H8 chemical shifts of A35 in the free 
TAR-RNA implies that the adenosine base is partially projected-out of the loop, 
thus occupying an optimal position for interacting with a ligand bound to the 
bulge on the side of the upper stem major groove. Large chemical shifts changes 
are observed upon titration of ligand 1 for the C2/H2 and C1’/H1’ resonances of 
A35. In particular, the linewidth of the A35-C2 decreases from 80 to 48 Hz at 900 
MHz, which suggests that in the free TAR this nucleotide assumes different 
conformations interchanging on a μs to ms time-scale, while in the complex the 
base occupies a well-defined position. Notable is the chemical shift change 
experienced by the base of G34, which varies the most upon formation of the 
complex without showing any direct contact to the ligand. This is indicative of a 
profound change in the electronic environment of G34 and possibly of the overall 
conformation of the loop, triggered by the interaction of A35 with the 
aminoglycoside analogue. The chemical shift change of the G34 C8/H8 is 
accompanied by a considerable decrease in the T2, indicating that G34, which is 
disordered in the free TAR and in the TAR/argininamide complex (Brodsky 
&Williamson, 1997; Aboulela et al., 1996), undergoes a slow (μs-ms time scale) 
conformational transition between two states in complex with 1. Considerable 
chemical shifts changes are observed also for the riboses of U31, G32 and G33. 
Clearly, the binding of the aminoglycoside analogue to A35 triggers a profound 
conformational change in the hexanucleotide loop, which moves from a 
completely disordered state to a partially ordered one.  
In the bulge, the largest chemical shift changes are observed for A22 and U23. 
U23 stacks on A22 in the free TAR-RNA (Aboulela et al., 1996), while in this 
complex it is involved in several contacts with the aminoglycoside analogue 1. 
The A22-U40 base pair, which is stably formed at low temperature in the HIV-2 
TAR-RNA, is disrupted in the complex, as confirmed by the failure to observe the 
U40 imino resonance even at 4 °C.  However, several NOEs indicate that both 
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A22 and U40 remain positioned between G21 and G26 and C39 and C41 
respectively. 
A35 is the only loop residue that directly contacts the ligand, suggesting that the 
interaction of 1 with the loop must be part of a more complex network of 
interactions holding the complex together. A cooperative binding of 1 to both the 
loop and the bulge of the TAR-RNA is supported by the chemical shift data, 
which indicate a Kd of comparable size for both the bulge and the loop sites. 
Moreover, while 1 inhibits the binding of Tat-derived peptides to the TAR-RNA, 
linear analogues of 1, or smaller cyclic analogues, do not show any biological 
activity (Kirschning et al., 2004), underlining the importance of a cyclic 
constrained structure of appropriate size for a cooperative binding to the bulge and 
loop regions of the RNA. Therefore, it is safe to conclude that one molecule of 
ligand 1 binds simultaneously to the loop and the bulge of the RNA.  
 




Fig. 3.2 (A) RNase protection analysis of the TAR/1 complex. The HIV-2 TAR-RNA (10 µM, 5' 
32P labeled) was digested with RNase A (selective for C and U) at 4 ºC. The digestion 
experiments were analyzed by gel electrophoresis. Lane 1, control without RNase; lane 2, 
compound 1 (10 mM); lane 3, compound 1 (5 mM); lane 4, compound 1 (500 μM); lane 5, 
compound 1 (1.2 μM); lane 6, compound 1 (0.12 μM). (B) The TAR-RNA (10 µM, 5' 32P 
labeled) was digested with RNase T1 (G selective) at 4 ºC. The digestion experiments were 
analyzed by gel electrophoresis. lane 2, compound 1 (10 mM); lane 3, compound 1 (5 mM); lane 
4, compound 1 (500 μM); lane 5, compound 1 (1.2 μM); lane 6, compound 1 (0.12 μM).  
 
Besides the bulge and the loop regions, a second binding site for the 
aminoglycoside analogue is identified on the TAR-RNA. A medium chemical 
shift change for the G43-C1’ upon titration of 1, together with NOEs between the 
aminoglycoside analogue 1 and both the G43-H1’ and the G44-H4’ reveal the 
additional binding of 1 to the minor groove of the RNA lower stem. This finding 
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is not surprising, as structural studies of the TAR/neomycin B complex (Faber et 
al., 2000) previously identified the lower stem minor groove as a binding site for 
positively charged aminoglycosides.  
Compound 1 can be produced with 15N and 13C labeling at reasonable cost. In the 
course of this study we produced a 15N-labeled batch of compound 1 (Jaunzems et 
al. 2004) with the aim of verifying the existence of H-bonds between the amino 
groups of the aminoglycoside analogue and the RNA phosphates by detection of 
15N-31P scalar couplings mediated by H-bonds. Unfortunately, no such coupling 
could be observed for the degenerate amino group. 
Quite surprisingly, the longitudinal relaxation rates R1 of the base carbons of the 
TAR-RNA decreased in complex with 1 by about 40%. This decrease cannot be 
explained by invoking dynamics, as it affects also the carbons of the stem bases, 
whose structure remains unchanged. Instead, the relaxation rates might indicate a 
change in the overall correlation time of the TAR-RNA. 
A few dipolar couplings measured at 800 MHz for the bases C-Hs assume values 
between -5 and -6 Hz. These figures exceed by far those expected for the TAR-
RNA aligned in the magnetic field due to the magnetic susceptibility anisotropy of 
the bases (Zhang et al., 2003). The largest dipolar coupling tensor is expected for 
coaxial stacking of the upper and lower stems and would correspond in a 800 
MHz field to a Dzz of 8 Hz and a rhombicity R between 0 and 0.1. For this tensor 
the largest base C-H dipolar coupling should not exceed –4 Hz. The high values 
found for the TAR/1 complex suggest that the RNA dimerizes in the presence of 
the ligand (Al-Hashimi et al., 2001). The dipolar couplings of the two stems can 
be best fitted assuming a Dzz of 7 Hz and a rhombicity of 0.55. The interstem 
angle resulting from the fitting of the dipolar couplings assuming Dzz = 7 Hz and 
R = 0.55 is around 60º. The experimentally determined dipolar coupling tensor 
fits well that predicted for a dimeric TAR-RNA, where the upper and lower stem 
of each unit form an angle of 60º and the two units are associated with two stems 
approximately parallel to each other and the other two stems pointing in opposite 
directions. 
The 3D 13C-edited / 12C-filtered HSQC-NOESY spectrum in D2O and the 3D 13C-
edited/12C/14N-filtered HSQC-NOESY in H2O acquired for a sample containing 
150 μM 13C/15N labelled RNA,150 μM unlabelled RNA and 3 mM ligand showed 
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no intermolecular NOEs between the two TAR-RNA molecules. This finding 
indicates that an aminoglycoside molecule mediates the dimerization of two TAR 
molecules and that no direct contact between the two RNA molecules is present in 
the dimer. The presence of only one set of resonances for the RNA further 
suggests that the complex is symmetric. 
 
 
Fig. 3.3 The function (D-DF)/(DB-DF) is plotted versus the concentration of the aminoglycoside 
analogue 1 in each lane of the PACE gel. D is the retardation distance in each lane, DF is the 
retardation distance of the TAR without 1 and DB is the retardation distance of the TAR-RNA 
completely bound to 1 (concentration of 1 = 500 μM). Six different cases were considered: a) one 
molecule of the TAR-RNA binds one molecule of 1 (yellow line); b) one molecule of the TAR-
RNA binds two molecules of 1 with the same Kd (green line); c) two molecules of the RNA bind 
one molecule of 1 (magenta); d) one molecule of the TAR-RNA binds two molecules of 1 with 
different Kds (blue line) e) one molecule of the TAR-RNA binds one molecule of 1 
( TAR + 1 Kd1← → ⎯  C1); subsequently the TAR/1 complex dimerizes ( 2 C1 Kd 2← → ⎯  C2 ) (close 
to the yellow line, not shown); f) two molecules of the RNA bind one molecule of 1 
( 2 TAR + 1 Kd1← → ⎯  C1); subsequently two molecules of 1 are recruited by the dimer for a total 
of two RNA molecules and three molecules of 1 ( C1 + 2 1 Kd 2← → ⎯  C2 ) (red line; Kd1 ≈ 20 μM2; 
Kd2 ≈ 3 mM2). The best fit is obtained for case f), which confirms the dimer stechiometry inferred 
from the NMR data. 
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The dipolar couplings define the relative orientation of the two RNA units. 
However, it remains to be defined if the two RNA molecules associate through the 
aminoglycoside molecule bound to the upper stem major groove site or to the 
lower stem minor groove site. Structure calculations were conducted for both 
cases: association through the molecule of 1 bound to the upper stem site resulted 
in high energy due to severe distortion of the aminoglycoside and large NOE 
violations. Therefore, dimerization through the molecule of 1 bound to the lower 
stem minor groove is exclusively compatible with the NOE data. 
PACE gel electrophoresis (Cilley & Williamson, 1997) was used to verify the 
stechiometry of the complex. As shown in Fig. 3.3, the PACE data could be 
poorly fitted assuming monomeric RNA (a-c) or formation of a dimer with one or 
two molecules of 1 (d-e). Instead, a good fitting of the retardation distances was 
obtained assuming a dimerization step including two RNA molecules and one 
molecule of 1, followed by subsequent recruitment of two additional molecules of 
the aminoglycoside (red curve, case f)), which confirmed the dimer geometry 
inferred from the NMR data.  
Structure calculations, including NOEs, dihedral angle restraints and dipolar 
couplings, were first conducted on a monomeric unit containing one TAR and one 
ligand molecule binding to the upper stem. This procedure allowed us to define 
both the binding site in the upper stem major groove, where the most profound 
contacts between the RNA and ligand 1 are situated, and the relative orientation of 
the two helices. Subsequently, a molecule of the aminoglycoside analogue 1 is 
docked in the minor groove of the lower stem of two TAR-RNA molecules, which 
were predisposed in the correct orientation to reproduce the experimentally 
derived dipolar coupling tensor. 
 
.3.2 Structure calculations  
 
The upper stem binding site. The final structure ensemble was obtained 
as explained in the Material and Methods section. Structure calculation employing 
NOEs and dihedral angle restraints exclusively, resulted in a well-defined RNA 
structure in both stems but in a poor definition of the relative orientation of the 
two stems (rmsd for the lower stem: 0.5 Å; rmsd for the upper stem = 0.8 Å). 
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Binding of the aminoglycoside analogue 1 to the upper stem major groove does 
not lead to the formation of the U23-A27-U38 base triple, as observed in the 
TAR/argininamide complex ( Brodsky & Williamson, 1997). The formation of the 
U23-A27-U38 base triple rigidifies the backbone at the bulge junction, triggering 
the coaxial stacking of the upper and lower stems. In the TAR/1 complex, instead, 
the relative orientation of the two stems around the flexible bulge is not defined 
by NOE data alone. 
Structure refinement with C-H field-induced dipolar couplings (fi-RDCs) for the 
bases and the riboses of the upper and lower stem positioned the two stems at a 
relative angle of ca. 60° and indicated association of two TAR/1 units with two 
stems of the two RNA molecules in a parallel orientation and the other two stems 
diverging from each other. 
The 14 lowest energy structures are shown in Fig. 3.4. These structures had total 
energy < -300 kcal/mol, no NOE violations > 0.5 Å and no angular violations > 
5Å. The RNA is very well defined with a total heavy atom rmsd (excluding the 
loop residues) of 0.92 Å. The base planes of the two stems form an angle of 60º. 
The A-form helix structure of the lower (nt. 16-21, 41-46) and upper (nt. 26-29, 
36-39) stems is conserved. The upper stem helix is, however, slightly distorted, 
with the α and γ angles varying from the A-form typical gauche – and gauche + 
conformations to the trans conformation for residues A27-C29 and C39. 
The aminoglycoside analogue 1 binds to the bulge and the loop residues on the 
major groove side of the upper stem (Fig. 3.4). Due to the four-fold symmetry of 
its resonances and the fast kinetics of complex dissociation, the structure of 1 in 
the complex cannot be determined. However, the salient features of the interaction 
between the aminoglycoside analogue 1 and the TAR-RNA are well defined and 
the rmsd of the whole complex excluding the loop residues 30-34 is 1.2 Å.  
The backbone of the 22-25 stretch “opens up” to allow for 1 to reach the major 
groove of the RNA upper stem (Fig. 3.4). The last base pair of the lower stem is 
disrupted, U40 stacks below C39; A22 stacks below G26 but tilts away from U40, 
to widen the major groove of the upper stem and make place for the ligand. Thus, 
in the TAR/1 complex A22 and U40 belong to the upper stem, while in the free 
TAR they stack on the top of the lower stem G21-C41 base pair. In agreement 
with the disruption of the A-form helix structure between G21 and A22, the 
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digestion of the TAR-RNA at the G21 site by RNase T1 increases upon titration 
of 1. The planarity of the G26-C39 base pair is slightly distorted, as indicated by 
the weakening of the G26 imino resonance upon complex formation. The π-
orbitals of the U23 and U25 bases entertain hydrophobic interaction with linker 5 
and sugar 2 and linker 3 of ligand 1, respectively (Fig. 3.5).  
 
A       B 
                                     
 
Fig. 3.4 (A) Superposition of the heavy atoms of 14 structures of the TAR/1 complex based upon 
residues 16-21, 26-29 and 36-46. Residues 30-35 and 23, 25 are not shown. The lower stem is 
colored in blue and the upper stem in green. A22 and U40 are highlighted in orange; the backbone 
of the bulge is in magenta. The backbone and the base stacking indicate that the upper and lower 
stems form an angle of about 60º. The aminoglycoside binding to the major groove of the HIV-2 
TAR-RNA upper stem is rendered in gray. (B) Same as in (A) after 180º rotation around the 
vertical axis. The ligand is not shown 
 
A35 stacks on the top of the sugar 1 moiety of the ligand and is involved in a π-
cation interaction with the positively charged amino group. This contact pulls A35 
out of the loop, causing G34 to move on the top of G36 in all structures. In 60% 
of the structures G34 stacks on the top of G36, while in the other 40% the two 
bases interact face to edge (Fig. 3.6). The presence of an equilibrium between two 
conformations is compatible with the large linewidth of the G34-C8, suggesting 
that the exchange between the face-to-face and face-to-edge orientations of G34 
and G36 occurs on a μs-ms timescale. 
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A            B 
               
 
Fig. 3.5 (A) View of the best energy structure of the family of Fig 3.4. The aminoglycoside 
analogue 1 in the atom coloring scheme is placed in the major groove of the upper stem of the 
HIV-2 TAR-RNA. A22 and U40, depicted in orange, clearly show that the hydrogen bonds 
between 22 and 40 are disrupted and that A22 tilts away from the major groove to accommodate 
the ligand. Besides A22 and G26, U23 in magenta, U25 in green and A35 in pink have direct 
contacts with the aminoglycoside analogue. The positively charged amino group of the ligand 
sugar 1 interacts with the π-orbital of the A35 base, the amino group of sugar 2 interacts 
electrostatically with the major groove face of G28 (yellow dashed lines), while the amino group 
of sugar 3 contacts the phosphate of A22 (yellow dashed line). G34, in yellow, stacks on the top of 
G36. The backbone of the loop is rendered in yellow. A similar intermolecular interaction pattern 
is observed also for the other structures of the family. (B) same as in A) after 90º rotation around 
the vertical axis.  
The ribose of G34 is in the C3’-endo pucker in all structures, in contrast to the 
free TAR where the G34 was found to assume the C2’-endo conformation 
(Brosky & Williamson, 1997) . Instead, the ribose sugar of G33 and A35 assume 
a well defined C2’-endo pucker. 
The positively charged amino groups of the four sugars of ligand 1 interact with 
various functional groups of the RNA (Fig. 3.5). The amino group of sugar 1 
(Scheme 1.1) is involved, as mentioned, in a π-cation interaction with A35 and in 
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long-range electrostatic interactions with the O2 of U25. The amino group of 
sugar 3 is directed towards the major groove carbonyls of the A27-U38 and G28-
C39 base pairs in all structures but two, while the amino group of sugar 5 is close 
to the phosphate backbone of A22 and/or to the O4 of U23.  Finally, no consistent 
contact is found for the amino group of sugar 7. These results are in agreement 
with the failure to detect H-bonding of the amino groups of ligand 1 to the 
phosphate backbone of the RNA by the JNP scalar coupling, as most of the 
electrostatic contacts of the amino groups of the ligand involve base functional 
groups rather than phosphates. 
 
A     B 
 
                 
 
Fig. 3.6 A35 interacts with the ligand and therefore moves out of the loop. As a consequence of 
this, G34 moves on the top of G36 of the upper stem. The two bases interact either face-to-face 
(A) or face-to-edge (B). The two conformations are likely to be in intermediate exchange (μs-ms 
time scale), as inferred from the linewidth of the G34-C8 
 
Definition of the second binding site and dimer geometry. Similarly to 
neomycin (Ferber et al., 2003), the aminoglycoside analogue 1 binds also to the 
minor groove of the lower stem of the TAR-RNA. The chemical shift change of 
the G43-C1’ is maximum at a 1:1 ratio of RNA:aminoglycoside, as opposed to the 
chemical shift changes in the bulge and loop region, which increase up to a 1:10 
ratio. Thus, the binding constant of 1 to the minor groove of the TAR-RNA is 
higher than that to the bulge and loop regions. This finding is confirmed by the 
analysis of the PACE data (see caption to Fig. 3.3).  
Having identified dimer formation through the aminoglycoside bound to the lower 
stem minor groove as the only one compatible with the NOE data, a molecule of 1 
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was docked to the minor groove of the lower stem of two TAR-RNA molecules 
with the help of the NOEs between 1 and the G43-H1’ and G44-H4’ protons. The 
two RNA molecules were pre-oriented such that the magnetic susceptibility tensor 
of the dimer well agrees with the experimentally determined one (Fig. 3.7).  
The aminoglycoside analogue 1 binds symmetrically to the minor groove of the 
lower stem of the two TAR-RNA units. One amino group enjoys electrostatic 
interactions with the negative spot created by the phosphate groups of G21, A22 
and U23, while another amino group closely contacts the 2’-hydroxyl of C45. 
Two sugars and the intervening linker of 1 penetrate the minor groove of each 
RNA molecule at the G43-C45 site (Fig. 3.7). 
 
 
Fig. 3.7 The TAR-RNA with one molecule of 1 bound to the upper stem major groove dimerizes 
through an aminoglycoside molecule bound to the lower stem minor groove. The two RNA 
molecules are oriented with the lower stems roughly parallel to each other (interhelical angle θ ≈ 
30°) and the upper stem diverging from each other. From the magnetic susceptibility tensor of the 
dimeric RNA a dipolar coupling tensor can be calculated, which fits well the experimentally 
determined one (Dzz = 6.8 Hz; R = 0.54).  The color-coding is the same as in Fig. 3.5, with the 











4.1 The structure of the TAR-RNA bound to the aminoglycoside.  
 
The upper stem binding site. The aminoglycoside analogue 1 binds to the 
TAR-RNA in the major groove of the upper stem and contacts extensively the 
bulge nucleotides 22-25 and A35 of the hexanucleotide loop. The bulge of the 
TAR-RNA has been identified as the major binding site for the Tat-protein and 
several studies have been targeted to find competitive inhibitors of the Tat/TAR 
interaction among ligands binding to the RNA bulge. The conformation induced 
by ligand 1 at the bulge site of the TAR-RNA, as well as the relative orientation 
of the two stems, differ from those found in the Tat/TAR complex. Binding of 1 
does not induce either the formation of the U23-A27-U38 base triple or the 
subsequent coaxial stacking of the upper and lower stem. Instead, the bulge 
nucleotides are all exposed to the solvent in the TAR/1 complex and the axes of 
the two stems form an angle of about 60º. The relative position of the two 
domains is probably a consequence of the disruption of the A22-U40 base pair, of 
the tilting of A22 to accommodate the large ligand and of the electrostatic 
interactions of the ligand amino group with the phosphate of A22. The sugars and 
the linkers of the ligand have extensive hydrophobic contacts with the U23 and 
U25 rings. Such hydrophobic contacts resemble a well-known interaction motif in 
complexes of proteins with oligosaccharides, where the sugars often stack below 
aromatic side-chains (Weis & Drickamer, 1996).  
The aminoglycoside analogue 1 represents a promising scaffold for the 
development of a new TAR-binders generation for two reasons: a) its cyclic, 
flexible structure presents functional groups that bind to multiple RNA sites; b) 
the ligand interacts with the A35 of the hexanucleotide loop, thereby rigidifying 
the loop structure in a way which might resemble that needed for the binding of 
CycT1 to the TAR-RNA. 
 148
It is widely recognized that the intermolecular surface in RNA/protein complex is 
rather large and therefore small molecules cannot efficiently compete with 
proteins for RNA binding. Despite many efforts in the search for a competitive 
inhibitor of the Tat/TAR interaction, no drug lead has been identified to date. The 
major difficulty in the development of TAR-binders in potential therapeutic 
agents is their low specificity. The problem might be alleviated by simultaneously 
targeting multiple binding sites on the TAR-RNA (Davis et al., 2004; Hermann & 
Westhof, 1999). Three “hot spots” for the binding of cations on the TAR-RNA 
have been recognized in the lower stem major groove, bulge and loop sites by 
molecular dynamics simulations ( Hermann & Westhof, 1999). In another study, 
an extended effort in identifying the minimal number of interactions necessary to 
stabilize the Tat-bound conformation of the TAR-RNA resulted in the detection of 
two binding sites for positively charged groups at the bulge site and in the upper 
stem major groove close to A27 and G28 ( Davis et al., 2004). Synthetic ligands 
exploiting both binding sites showed the highest activity and induced an RNA 
conformation similar to that binding to the Tat-protein ( Davis et al., 2004). The 
amino groups of ligand 1 contact both the bulge site and the major groove 
functional groups at the G28 site (Fig. 3.5). While the interaction with the bulge is 
suboptimal and could be improved by introducing a guanidinium group at the C1 
or C5 of sugar 5, the amino group of sugar 3 nicely interacts with the negatively 
charged spot at the G28 and U38 site (Fig. 3.5), in accord to what is predicted and 
observed by theoretical calculations and NMR for positively charged ligands 
(Davis et al., 2004). Additionally, the amino group of sugar 1 interacts with the 
loop residue 35. Thus, the large but flexible scaffold of 1 allows reaching multiple 
binding sites on the TAR-RNA, and therefore represents a valuable starting 
structure for the design of binders, which exploit all “hot spots” for cations 
identified in the TAR upper stem. 
The value of cyclic structures as a conformationally constrained backbone for 
TAR binders has been proven by the design of peptidomimetics based on a cyclic, 
β-hairpin like scaffold ( Leeper et al., 2005), binding the TAR-RNA with a much 
higher affinity than the linear analogues ( Athanassiou et al., 2004). The structure 
of the BIV (Bovine Immunodeficiency Virus) TAR-RNA bound to one of these 
peptidomimetics revealed extensive interactions with the upper stem major 
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groove, including a conserved hydrophobic contact of a Ile residue with the 
bulged-out U of the base triple and electrostatic contacts of arginine side-chains 
with the tetraloop capping the upper stem and with the second and third base pairs 
of the upper stem ( Leeper et al., 2005). Intermolecular contacts of similar nature 
are found for ligand 1 and the bulge, major groove base pairs and loop residues of 
the HIV-2 TAR-RNA. Analogously to the BIV TAR-RNA/peptide complex, 
ligand 1 uses hydrophobic contacts to bind the bulge pyrimidines and electrostatic 
contacts to bind to the major groove face of the upper stem base pairs and to the 
loop residues. As observed for the peptides, linear 
neooligoaminodeoxysaccharides show a much lower affinity for the TAR-RNA 
than their cyclic analogue 1 ( Kirschning et al., 2004).  
The formation of the Tat/TAR complex is required for the recruitment of the P-
TEFb complex and for the phosphorylation and subsequent activation of the RNA 
polymerase stalled at the TAR-RNA site. The P-TEFb complex consists of the 
kinase component CDK9 and the cyclin T1 subunit. The complex binds to the 
TAR-RNA through the CycT1 subunit in a Tat dependent manner. The interaction 
site of CycT1 with the TAR-RNA is localized in the apical loop and is facilitated 
by the binding of Tat to the bulge. The mechanism by which the Tat protein 
favors the interaction of CycT1 with the apical loop is not known, although it is 
reasonable to hypothesize that Tat structurally organizes the RNA for the binding 
of CycT1.  
The hexanucleotide apical loop has been found to be quite flexible in all NMR 
studies (Colvin et al., 1993; Jäger & Tinoco, 1993; Aboulela et al., 1995) with the 
riboses of C30, G33 and G34 averaging between the C2’ and a C3’ 
conformations. Base stacking of A35 on G36 and of G34 on G36 was found to be 
consistent with structural restraints derived by NMR for a 14- and a 19-
nucleotides hairpin containing the TAR hexanucleotide loop ( Colvin et al., 1993; 
Jäger & Tinoco, 1993). Indications of stacking on the 5’-site of the loop (C30 on 
C29 and U31 on C30) were less prominent than for the 3’-site. On the basis of 
such structural information, it was proposed that the apical loop is stabilized by 
base stacking on both sides and possibly by the formation of base pairs between 
C30 and A35+ or C30 and G34 (Jäger & Tinoco, 1993). In a more recent work, 
biochemical analysis of native and mutant TAR-RNAs was used together with 
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molecular dynamics simulation to show that the apical loop of the TAR-RNA is 
stabilized by a cross-loop base pair between C30 and G34, with A35 projected out 
of the loop ( Kulinski et al., 2003). This observation is not necessarily in contrast 
with the NMR studies hypothesizing the stacking of A35 on G36. The large line-
broadening of the A35-C2 resonance of the free TAR-RNA and the NOEs 
between the bases of G34, A35 and G36 are consistent with A35 being in a slow 
equilibrium between the stacked and looped-out conformations. 
Upon binding of the aminoglycoside analogue 1, the A35-C2 resonance shifts and 
the linewidth is reduced by a factor of 2. The equilibrium between the stacked and 
looped-out conformations is not present in the complex; instead, binding of the 
ligand stabilizes the looped-out conformation, where A35 can extensively interact 
with 1. As a consequence of that, the NOE contacts between the base of A35 and 
both G34 and G36 disappear while several NOEs appear between G34 and G36 
indicating that when A35 is looped-out, G34 moves on the top of G36. In this 
position G34 is in a favorable orientation for hydrogen bonding with C30; 
however, no evidence of the C30-G34 base pair could be found in the TAR/1 
complex. The ribose pucker of G34, which has been reported to be either C2’-
endo (Colvin et al., 1993) or a mixture of C2’- and C3’- endo (Jäger & Tinoco, 
1993) by NMR studies of free TAR, assumes the C3’-endo conformation in the 
complex. In agreement with our data, the C3’-endo pucker of the G34 ribose has 
been found to accompany the stacking of G34 upon G36 in molecular dynamics 
simulations ( Kulinski et al., 2003). By inspecting the linewidth of the G34-C8 
resonance in the TAR/1 complex we could detect the involvement of G34 in a 
conformational exchange process, taking place in the μs–ms timescale. This 
suggests that that G34, which undergoes rapid exchange among different 
conformations in the free TAR, is much more constrained in the TAR/1 complex. 
In agreement with the presence of a slow conformational exchange process, the 
NOE data are consistent with both a face-to-face (stacking) and a face-to edge 
interaction of G34 and G36. All in all, our data indicate that binding of a 
positively charged ligand of appropriate size to the bulge and the loop of the 
TAR-RNA on the major groove side of the upper stem leads to the stabilization of 
the looped-out conformation of A35 and consequently to the relocation of G34 on 
the top of G36. In the stacked conformation, the N7 and O6 functional groups of 
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G34 assume well-defined positions in the major groove and the formation of the 
C30-G34 base pair is possible. 
Comparison to the binding of CycT1 to the TAR loop. The cyclin T1 unit of 
the P-TEFb complex binds to the hexanucleotide loop of the TAR-RNA. The two 
functional groups O6 and N7 of G34 and G32 are essential for the interaction 
(Richter et al., 2002). Covariance studies showed that a base pair between the 
nucleotides at position 30 and 34 stabilizes the Tat/TAR/CycT1 complex but is 
not required for its formation (Richter et al., 2002). Additionally, the presence of 
a nucleotide in position 35 is necessary for the TAR/CycT1 interaction, but its 
nature is not critical (Richter et al., 2002). A small detrimental effect on the 
CycT1 binding is found only for the A35G mutant.  
On the basis of the structure of the complex of TAR with the aminoglycoside 
analogue 1, we propose an explanation for the dependence of the TAR/CycT1 
interaction on the Tat/TAR complex formation, which fits well the biochemical 
data summarized above. We suggest that the binding of Tat to TAR pre-organizes 
the hexanucleotide loop in a favorable conformation for CycT1 binding. It is 
conceivable that the arginine-rich stretch of the Tat protein, which is responsible 
for TAR binding at the bulge site, also contacts the A35 residue of the 
hexanucleotide loop and blocks it in its looped-out conformation, in a similar way 
as our aminoglycoside. The major driving force for this contact could be the 
interaction of an aromatic π orbital with a cation, similarly to that observed for the 
TAR/1 complex. A generic π-cation interaction provides a rationale for the 
insensitivity of the TAR/CycT1 interaction to the nature of the nucleotide in 
position 35. A small negative effect on complex formation is observed exclusively 
for the A35G mutant, where a possible cross-loop C30-G35 base pair would 
destabilize the looped-out conformation of the nucleotide in position 35. In 
agreement with our hypothesis, affinity cleaving experiments show that F38 of 
Tat is located in proximity of the nucleotides 34 and 35 of the TAR-RNA (Huq & 
Rana, 1997). Furthermore, residue K50 of the Tat-protein has been found to cross-
link with the TAR nucleotide 34, and this interaction is considerably enhanced by 
the binding of CycT1 to the Tat/TAR complex (Richter et al., 2002a). 
In the TAR/1 complex, the looped-out conformation of A35 is accompanied by 
the relocation of G34 upon G36. Analogously, in the Tat/TAR complex stacking 
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of G34 upon G36 would place the O6 and N7 functional groups of G34, which are 
essential for the binding of CycT1, in a well-defined position in the major groove 
of the TAR-RNA. The formation of a base pair between C30 and G34 would 
further stabilize the position of the G34 functional groups. In fact, such base pair 
has been shown to favor the interaction of the TAR- RNA with CycT1 without 
being directly involved in complex formation (Richter et al., 2002). 
Based on the irrelevance of the nucleotide nature at position 35, it has been 
hypothesized that this nucleotide functions as a spacer with no direct contact to 
the proteins. Contrarily, we suggest that A35 is a key regulatory element in the 
interaction of the TAR-RNA with the CycT1 and Tat-protein. Upon binding of a 
cofactor to the major groove of the upper stem, A35 is pulled out of the loop, G34 
moves upon G36 and the dynamics of the loop is restricted. Thus, A35 could be 
the basis of a regulation mechanism for the formation of the Tat/TAR/CycT1 
complex based on the conformational stability of the hexanucleotide loop.   
The lower stem binding site and dimerization. The aminoglycoside analogue 1 
binds to the minor groove of the lower stem of the TAR-RNA. Similar to 
neomycin B (Ferber et al., 2003), the aminoglycoside analogue contacts the 43-44 
site. However, only two sugar rings of 1 bind to the lower stem minor groove of 
one RNA molecule, leaving the other two sugar rings free for binding to an 
additional RNA molecule and leading to dimerization. This process is likely to be 
entropy-driven and favored by the constrained cyclic structure of 1. 
Significance for drug design. The design of drug leads targeting the TAR-RNA 
has almost exclusively focused on the inhibition of the Tat/TAR interaction at the 
bulge site. However, the TAR/1 complex structure suggests that a cyclic scaffold 
can be used to design ligands, which extensively bind to the entire upper stem 
major groove of the TAR-RNA up to the capping loop. An NOE between a 
compound binding to TAR in a Tat-similar manner and the A35-H8, which was 
identified in a previous study (Davis et al., 2004), confirms that the interaction 
with A35 is a general feature of large ligands binding to the major groove of the 
TAR-RNA. The cyclic scaffold of ligand 1 can be utilized in the design of TAR 
binders, which capture A35 in the looped-out conformation, induce the relocation 
of G34 on the top of G36 and are decorated with appropriate functional groups to 
compete with CycT1 for the G34 functional groups. Large ligands interfering with 
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both the Tat/TAR and the Tat/TAR/CycT1 complex formation and contacting the 
TAR-RNA at several “hot spots” could represent an improved class of drug leads 





Novel methodology to determine the conformation of the 
2’-hydroxyl group in RNA  
 
5.1 The conformation of the 2’-OH group in RNA.  
 
The 2‘-OH hydroxyl group is a major determinant for both the structure 
and the function of RNA, where the sugars are all riboses. The presence of the 
ribose 2'-OH hydroxyl group in RNA engenders a preference for the C3’-endo 
puckering, thereby providing the decisive factor for the differences in 
conformation, hydration and thermodynamic stability between canonical RNA 
and DNA helices (Gyi et al., 1998). A high resolution crystal structure of an RNA 
duplex  (Egli et al., 1996) revealed the existence of a complex hydration network 
in the minor groove of the A-form helix, which is supported by the specific 
distribution of the 2'-hydroxyl groups. The presence of water molecules in the 
RNA minor groove, anchored by electrostatic interactions to both the ribose and 
the base, provides an enthalpic contribution to A-form helix stability and, 
additionally, offers a basis for the entropic regulation of ligand binding to the 
minor groove. Non-canonical RNA structural elements, such as tetraloops and 
pseudoknots, can be stabilized by H-bonds involving the 2’-hydroxyl group as 
well (Williams et al., 2001; Nixon et al., 2002; Theimer et al., 2005). Moreover, 
the 2’-hydroxyl group is an established player in RNA catalysis. Numerous 
examples of the role of the 2’-hydroxyl group in catalytic RNAs are documented 
for self-splicing viral ribozymes, type II introns and the pre-mRNA processing 
machinery (Gesteland & Chech, 1998; Eckstein & Lilley, 1996; Doherty & 
Doudna, 2000) 
Despite the importance of the 2’-hydroxyl group in RNA structure stabilization 
and function, only limited structural data is available for the 2’-OH proton of 
RNA (Giedroc et al., 2003; Conte et al., 1996; Lynch et al., 1996; Gyi et al., 
1998). Protons are not directly observable in crystal structures; in aqueous 
solution the rapid exchange of the hydroxyl proton with the solvent typically 
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prevents its observation for RNA at room temperature by NMR. Consequently, in 
the absence of structural information on the 2’-OH proton, the torsion angle θ 
(H2’-C2’-O2’-OH) remains undetermined. Molecular dynamics (MD) simulations 
of an RNA hairpin identified three energetically preferred orientations that the 2′-
hydroxyl proton can assume if a ribose sugar adopts the C3′-endo pucker, as is the 
case in canonical RNA A-form helix (Auffinger, & Westhof, 1997) (Fig. 5.1): (A) 
toward the O3′, stabilized by attractive electrostatic interaction with the phosphate 
backbone (O3’ domain), (B) toward the O4′, stabilized by favorable intra-ribose 
electrostatic interactions (O4’ domain), and (C) toward the base, stabilized by 
electrostatic interaction with the N3 or O2 atom of the attached base (base 
domain). 
 
Fig. 5.1 Energetically favored orientations of the 2'-hydroxyl group when the ribose is in the C3'-
endo conformation. The ribose sugar ring is schematically shown in the middle with oxygen atoms 
in grey and carbon atoms in black. According to MD simulations (Auffinger, & Westhof, 1997), 
the torsion angle θ (H2'-C2'-O2'-OH) can populate three regions, highlighted in grey: the O3' 
domain, torsion angle θ = 50°-140°; the O4' domain, torsion angle θ = 175°-230°; the base 
domain, torsion angle θ = 270°-345°. 
 
Experimental determination of the 2’-hydroxyl proton location in RNA structures 
is essential to verify the role of the 2’-hydroxyl group in the stabilization of RNA 
folding motifs. Here, we carried out the nearly complete assignment of 2'-OH 
proton resonances of the HIV-2 TAR-RNA and the conformational analysis of the 
torsion angle H2’-C2’-O2’-OH based on NOE data and on the measurement of the 
three scalar couplings between the 2’-OH proton and the H2’, C2’ or C3’ ribose 
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nuclei (3JH2’,2’OH, 3JC1’,2’OH and 3JC3’,2’OH). To the best of our knowledge, this work 
represents the first assignment and conformational analysis of the 2’-hydroxyl 
group in a medium sized RNA; all previous conformational studies on the H2’-
C2’-O2’-OH torsion angle via scalar couplings were conducted on single 
nucleotides in DMSO (Acharya & Chattopadhyaya, 2002). The NMR techniques 
presented here provide a uniformly applicable way to study the orientation of the 
2’-OH group in RNA in solution, thereby allowing association of the 2’-hydroxyl 
group conformation with specific RNA functions such as RNA catalysis. 
 
5.1.1 The question we ask. 
In this work we wish to answer the following questions: 
1. Is it possible to assign the 2’-OH protons in a medium sized RNA? 
2. Can we observe NOEs between the 2’-OH protons and ribose or base protons at 
low temperature? 
3. What are the preferred conformation around the C2’-O2’ bond in helical and 
non-helical structural regions? 
4. Do the conformational preferences of the H2’-C2’-O2’-OH torsion angle 
support the involvment of the 2’-OH proton in a network of H-bonds spanning the 
minor groove and involving water molecules, which was proposed to stabilize 
RNA A-form conformation (Egli et al., 1996)?  
In order to answer these questions we performed a detailed conformational 
analysis around the H2’-C2’-O2’-OH torsion angle for the 30mer HIV-2 TAR-
RNA. To this purpose we developed new NMR experiments aimed to measure the 
three 3J couplings (3JH2’,2’OH, 3JC1’,2’OH and 3JC3’,2’OH), which define the H2’-C2’-
O2’-OH torsion angle. 
 
5.2 The experiments 
 
5.2.1 The assignment of the 2’-OH protons 
The resonance assignments were obtained using two-dimensional 
homonuclear TOCSY (Cavanagh & Rance, 1992) and NOESY (Lippens et al., 
1995) experiments performed at 600 MHz. All experiments were conducted at 
5ºC to slow down solvent exchange. The exchange rate constant of the 2'-OH 
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protons with bulk water is approximately 15 Hz under these conditions, as 
estimated from the intensity of the exchange cross-peaks in the NOESY spectrum. 
This value is in good agreement with the value reported by Gyi et al. (Gyi et al., 
1998)  for an RNA and an RNA-DNA duplex. The TOCSY experiment (Fig. 
5.2B) shows intense correlations connecting the 2'-OH and the scalar coupled H2' 
protons. In qualitative agreement with vicinal 3JH2’,2’OH couplings measured for 
isolated nucleotides in DMSO (Acharya & Chattopadhyaya, 2002), the through-
bond 2'-OH–H2' crosspeaks are intense, reflecting 3JH2’,2’OH couplings greater than 
2 Hz. The NOESY spectrum (Fig. 5.2C) reveals several through-space NOE 
correlations of medium intensity between the H1' and the 2'-OH protons. 
Additional crosspeaks in the region ω2 = 5.1-5.9 ppm and ω1 = 6.8-7.1 ppm stem 
from NOE correlations between cytidine amino and aromatic H5 protons, as 
confirmed using a 15N-labeled RNA sample. NOE correlations between 2'-OH 
hydroxyl and other ribose protons are difficult to analyze due to extensive 
resonance overlap. 
 
Fig. 5.2. A) Sequence and secondary structural representation of HIV-2 TAR-RNA. Assigned 2'-
OH protons are highlighted, tentatively assigned residues A20 and G44 are shown orange. B) 
Expansion of the 2'-OH–H2' region of the TOCSY experiment. Unambiguous assignments are 
given with one-letter code followed by the residue number. The clean DIPSI-2rc (Cavanagh 
&Rance, 1992) mixing sequence was applied for τm=43 ms, using a γB1/2π=10.04 kHz field 
strength. C) Expansion of the 2'-OH–H1' region of the water flip-back NOESY experiment 
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(Lippens et al., 1995). The mixing time was τm=50 ms. Water suppression was achieved with 
excitation sculpting (Hwang & Shaka, 1995). The 1H Carrier position was 4.98 ppm. High power 
proton pulses were applied with a field strength of 35.5 kHz. 368 complex points were recorded 
with an acquisition time of 28.3 ms for 1H (ω1), and 2048 complex points with an acquisition time 
of 157.5 ms for 1H (ω2). A recycle delay of 1.2s between transients was used, with 64 scans 
accumulated per complex increment (total measuring time 17.5 h each). Both spectra were 
recorded on a four-channel Varian Inova 600 MHz spectrometer equipped with an actively 
shielded z-gradient triple-resonance probe, at a temperature of 278 K. Spectra were processed and 
analyzed using FELIX 2000 (MSI, San Diego, USA) and NMRPipe program packages. Spectra 
were recorded on 2 mM unlabeled HIV-2 TAR-RNA The sample buffer contained 10 mM 
phosphate buffer, pH 6.4, 50 mM sodium chloride and 0.1 mM EDTA in 500μl 90% H2O/10% 
D2O. 
 
5.2.2 Novel NMR experiments for the measurement of the 3J couplings 
involving the 2’-OH proton. 
The homonuclear and heteronuclear 3JH2’,2’OH, 3JC1’,2’OH and 3JC3’,2’OH  scalar 
couplings of the HIV-2 TAR-RNA have been measured in specifically tailored 
two-dimensional NMR experiments using the quantitative J approach (Vuister & 
Bax, 1993). Briefly, the 3JH2’,2’OH couplings were measured in a H2’-Hbase NOESY 
correlation experiment (Fig. 5.3A and 5.4). We chose this correlation for its 
highly efficient NOESY transfer and decent resolution. It should be mentioned 
that this experiment benefited from the use of a 0.7 mM HIV-2 TAR-RNA sample 
consisting of d4-nucleotides lacking all but H1' and H2' ribose protons (Scott et 
al., 2000). This specific deuteration pattern allows for selective detection of the 
H2’-Hbase NOEs with high sensitivity, while circumventing overlap with other 
Hribose-Hbase NOEs. If such a selectively deuterated sample is not available, a 
three-dimensional 13C-edited NOESY correlation is necessary to achieve the 
desired resolution of the H2’-Hbase peaks. In the cross experiment, we employed a 
constant time of 40 ms, during which the H2’ proton magnetization is transversal 
and subjected to J-dephasing effects, which results in measurable attenuation of 
the observed H2’-Hbase cross peaks. In the reference experiment, the evolution of 
the vicinal 3JH2’,2’OH coupling is refocused by use of a REBURP pulse of duration 
4 ms centered at 4.16 ppm. This pulse selectively refocuses the H2’ protons at a 
proton resonance frequency of 800 MHz, without affecting the 2’-OH and the H1’ 
resonances (excitation bandwidth: ± 550 Hz; transition region: 250 Hz). In 
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contrast, the 3JH2’,2’OH coupling is active during the cross experiment by 
simultaneous application of the H2’ REBURP pulse and of a 4 ms IBURP pulse 
centered in the 2’-OH region at 6.97 ppm in the center of the constant time period. 
The IBURP pulse selectively inverts the 2’-OH protons leaving the resonances of 
the H1’ protons unaffected at a 800 MHz field (excitation bandwidth: ± 550 Hz; 




Fig. 5.3 A) Pulse sequence for the quantitative J-CT-NOESY employed for the measurement of 
the 3JH2’,2’OH couplings. In the reference experiment the selective pulse on the 2’-OH is applied in 
position A, in the cross experiment it is applied in position B. The carrier positions for 13C and 1H 
were at 85.0 ppm and 5.1 ppm respectively. The selective 2’-OH IBURP1 pulse (Geen & Freeman, 
1991) of duration 4 ms was applied with a field strength of 250 Hz and centered at 6.97 ppm. The 
second IBURP1 pulse at the end of the evolution time compensates for Bloch-Siegert-shifts. The 
selective H2’ REBURP (Geen & Freeman, 1991) pulse of duration 4 ms was applied with a field 
strength of 250 Hz and centered at 4.15 ppm. Sine shaped pulsed field gradients were applied for 
1.0 ms with relative peak amplitudes (in %): G1 = 30%, G2 = 30%, G3 = 40%, G4 = 50%, G5 = 
50%, where 100% corresponds to 50 G/cm. Phasecycling: φ1 = x, -x; φ2 = 2(x), 2(-x), 2(y), 2(-y); 
φrec = 2(x, -x), 2(-x, x). Quadrature detection in the t1 dimension was achieved by altering φ1 
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according to STATES-TPPI (Marion et al., 1989) Water suppression was achieved using the 
Watergate-sequence for the last 180°-pulse (Piotto et al. 1992). The experiments were carried out 
in 90% H2O, 10% D2O on a Bruker 800MHz DRX spectrometer equipped with a 5 mm triple 
resonance (1H,13C-15N-TXI) probe with a shielded z-axis gradient. B) Pulse sequence for the 
quantitative J-CT-HSQC employed for the measurement of the 3JC1’/C3’,2’OH couplings. In the cross 
experiment the 2’-OH band-selective pulse is applied in position A, in the reference experiment in 
position B. The carrier position for 13C was at 90.0 ppm for the C1’-H1’ correlation and at 73 ppm 
for the C3’-H3’ correlation, while the proton carrier was centered at 5.1 ppm. The selective 2’-OH 
IBURP1 of duration 4 ms was applied with a field strength of 250 Hz and centered at 7.3 ppm. 
Sine shaped pulsed field gradients were applied for 1.0 ms with relative peak amplitudes (in %): 
G1 = 50, G2 = -25%, where 100% corresponds to 50 G/cm. Phasecycling: φ1 = 2(x), 2(-x); φ2 = 
8(x), 8(-x); φ3 = x, -x; φ4 = 2(y), 2(-y); φ5 = 4(x), 4(-x); φ6 = 4(x), 4(-x); φ7 = 8(x), 8(-x); φ8 = 2(y), 
2(-y); φrec = 2(x, -x), 2(-x, x). Quadrature detection in the t1 dimension was achieved by altering φ3 
according to STATES-TPPI. The experiments were carried out in 90% H2O, 10% D2O on a Bruker 
800MHz DRX spectrometer equipped with a 5 mm triple resonance (1H,13C-15N-TXI) probe with a 





Fig. 5.4. Spectra were recorded on 0.6 mM 3', 4', 5', 5''-d4-HIV-2 TAR-RNA, where all ribose 
protons but the H1’ and H2’ were replaced by deuterons. The sample buffer contained 10 mM 
phosphate buffer, pH 6.4, 50 mM sodium chloride, and 0.1 mM EDTA in 500 μL of 90% 
H2O/10% D2O. The spectra were recorded on a Bruker 800MHz spectrometer equipped with a z-
gradient triple-resonance probe, processed with the NMRPipe program and analyzed using FELIX 
2000 (MSI, San Diego, USA). Cross experiment of the H2’(i)-H6/8(i+1) NOESY correlation for 
the measurement of the 3JH2’,2’OH couplings. In the cross experiment, we employed a constant time 
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delay of 40 ms, during which the H2′ proton magnetization is transversal and subjected to J-
dephasing effects, which results in measurable attenuation of the observed H2′-Hbase cross peaks. 
In the reference experiment, the evolution of the vicinal 3JH2’,2′OH coupling is refocused by use of a 
REBURP pulse of duration 4 ms centered at 4.16 ppm. In contrast, the 3JH2′-2′OH coupling is active 
during the cross experiment by simultaneous application of the H2′ REBURP pulse and of a 4 ms 





Fig. 5.5 Expansion of the cross spectrum of the C1′-H1′ CT-HSQC for the measurement of the 
heteronuclear 3JC1’,2’OH. Evolution of the 3JC1’,2′OH  scalar couplings during the constant time of the 
cross experiment was achieved by simultaneous application of a carbon pulse and a 4ms IBURP 
pulse centered in the 2′-OH region at 7.3 ppm. A constant time period of 25 ms was used to 
achieve optimal sensitivity and resolution. 
 
The 3JC1’,2’OH and 3JC3’,2’OH scalar couplings were measured in constant-time C1’-
H1’ and C3’-H3’ HSQC correlations, respectively (Fig. 5.3B, 5.5 and 5.6). Here, 
evolution of the 3JC1’-2’OH and 3JC3’-2’OH scalar couplings during the constant time of 
the cross experiment was achieved by simultaneous application of a carbon pulse 
and a 4ms IBURP pulse centered in the 2’-OH region at 7.3 ppm. A constant time 
period of 25 ms was used to achieve optimal sensitivity and resolution for both the 
C1’-H1’ and the C3’-H3’ correlations. The J-coupling constants were extracted 
from the intensity ratio of peaks in the cross and reference experiments, according 
to Eq. 5.1 (Vuister & Bax, 1993):  




= cos(πJT)                                            (Eq. 5.1) 
 
where T is the length of the constant time period. It should be noted that the 
effective J-evolution periods employed in the calculations are compensated for the 
evolution of the couplings during the IBURP pulses, which resulted in constant 
times of 34.76 ms, 22.05 ms, 22.05 ms for the three 3JH2’,2’OH, 3JC1’,2’OH and 
3JC3’,2’OH scalar couplings, respectively. 
 
A    B 
 
Fig. 5.6 Expansions of the cross and reference spectra of the CT-HSQC for the measurement of 
the heteronuclear 3JC3’,2’OH  couplings. The constant time T delay was 25 ms (A cross, B reference 
spectrum for the C3'-H3' correlation). Spectra shown in A) and B) were recorded on 1.0 mM 1', 2', 
3', 4', 5'-13C5-1', 2'-d2-HIV-2 TAR-RNA where ribose protons H1’ and H2’ are replaced by 
deuterons, thereby reducing potential overlap problems for 13C2'-H2' and 13C3'-H3' cross peaks. 
The sample buffer contained 10 mM phosphate buffer, pH 6.4, 50 mM sodium chloride, and 0.1 
mM EDTA in 500 μL of 90% H2O/10% D2O. The spectra were recorded on a Bruker 800MHz 
spectrometer equipped with a z-gradient triple-resonance probe, processed with the NMRPipe 









5.3.1 The assignment of the 2’-OH protons. 
We could unambiguously assign 20 out of 30 2'-OH hydroxyl protons of 
the HIV-2 TAR-RNA (Fig. 5.2 and Table 5.1). Five of the 10 missing 2'-OH 
hydroxyl protons belong to the loop nucleotides 30-35, where 2'-OH protons are 
probably not participating in a stable network of hydrogen bonds. As a 
consequence, the exchange rate of those 2'-OH protons with water is fast, 
impeding their detection even at 5 ºC. We could not observe the 2'-OH protons of 
the two nucleotides constituting the terminal, fraying base pair for similar reasons. 
Three additional 2'-hydroxyl protons in the lower stem could not be identified 
unambiguously due to resonance overlap (A20 and G43 are tentatively assigned, 
see Table 5.1). Our attempts to assign these resonances from a 13C-edited NOESY 
acquired using a more dilute, 13C/15N-labeled TAR-RNA sample (0.7 mM) failed 
because of vanishing NOE intensities. To the best of our knowledge, this 
represents the first nearly complete assignment of 2'-OH proton resonances of an 
RNA molecule. 
 
Table 5.1. Assignment of the 2’-OH Resonances of the HIV2 TAR-RNAa 
   Nt. # C.S. [ppm]    Nt. # 
C.S. 
[ppm]    Nt. # 
C.S. 
[ppm] 
G16   n.a.  A27 6.76 C37 6,84 
G17 6.93 G28 7,07 U38 6,81 
C18 6,80 C29 6,84 C39 6,91 
C19 6,63 C30 n.a.   U40 6,94 
A20 6.96b U31 6,84 C41 6,75 
G21 6.99 G32   n.a.   U42 6,82 
A22 n.a.   G33  n.a.  G43 6.79b 
U23 6,80 G34   n.a.   G44 6,89 
U25 6,93 A35   n.a.   C45 6,84 
G26 6,78 G36 6,89 C46  n.a.  
 
a C.S. stands for chemical shift, Nt. for nucleotide and n.a. for not assigned. The columns 
containing the nucleotides numbers are in bold. b The assignments are only temptative.  
 
With the exception of C19 and G28 (Fig. 5.2), the chemical shift dispersion of the 
2'-OH hydroxyl protons is rather limited with resonance frequencies clustering 
between 6.75 and 7.00 ppm, which is in good agreement with chemical shift 
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ranges reported previously (Gyi et al., 1998; Lynch et al., 1996; Acharya & 
Chattopadhyaya, 2002)  
NOE correlations between the 2'-OH and aromatic H6 or H8 protons of the 
following nucleotide could be observed for 13 of the assigned 2'-OH hydroxyl 
protons (G17, C18, C19, U23, G26, G28, G36, C37, C39, U40, U42, G44, C45) 
(Fig. 5.7). 
Molecular dynamic (MD) simulations of an RNA hairpin show that the 
conformation of the 2'-OH group depends on the sugar pucker (Auffinger & 
Westhof, 1997). Three orientations are accessible to the 2'-OH hydroxyl group 
when the ribose is in the typical RNA C3'-endo conformation (Fig. 5.1): A) 
towards the O3' stabilized by attractive electrostatic interaction with the phosphate 
backbone, B) towards the O4' stabilized by favorable intra-ribose electrostatic 
interactions, and C) towards the base stabilized by electrostatic interaction with 
the N3 or O2 atom of the attached base. The 3JH2’,2’OH coupling can adopt values 
higher than 4 Hz in all three domains, so that the detection of a 2'-OH-H2' 
crosspeak in TOCSY spectra is not indicative of a specific domain (Fraser et al., 
1969). 
 
Fig. 5.7 Expansions of the water flip-back NOESY experiment (τm=50 ms), recorded on a four-
channel Varian Inova 600 MHz spectrometer equipped with an actively shielded z-gradient triple-
resonance probe, at a temperature of 278 K. The sample was the same as in Fig. 5.2. All regions 
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are plotted using the same contour levels and multipliers. Unambiguous assignments are given 
with oneletter code followed by the residue number. A) 2'-OH(i)–H2',3',4',5',5''(i) region (red 
contours) overlaid with the same region of the 2'-OH(i)–H2'(i) TOCSY (DIPSI-2rc mixing 
sequence, τm=43 ms) experiment (blue contours). B) 2'-OH(i)–H1'(i) region. C) 2'-OH(i)-
H6(pyrimidine),H8(purine)(i+1) region.  
 
5.3.2 The 3J couplings involving the 2’-OH proton. 
The 3JH2′,2′OH couplings measured for the HIV-2 TAR-RNA at 5°C are 
shown in Fig. 5.8A. In general, the 3JH2′,2′OH couplings cluster between 3 and 4.5 
Hz and, except for C18, no value exceeds 5.5 Hz. Chemical exchange of the 2′-
OH proton with the solvent can potentially reduce apparent 3JH2′,2′OH coupling 
values. We determined the exchange rate constant kex of the 2′-OH protons with 
bulk water for C19 from the intensity of the exchange cross-peak in NOESY 
spectra at 1, 5 and 10°C. The measured kex value for C19 of approximately 15 Hz 
at 5°C is in good agreement with the value reported by Gyi et al. for an RNA and 
an RNA-DNA duplex (Gyi et al., 1998) Unfortunately, severe overlap of the 
remaining 2′OH proton resonances impeded the accurate determination of the kex 
values for the other nucleotides.  
When a substantially larger kex = 25 Hz is assumed, the apparent 3JH2′,2′OH 
coupling measured over a 40-ms long constant time is approximately 85% of the 
actual 3JH2′,2′OH coupling. For the majority of nucleotides, however, this 15% 
tolerance would be well within the limits of the experimental error. Thus, for kex 
up to 25 Hz, we could consider the effective J-coupling scaling factor from 
solvent exchange to be negligible. 
The stability of RNA structures can locally fluctuate. Consequently, in order to 
locate secondary structural elements within the TAR-RNA structure (Fig. 5.2A), 
where 3JH2′,2′OH couplings are considerably influenced by solvent exchange, we 
carefully compared the 3JH2′,2′OH couplings values obtained at 5 and 1°C. 
Substantial differences in the 3JH2′,2′OH couplings at 5 and 1°C are expected for 
nucleotides with kex > 1/T (T being the length of the constant time period). No 
significant modulation is expected for nucleotides with kex ≤ 1/T.  
The results from this comparison are striking. The 3JH2′,2′OH coupling values of 
canonical Watson-Crick C-G or G-C base pairs of the lower stem remain the same 
at 5 and 1°C within experimental error. Coupling values of nucleotides A20, U40, 
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and U42, of all nucleotides located in the shorter upper stem, and of the loop 
nucleotide C30 experience increases ranging from 30 to 50% when the 
temperature is decreased from 5 to 1°C. Surprisingly, the 3JH2′,2′OH couplings of 
bulged nucleotides U23 and U25 do not change as a function of temperature.  This 
clearly indicates that the kex rate of these nucleotides is similar to the kex rate of 
canonical CG base pairs.  
Taken together, our results strongly suggest a correlation between 2′-OH proton 
solvent exchange rates kex and base-pair opening rates (probed by imino proton 
exchange) in canonical A-form helical structures. The exchange process of H-
bonded imino protons with solvent can be qualitatively explained on the basis of a 
two-state model involving open and closed states of Watson-Crick pairs. If it 
assumed that the closed A-form geometry is stabilized by an ordered series of 
hydrogen-bonds involving the ribose 2′-hydroxyl group, the functional groups 
within the bases, and water molecules bound in the minor groove, we speculate 
that the transient opening of the base pair favors the exchange of bound water 
with the bulk solvent, thereby directly influencing the kex rate of the 2′-OH proton. 
Imino protons can only exchange with bulk water from transiently opened 
conformations through acid-base reactions catalyzed by proton acceptors; they are 
protected when engaged in a closed base pair (Gueron & Leroy, 1995; Snoussi & 
Leroy, 2001). Base pair opening events can occur via two pathways as revealed 
by MD simulations (Pan & MacKerell, 2003; Giudice, E. & Lavery, 2003). Both 
major and minor groove opening is feasible with the major groove pathway being 
energetically slightly more favorable. Our hypothesis of correlated imino and 2′-
OH proton exchange is supported by the fact that the base-pair lifetimes of RNA 
A-U base pairs in the A-form helix geometry are substantially shorter than those 
of G-C base pairs (Gueron & Leroy, 1995; Snoussi & Leroy, 2001). Subsequently, 
only the cytidines and guanosines of the lower stem and the two bulged uridines 
were further considered in the quantitative evaluation of the 3JH2′,2′OH, 3JC1′,2′OH and 
3JC3′,2′OH scalar couplings. 
A Karplus curve showing the dependence of the 3JH2′,2′OH on the intervening 
torsion angle H2′-C2′-O2′-OH is shown in Fig. 5.8D (blue line) (Fraser et al., 
1969). The upper limit of 5.5 Hz observed for the nucleotides of the lower stem 
excludes the possibility that any of these 2′-OH hydroxyl groups occupy the O4′ 
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domain. This observation indicates that the 2′-OH is not involved in intra-ribose 
2′-OH···O4′ electrostatic interactions, but rather contacts either the base (2′-OH 
conformation in the base domain) or the phosphate backbone (O3′ domain). The 
absence of 2′-OH protons in the O4′ domain in canonical A-form helical structure 
of the lower stem in the TAR-RNA is consistent with our semi-quantitative 
analysis of detectable NOE cross peaks in a short mixing time 2D NOESY 
experiment (τm=50 ms). Even at 1°C, only the 3JH2′,2′OH of residue C30 reaches 7 
Hz, while larger values (> 8 Hz) of the 3JH2′,2′OH, associated with a significant 




Fig. 5.8. A) 3JH2′,2′OH couplings measured at 5°C employing the quantitative-J H2′i-H6/8i+1 CT-
NOESY experiment. The dotted line indicates 3JH2′,2′OH = 5.0 Hz B) 3JC1′,2′OH couplings obtained at 
5°C using the quantitative-J C1′i-H1′ CT-HSQC experiment. C) 3JC3′,2′OH couplings obtained at 5°C 
from the quantitative-J C3′i-H1CT-HSQC experiment. Apical hexaloop nucleotides are shaded in 
grey. D) Karplus-like dependence of the homonuclear 3JH2′,2′OH coupling (blue line) on the torsion 
angle θ (H2′-C2′-O2′-H) according to Fraser et al., 1969. No Karplus parameterization is available 
for the heteronuclear 3JC1′,2′OH and the 3JC3′,2′OH couplings. The red and green lines for the 3JC1′,2′OH 
and the 3JC3′,2′OH couplings, respectively, represent approximated Karplus curves derived by scaling 
the coefficients of the 3JC,H Karplus-relation in alkenes (3JC,H = 3.6 cos2φ -1.0 cosφ + 4.3) to reflect 
the averaged value of the 3JC,OH coupling in ethanol (2.9 Hz) (Kalinoswki et al., 1988) We assume 
equal populations of the trans, gauche+ and gauche– conformations for ethanol. Neither the 
 168
difference in the substituents of the C1′ and C3′ nuclei nor the fact that these nuclei are part of a 
conformational restricted ring system are considered in this approximation; therefore the Karplus-
relations for the 3JC1′,2′OH or the 3JC3′,2′OH couplings represent crude approximations. Boxed yellow 
areas correspond to the energetically favored orientational domains (O3', O4', and Base, 
respectively) of the 2'-hydroxyl group, according to Auffinger & Westhof, 1997. The pale yellow 
delimit the regions of these domains where the 3JH2′,2′OH coupling is less than 5.0 Hz. 
 
The heteronuclear 3JC1′,2′OH couplings proved to be difficult to measure due to the 
limited resolution of the C1′-H1′ correlation in canonical A-form geometry (Fig. 
5.8B). Moreover, 8 out of 29 carbons (G26, A27, U31, G32, G33, G34, A35 and 
G36) are not observed at 5°C, which can be attributed to interconverting C2′-endo 
and C3′-endo sugar puckers. Those nucleotides are located predominantly in the 
apical hexanucleotide loop and assume averaged 3JH1′-H2′ coupling values at 
elevated temperatures (25°C), indicative of fast exchange between C2′-endo and 
C3′-endo sugar puckers. With the exception of residue U23, all measurable 
heteronuclear 3JC1′,2′OH couplings are smaller than 4 Hz with nucleotides in the 
lower stem exhibiting particularly small values (3JC1′,2′OH ≤ 3 Hz). Due to their 
small size, the achievable precision for the 3JC1′,2′OH coupling measurements is 
limited, as evident from inspecting the relatively high error bars. 
Similarly, resonance overlap and the absolute coupling size affect the 
measurement of the heteronuclear 3JC3′,2′OH couplings (Fig. 5.8C) using the C3′-
H3′ correlation. The observed 3JC3′,2′OH couplings are on an average larger than the 
corresponding 3JC1′,2′OH couplings. Again, the smallest values are observed for the 
nucleotides in the lower stem. Interestingly, the C3′-H3′ cross peaks of the apical 
hexaloop nucleotides do not disappear due to the conformational exchange of the 
ribose but considerably decrease in intensity. Therefore, the loop nucleotide 
3JC3′,2′OH couplings are characterized by large errors and are not reported here. 
Unfortunately, no Karplus parameterization is available for either one of the 
heteronuclear J-couplings, 3JC1′,2′OH or 3JC3′,2′OH. However, an approximated 
Karplus curve for the 3JC1′,2′OH and the 3JC3′,2′OH coupling can be obtained (Fig. 
5.8D, red and green lines) by scaling the coefficients for 3JC,H couplings in alkenes 
(3JC-H = 3.6 cos2φ -1.0 cosφ + 4.3) such that they are consistent with the averaged 
value of the 3JC,OH coupling observed in ethanol (2.9 Hz) (Kalinowski et al., 
1988). Evidently, neither the difference in the substituents of the C1′ and C3′ 
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nuclei nor the fact that these nuclei are part of a conformationally restricted ribose 
ring is considered in this crude estimate; therefore, this approximated Karplus 
relation as shown in Fig. 5.8D should not be used to quantitatively interpret the 
3JC1′,2′OH or the 3JC3′,2′OH couplings. A qualitative inspection of the approximated 
Karplus curves nevertheless permits us to assume that 3JC1′,2′OH < 3JC3′,2′OH in the 
base domain and in the region of the O3′ domain where θ > 90° , whereas 3JC3′,2′OH 
< 3JC1′,2′OH in the region of the O3′ domain with θ < 90°. 
Subsequently, we performed a detailed conformational analysis of the θ (H2′-C2′-
O2′-OH) torsion angle for the cytidines and guanosines located in the lower stem 
of the TAR-RNA and of bulged uridines using a combination of three 3JH2′,2′OH, 
3JC1′,2′OH and 3JC3′,2′OH scalar couplings and the NOE data. The nucleotides located 
in the upper stem and the AU base pairs of the lower stem were not included in 
the analysis because the aforementioned rapid exchange of the 2′-OH with the 
solvent renders those J-coupling values meaningless. The nucleotides of the 
hexanucleotide loop were not considered either due to the apparent intermediate 
conformational exchange between the C2′-endo and the C3′-endo pucker of the 
ribose.  
Our conformational analysis is based on the following criteria:  
• Quantitative interpretation of the homonuclear 3JH2′,2′OH scalar coupling 
according to the available Karplus parametrization (Fraser et al., 1969).  
• Semi-quantitative interpretation of the relative magnitude of the 
heteronuclear 3JC1′,2′OH and 3JC3′,2′OH scalar couplings. 
• Existence of the 2′-OH(i)-H6/H8(i+1) NOE cross peak which is strongest 
for the 2′-OH proton in the base domain or in a small region of the O3′ domain 
(θ ≈ 60°).  
For example, residue G17 shows a weak 2′-OH(i)-H6/H8(i+1) NOE cross peak,  
which taken together with the value of the 3JH2′-2′OH coupling, permits the 
intervening torsion angle θ to be either θ ≈ 45° or θ ≈ 315°; a final comparison of 
the 3JC1′-2′OH and 3JC3′-2′OH scalar coupling magnitudes allows to discriminate 
between the two alternative solutions and rotates the torsion angle θ of G17 into 




Fig. 5.9. A) Summary of the conformational preferences of the H2′-C2′-O2′-OH torsion angle θ of 
the cytidines and guanosines of the lower stem and bulged uridines of the HIV-2 TAR-RNA. Both 
the base and the O3′ domain are populated in an alternating manner, the bulged uridines show a 
clear preference for the O3′ domain. Not a single H2′-C2′-O2′-OH torsion angle in the O4′ domain 
was observed. The boxed four closing basepairs of the lower stem are shown in B). B) Network of 
water molecules bridging the nucleotides C18 and C45 in the minor groove of the lower stem of 
the HIV-2 TAR-RNA, modeled in an ideal A-form helix. Functionally important groups are 
colored: C18 and C45 base nitrogens are shown in blue; O2 base, O3′ backbone, and ribose O2′ 
oxygens are shown in red; lone pairs of water, O2 base, and ribose O2′ oxygens are colored 
yellow. One water molecule is situated in the base plane of C18, where it participates in an H-bond 
as proton donor with the O2 of the base and in an H-bond as proton acceptor with the 2′-OH 
(conformation in the O3′ domain). The second water molecules is located in the plane of C45, 
where it participates as proton donor in an H-bond with the O2 of the base and in an H-bond with 
the 2′-OH (conformation in the base domain). 
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A schematic representation of the results obtained from this analysis for the 
nucleotides of the lower stem of the TAR-RNA is shown in Fig. 5.9A. The 
conformation of the 2′-OH groups of G17 and C45 is found in the base domain, as 
indicated by the presence of the 2′-OH(i)-H6/H8(i+1) NOE and by the relatively 
small value of the 3JC1′,2′OH coupling. The 2′-OH groups of C18, U23, and G44 
adopt an orientation within the O3′ domain with the torsion angle θ ≈ 60°, 
corroborated by the presence of the 2′-OH(i)-H6/H8(i+1) NOE, the high value of 
the 3JC1′,2′OH coupling, and/or the small 3JC3′,2′OH coupling. G21, U25, C41 and G43 
project the 2′-OH group towards the O3′-oxygen with θ ≈ 120°, as indicated by 
the absence of the 2′-OH(i)-H6/H8(i+1) NOE, a small value of the 3JC1′,2′OH 
coupling, and/or a large value of the 3JC3′,2′OH coupling. Finally, the conformation 
of the 2′-OH proton of C19 can only be restricted by the presence of the 2′-OH(i)-
H6/H8(i+1) NOE because both heteronuclear 3JC1′,2′OH and 3JC3′,2′OH couplings 
could not be measured reliably for this nucleotide. In summary, our analysis 
reveals that the H2′-C2′-O2′-OH torsion angles of the canonical A-form lower 
stem nucleotides of the TAR-RNA populate both the base and the O3′ domain, 





It has been commonly accepted that the 2'-OH hydroxyl points towards the 
phosphate backbone, and away from the ribose H1' proton. This picture has been 
supported by MD simulation of an RNA hairpin (Singh & Kollman, 1996) which 
provided evidence for a strongly preferred orientation towards the O3', and by the 
NMR data available to date (Conte et al., 1996), where only very weak 2'-OH-H1' 
NOE crosspeaks could be detected. However, more recent MD simulations 
describe three energetically favored orientations for the 2'-OH hydroxyl proton 
(Auffinger & Westhof, 1997). The 2'-OH-H1' NOEs of medium intensity 
observed for the HIV-2 TAR-RNA contradict the paradigm that the 2'-OH 
hydroxyl typically points away from the ribose H1' proton. The presence of many 
detectable NOE correlations involving aromatic H6/H8(i+1) protons suggest that 
the orientation towards the base is more common than currently appreciated.  
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A network of water-mediated hydrogen bonds anchored by the 2′-hydroxyl group 
has been proposed to stabilize the A-form RNA duplex (Egli et al., 1996). The 
results of our conformational study on the H2’-C2’-O2’-OH torsion angle, based 
on both NOEs and scalar coupling data, are in excellent agreement with this 
model. The 2′-hydroxyl group in the base domain donates an H-bond to a water 
molecule in the base plane, while the 2′-hydroxyl group projecting towards the 
O3′ oxygen can accept an H-bond from a water molecule in the same base plane 
(Fig. 5.9B). In contrast, if the 2′-OH group adopted a conformation within the O4′ 
domain, the lone pair electrons of the O2′ oxygen would occupy an unfavorable 
orientation for their participation in an H-bonding network involving water 
molecules located in the base plane. Consequently, the 2′-OH groups in the 
canonical A-form lower stem of the TAR-RNA never project into the O4′ domain. 
Furthermore, we observe an alternating pattern of θ torsion angles in the base and 
in the O3′ domain for 3′- and 5′-strand nucleotides in consecutive Watson-Crick 
G-C base pair steps (5′-nucleotides 17-19 and 3′-nucleotides 43-45, respectively). 
Despite the limited statistical significance of this observation, such an alternating 
pattern with the H2′-C2′-O2′-OH torsion angle adopting base and O3′ domain 
conformations is required to fully support the network of hydrogen bonds 
described in the crystal structures of the RNA duplex (Egli et al., 1996). In the 
crystal, the two water molecules spanning the minor groove share an H-bond with 
each other and function as H-bond donors to the functional N3/O2 groups within 
the base moiety. To complete an uninterrupted chain of H-bonds in the minor 
groove, one of the two water molecules must accept and one must donate an H-
bond to the 2′-hydroxyl groups of nucleotides of opposite strands in consecutive 
base pair steps (Fig. 5.9B). The 2′-hydroxyl group can function as an H-bond 
donor to a water molecule in the base plane when θ is in the base domain and, 
conversely, is able to accept a proton from the same water molecule when θ is in 
the O3′ domain. The ideal network of H-bond spanning the minor groove, 
postulated on the base of the crystal structure of an RNA duplex, therefore 
requires that the H2′-C2′-O2′-OH torsion angles of two nucleotides belonging to 
opposite strands in base pair steps assume alternating base and O3′ domain 
conformations. 
 173
Interestingly, the solvent exchange rates of the 2′-OH protons of the bulge 
nucleotides U23 and U25 are similar to those of the cytidines and guanosines in 
the lower stem. The scalar coupling data for the 2′-hydroxyls of U23 and U25 can 
be interpreted assuming a single conformation where the proton points towards 
the phosphate backbone in the O3′ domain. The TAR-RNA bulge region is 
intimately involved in ligand binding events. The bulged nucleotides, which are 
relatively flexible in the free TAR-RNA, assume a well-defined, rigid 
conformation upon argininamide or magnesium binding (Zacharias. & Hagerman, 
1995; Brodsky & Williamson, 1997; Pitt et al., 2004). The NMR experiments 
described here were conducted in absence of any ligands and thus may indicate 
pre-organized local conformation of the riboses of U23 and U25. It should be 
noted that the phosphate between U23 and A22 located at the junction of the 
bulge and lower stem is important for Tat binding in the major groove of TAR 
(Hamy et al., 1993). Further studies that address the role of the 2′-hydroxyl group 
of uridines U23 and U25 in the specific recognition of positively charged ligands 
are ongoing. 
In conclusion, the results obtained in this study are in good agreement with both 
molecular dynamics calculations (Auffinger & Westhof, 1997) and X-ray studies 
(Egli et al., 1996) and confirm the fundamental role of the 2′-hydroxyl group in 
building a network of hydrogen bonds in the minor groove, which stabilizes the 
preferred canonical A-form geometry of RNA. These data have important 
implications for the future understanding of high-affinity recognition and 
discrimination of A-form like geometries over canonical B-form or other helices 
in RNA-protein complexes. The methodology and experiments developed here are 
of general relevance to structural studies of RNAs and allow for an accurate 
determination of the location of the 2′-hydroxyl proton, which will help elucidate 





In this work we have studied the principle of molecular recognition by NMR in 
three complexes: a) the protein tubulin in complex with the microtubules 
stabilizing agent epothilone; b) the small peptidic toxin κM-conotoxin RIIIK, 
derived from the sea snail Conus radiatus, in complex with K+ channels; c) the 
30mer HIV TAR-RNA in complex with an aminoglycoside derivative. The first 
two complexes are too large to obtain detailed structure information by classical 
NMR methods. Additionally the protein receptors (tubulin and TSha1 K+ channel) 
are not available by recombinant techniques with the 13C, 15N and 2D labelling 
scheme necessary to conduct multidimentional NMR experiments on the protein. 
Therefore, novel NMR methodologies and a combined approach using 
computational, biological and NMR-derived structural data were developed to 
access the desired structure. These studies prove that the size limit of 50 kDa, 
usually posed to solution NMR, can be successfully overcome. Structural 
information can be obtained for complexes as large as 1 MDa 
(tubulin/epothilone), if we wish to answer specific questions about intermolecular 
recognition rather than to reveal the structure of the whole complex. The 
techniques developed in this study, inluding transferred cross-correlated 
relaxation rates and the INPHARMA approach (Interligand NOE for 
PHARmacophore MApping) are of general applicability to ligand/target 
complexes with a Kd in the micromolar range and are expected to have a 
significant impact in the process of structure-based drug design. 
The structural information gained in the three projects sheds a new light on the 
intermolecular interaction governing the biological function in the three systems. 
During this work we determined the bound conformation and the binding mode of 
the potent anticancer drug epothilone to tubulin in aqueous solution by tr-NOEs, 
tr-CCR rates and by the INPHARMA approach. On the basis of our structural 
model we proposed a mechanism for the microtubules stabilizing activity of the 
drug based on the fine regulation of the position of the H7 helix. The EpoA – 
tubulin complex structure explains well the epothilone structure-activity data both 
for native and mutant tubulins, provides a rationale for the highest activity of 
EpoB with respect to EpoA and supports the existence of a common 
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pharmacophore for epothilone and paclitaxel. The structure presented here differs 
from the EC-derived structure of EpoA bound to tubulin in Zn-stabilized sheets, 
which significantly contradicts all NMR-derived structural data. This discrepancy 
suggests that the binding mode of EpoA to tubulin depends on the tubulin 
polymerization state. While tubulin polymerized in Zn-stabilized sheets is an 
artificial system, the soluble protein is a physiologically relevant state in the 
tubulin cell cycle. Therefore, the pharmacophore of epothilone bound to soluble 
tubulin is highly relevant for the structure-based design of improved anticancer 
drugs.  
The structural model of the peptidic toxin κM-conotoxin RIIIK in complex with 
the TSha1 K+ channel reveals a novel pharmacophore, where no positively 
charged side chain occludes the channel pore. We have proven that κM-RIIIK 
does not possess the functional dyad constituted by a positively charged and an 
hydrophobic side-chain, which had been proposed to be the minimal functional 
element for the binding of peptidic toxins to K+ channels. Instead, the positive 
charged residues of the toxin form a basic ring: κM-RIIIK is anchored to the K+ 
channel via electrostatic interactions of this basic ring with the loop and pore helix 
residues of the channel. The electrostatic complementarity between this ring and 
the channel side chains is likely to be responsible for the selectivity of κM-RIIIK 
towards the TSha1 channel. The role of the positive charged side chain that in 
many peptide – ion channel complexes occludes the channel pore, is partially 
exerted by O15, whose side chain, however, is too short to penetrate the pore. 
This novel, experimentally-based pharmacophore model proves the existence of 
diverse binding modes of peptidic toxins to K+ channels and underlines the role of 
intermolecular electrostatic interactions involving channel loop side chains in 
determining the selectivity of toxins for specific K+ channel types. The binding 
mode of κM-RIIIK to the TSha1 channel closely resembles that of μ-conotoxin 
GIIIA to the NaV1.4 Na+ channel. O15 of κM-RIIIK occupies the homologous 
position of R13 of μ-GIIIA, which is known to occlude the Na+ channel pore. 
Both peptides contain a basic ring, although the form and the charge density at the 
surface differs. This observation demonstrates that the two conotoxins have 
developed a similar scaffold and binding geometry to their respective targets, 
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while the pharmacological selectivity is determined by the exact charge 
distribution and three-dimensional shape. 
The three-dimensional structure of the TAR-RNA in complex with a novel 
macrocyclic aminoglycoside analogue reveals interaction of the ligand with the 
bulge, the upper stem major groove and the loop of the TAR-RNA. This is the 
first example of a positively charged ligand contacting the capping loop of the 
TAR-RNA. In particular the aminoglycoside analogue binds to the A35 residue of 
the hexanucleotide loop, thereby inducing a partial structuring of the loop. The 
correct replication of the HIV virus requires the binding of the TAR-RNA to both 
the Tat-protein and the P-TEFb complex. The role of the TAR-RNA loop in 
interacting with the Tat-protein and the P-TEFb complex has been demonstrated 
by many biological data; however no defined structure could be identified for the 
loop of the TAR-RNA either alone or in complex with cofactors.  Our structural 
study identifies for the first time well-defined structural features induced in the 
capping loop of the TAR-RNA by binding to the aminoglycoside analogue. 
Biological data indicate that the subunit CycT1 of the P-TEFb complex binds to 
the loop of the TAR-RNA in a Tat dependent manner. We suggest that the 
conformational change observed in the loop of the TAR-RNA upon binding of the 
aminoglycoside analogue resembles the restructuring of the loop required for 
CycT1 binding and that this restructuring is induced by Tat. On the basis of the 
structural information obtained in this study, we believe that the amino glycoside 
analogue holds promises to be used  as a scaffold for the design of a new 
generation of TAR binders, which  can target several binding sites in the bulge, 
major groove and loop of the TAR-RNA and inhibit both the Tat/TAR and 
Tat/TAR/CycT1 complex formation.  
In conclusion, in this work we have provided new valuable methodology to 
investigate the principles of intermolecular interactions in large complexes in 
solution and could reveal the mechanisms of intermolecular recognition in three 
biological systems. The structural and biological information gained in this work 
represent a conspicuous progress in our understanding of intermolecular 
interactions, while the developed methodology provides us with new instruments 
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